NEAR INFRA-RED DYES BASED ON p-EXTENDED BODIPYS by NI YONG
 NEAR INFRA-RED DYES BASED ON π-EXTENDED 
BODIPYs 
NI YONG 
(B.S. ZheJiang University) 
A THESIS SUBMITTED FOR THE DEGREE OF 
DOCTOR OF PHILOSOPHY 
DEPARTMENT OF CHEMISTRY 





It’s my great pleasure to express my sincerest gratitude to many people 
for their kindly support and encouragement during my Ph.D. period. First of 
all, I wish to give my deepest appreciation to my supervisor Prof Wu Jishan, 
for his unreserved guidance and continuous inspiration. His wide academic 
knowledge, constructive criticisms and insightful comments have provided a 
fundamental and significant basis for the present thesis. Moreover, although 
we always jokingly call him a ‘boss’, he is definitely a valuable mentor both in 
my future career and life. I still remember the words he said when I was 
struggling for my project ‘You need to be patient, keep thinking alternatives, 
and you will make it finally’ and the words he used to encourage me whenever 
I made a tiny breakthrough ‘Now you have open new gate for something 
interesting, keep going and you can do many things meaningful’. I could not 
have listed enough of the inspirations and supports from Prof. Wu, and I could 
not imagine having a better supervisor and mentor for my PhD study. Sincere 
thanks also go to Prof. Chi Chunyan for her enlightening suggestions and kind 
help over the years. 
Next, I am truly grateful to all the past/current lab-mates and 
collaborators in both Prof Wu’s and Dr. Chi’s groups: Dr. Lintao Zeng, Dr. Kai 
Zhang, Dr. Baomin Zhao, Dr. Yuan Li, Dr. Ding Luo, Dr. Hemi Qu, Dr. 
Chongjun Jiao, Dr. Jing Cao, Dr. Soumyajit Das, Dr. Fei Gao, Dr. Jinling Li, 
Dr. Suvankar Dasgupta, Dr. Jie Luo, Dr. Zebing Zeng, Dr. Chenhua Tong, Dr. 
Jinjun Shao, Dr. Zhe Sun, Dr. Qun Ye, Dr. Lu Mao, Tianyu Lan, Wangdong 
Zeng, Zhou Sha, Gaole Dai, Jingjing Chang, Zhiming Kam, Yonghao Lim, 
Xueliang Shi, Pan Hu, Qingbiao Qi, Yuhong Sun, Minghui Chua, Fang Miao. I 
really appreciate the time working with them and the experience they shared 
with me, our friendship will last all through the lifetime. 
Furthermore, I would like to thank all our collaborators including Prof 
II 
 
Huang Kuo-wei, Prof Chang Young-Tae, Prof Dongho Kim, Dr. Qing Wang 
and so on. Without their professional support, the accomplishment of this 
thesis would not have been possible. 
In addition, I would like to thank the National University of Singapore 
for admitting me as a Ph. D student and NUS Environmental Research 
Institute, SPORE for providing me the scholarship.  Moreover, I have greatly 
benefited from many staffs from chemistry department administrative office, 
the NMR laboratory and the Mass laboratory. 
Last but not least, I would like to express thanks to my loved ones, my 
parents Dangsheng Ni and Xiuying Zou, my elder brother Min Ni and my 
sister in-law Honghua Li. Their unconditional love and support are the motive 




























I hereby declare that this thesis is my original work and it has been written by 
me in its entirety, under the supervision of Prof Wu Jishan, (in the laboratory 
Organic Electronics & Supermolecular Chemistry), Chemistry Department, 
National University of Singapore, between 2010 and 2014.  
I have duly acknowledged all the sources of information which have been used 
in the thesis. 
This thesis has also not been submitted for any degree in any university 
previously. 
The content of the thesis has been partly published in:  
1. Y. Ni, W. Zeng, K. Huang and J. Wu, “Benzene-fused BODIPYs: synthesis and the 
impact of fusion mode”, Chem. Commun. 2013, 49, 1217. 
2. Y. Ni, J. Wu, “Far-red and near infrared BODIPY dyes: synthesis and applications 
for fluorescent pH probes and bio-imaging”, Org. Biomol. Chem. 2014, 12, 3774. 
3. Y. Ni, L. Zeng, N. Kang, K. Huang, L. Wang, Z. Zeng, Y. Chang] and J. Wu, 
“meso-Ester and Carboxylic Acid Substituted BODIPYs with Far-Red and 
Near-Infrared Emission for Bioimaging Applications”, Chem. Eur. J. 2014, 20, 2301. 
 
     NI YONG      









Table of Contents 
Acknowledgements .......................................................................................... I 
Declaration..................................................................................................... III 
Summary ..................................................................................................... VIII 
Chapter 1: Introduction .................................................................................. 1 
1.1 Overview on BODIPYs…………………………………………………………... 2 
1.1.1 Fundamental Chemistry of BODIPYs ......................................................... 2 
1.1.2 Basic procedures to synthesize BODIPYs ................................................... 3 
1.2 Strategies toward BODIPY-based far-red and NIR dyes………………………… 6 
1.2.1 α, β and meso- Substituted BODIPYs .......................................................... 7 
1.2.1.1 α-Aryl substituted BODIPYs .................................................................... 7 
1.2.1.2 Alkenyl and alkynyl substituted BODIPYs and related structures ......... 11 
1.2.2 Fusion of aromatic units at the [a] bond, [b] bond and the “zig-zag” edge 15 
1.2.2.1 Aromatic units [a]-fused BODIPYs ........................................................ 15 
1.2.2.2 Aromatic units [b]- fused BODIPYs ....................................................... 18 
1.2.2.3 BODIPYs with fusion at the “zig-zag” edge........................................... 21 
1.2.2.4 Benzo-[a] or [b]-fused bis-BODIPY structures ...................................... 22 
1.3 Applications of NIR BODIPY dyes…………………………………………….. 27 
1.3.1 For Dye Sensitized Solar Cells (DSSCs) ................................................... 27 
1.3.2 For Bio-imaging Applications ................................................................... 29 
1.3.2.1 In vivo imaging for metal ions ................................................................ 29 
1.3.2.2 Bio-imaging for small molecules ............................................................ 31 




Chapter 2: Naphthalene and Anthracence Fused BODIPYs: Synthesis and 
Impacts of the Electronic Structures on the Intramolecular Cyclization 
and Intermolecular Coupling........................................................................ 45 
2.1 Introduction………………………………………………………………………45 
2.2 Results and discussion…………………………………………………………... 51 
2.2.1 Synthesis .................................................................................................... 51 
2.2.2 Photophysical and electrochemical properties ........................................... 55 
2.2.2.1 Photophysical and electrochemical properties of anthracene-substitued 
and fused BODIPYs ............................................................................................ 55 
2.2.2.2 Photophysical and electrochemical properties of naphthalene-substituted 
and fused BODIPYs ............................................................................................ 59 
2.3 Conclusion………………………………………………………………………. 63 
2.4 Experimental Section……………………………………………………………. 65 
2.4.1 General Experimental Methods ................................................................. 65 
2.4.2 Material Synthesis and Characterization Data ........................................... 66 
Appendix.…………………………………………………………………………….73 
Reference…………………………………………………………………………… 85 
Chapter 3: Benzene-fused BODIPYs: Synthesis and the Impact of Fusion 
Mode ................................................................................................................ 88 
3.1 Introduction………………………………………………………………………88 
3.2 Results and discussion…………………………………………………………... 90 
3.2.1 Synthesis .................................................................................................... 90 
3.2.2 Photophysical properties ............................................................................ 92 
3.2.3 Electrochemical properties ......................................................................... 93 
3.2.4 TD-DFT calculations and electronic Structures ......................................... 95 
3.3 Conclusion………………………………………………………………………. 97 
3.4 Experimental Section……………………………………………………………. 98 
3.4.1 General Experimental Methods ................................................................. 98 





Chapter 4: meso-Ester and Carboxylic Acid Substituted BODIPYs with 
Far-red and Near-Infrared Emission for Bio-imaging Applications ...... 111 
4.1 Introduction……………………………………………………………………..111 
4.2 Results and discussion…………………………………………………………. 115 
4.2.1 Synthesis .................................................................................................. 115 
4.2.2 Optical properties ..................................................................................... 120 
4.2.3 DFT calculations ...................................................................................... 123 
4.2.4 Cell staining test ....................................................................................... 126 
4.3 Conclusion……………………………………………………………………... 129 
4.4 Experimental Section…………………………………………………………... 130 
4.4.1 General Experimental Methods ............................................................... 130 
4.4.2 Materials Synthesis and Characterization Data ........................................ 131 
Appendix……………………………………………………………………………140 
References…………………………………………………………………………. 151 
Chapter 5: Enhancing the Panchromaticity of meso-Ester and Carboxylic 
Acid Substituted BODIPYs by Tuning the Donor Groups at the α-methyl 
site .................................................................................................................. 156 
5.1 Introduction……………………………………………………………………..156 
5.2 Results and Discussion………………………………………………………… 159 
5.2.1 Synthesis .................................................................................................. 159 
5.2.2 Optical properties of the sensitizers 5-1 – 5-4 ......................................... 160 
5.2.3 Electrochemical properties ....................................................................... 161 
5.3 Conclusion……………………………………………………………………... 163 





Chapter 6: para- and meta-Quinodimethane Bridged BODIPY Dimers: 
Synthesis, Biradical Character, Physical Properties and Selective Reaction 
with Reactive Oxygen Species ..................................................................... 176 
6.1 Introduction……………………………………………………………………..176 
6.2 Results and Discussion………………………………………………………… 181 
6.2.1 Synthesis .................................................................................................. 181 
6.2.2 Steady-State and Transient Absorption Spectroscopic Measurements of the 
BODIPY dimers 6-1 and 6-2 ............................................................................ 183 
6.2.3 DFT Calculations ..................................................................................... 190 
6.2.4 Electrochemical Properties, Molecular Orbital Profiles and Energy 
Diagram ............................................................................................................ 192 
6.2.5 Selective Fluorescence Turn-on Detection for Hydroxyl Radical over Other 
Reactive Oxygen Species .................................................................................. 195 
6.2.5.1 Titration with Different Reactive Oxygen Species ............................... 195 
6.2.5.2 Considerations on the Additive Reactions with Hydroxyl Radical ....... 200 
6.4 Conclusion……………………………………………………………………... 204 
6.4 Experimental Section…………………………………………………………... 205 
6.4.1 General Experimental Methods ............................................................... 205 







4,4-Difluoro-4-borata-3a,4a-diaza-s-indacene (abbreviated as BODIPY) 
is one of the most popular families amongst highly fluorescent dyes, and the 
excellent features have made this dye family facilitating in both materials 
science and bio-technology once the optical profiles were altered indeed. 
Thereby, this thesis described a series of BODIPY-based far-red and near-IR 
chromophores from the design concept, synthetic approaches, photo-physical 
properties, electronic features, and potential applications. The perfect fit 
between dye structure and its desired spectroscopic and photophysical 
characteristics were realized, and upon bearing with functional groups or 
specific moieties, these BODIPY-based NIR chromophores tend to be 
perspective in various applications. 
Chapter 1 firstly presents the advantages of NIR chromophores in both 
materials science and bio-technology. As one of the most promising dye sets, 
the fundermental chemistry and general synthesis of BODIPY framework 
were overviewed consequently, followed by recent advances on construction 
of BODIPY-based NIR derivatives. Their synthesis and design concept were 
highlight, meanwhile their primary optical properties, applications as 
sensitizers and fluorescent probes are demonstrated.  
In chapter 2, the synthesis of naphthalene, anthracene fused BODIPYs 
through oxidative cyclo-dehydrogenation strategy were presented and the 
impacts of electronic structures to oxidative process were discussed in details. 
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Moreover, the primary properties of the unfused BODIPY precursors as well 
as the fused structures were also investigated. 
In Chapter 3, novel synthetic approaches to access 
aromatic-units-fused-BODIPY structures without electron donating 
substituents were disclosed. A series of derivatives with benzene units fused at 
different sites of BODIPY framework were afforded. Moreover, upon 
investigating their electro-chemical properties, specific impacts of different 
fusion modes were revealed. 
In Chapter 4, the challenge synthesis of a series of meso-ester and 
‘COOH’ substituted BODIPY derivatives were described. Their 
photo-physical properties, water-solubility, cell-membrane permeability were 
successively investigated. Moreover, structural dependent Stokes Shifts 
among the meso-ester BODIPY structures were intensively studied on the 
basis of DFT calculations.  
Chapter 5 presents an extension of the meso-ester and ‘COOH’ 
substituted BODIPYs. Different donor groups were introduced through 
functionalization at the α-methyl sites, the absorption spectra revealed highly 
improved panchromaticity for these chromophores, making them highly 
attractive in photovoltaic devices. 
In Chapter 6, two fully-conjugated di-BODIPY isomers were synthesized 
by bearing BODIPY units with benzenoid structure. Both isomers feature as 
close-shell in the ground state, they serve as perspective NIR candidates owing 
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to the excellent NIR features and noteworthy stability. Moreover, the two 
structures displayed fluorescence turn-on response to hydroxyl radicals 
selectively over other reactive oxygen species, representing the first example 
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Scheme 2.2 Oxidative dehydrogenation of aromatic units substituted BODIPYs 
without electron donating groups. 
Scheme 2.3 Synthetic pathways for anthracene and naphthalene substituted or fused 
BODIPYs. Reagents and conditions: a) 4-tert-butyl-benzaldehyde, 95 % H2SO4, 0-5
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゜C, 2 hours, 36 %; b) dichloromethyl methyl ether, TiCl4, DCM, r.t, overnight, 67 %; 
c) 1. corresponding pyrrole, TFA, DCM, r.t., 2 hours; 2. DDQ, r.t., 1.5 hour; 3. TEA, 
BF3·OEt2, 2 hours; 54.4 % for 2-9, 55 % for 2-12, 57 % for 2-13, 45 % for 2-14, 52 % 
for 2-15, 45 % for 2-16; d) FeCl3, DCM, r.t., 0.5 hour, 35 % for 2-10, 42 % for 2-17; 
e) CHCl3, Br2, r.t., 12 hours, 90 %; f) n-butyllitium, -78゜C, 2 hours, DMF, r.t., 12 
hours, 76 %; g) C8H17Br, K2CO3, DMF, 60 ゜C, 8 hours, 66 % for 2-30, 68 % for 
2-33; h) POCl3, DMF, 60゜C, 2 hours; 64 % for 2-31, 59 % for 2-34, 42 % for 2-36; i) 
Me2SO4, toluene, 80゜C, 87 %. 
Scheme 3.1 Synthetic procedures. Reagents and conditions: (a) DMF, 90 
o
C, 16 h, 
72%; (b) 2,4-dimethylpyrrole, POCl3, DCM, r.t., 12 h; (c) BF3•OEt2, TEA, DCM, 2h, 
42% for 3-1 from 3-5, 20% for 3-2 from 3-9, 24% for 3-3 from 3-13; (d) 
phenylboronic acid, Pd(PPh3)4, Na2CO3, toluene, 110 
o
C, 24 h,  81%; (e) 10% NaOH, 
DMSO, EtOH, 50
 o
C, 94%; (f) Benzaldehyde, 37% HCl, MeOH/EtOH, r.t., 12h; (g) 
DDQ, DCM, refluxing, 2h; (h) i: LDA, THF, -78 
o
C, 2h; ii: 2-iodobenzoylchloride, 
r.t., 12h, 21%; (i) Cu, DMF, 140 
o
C, 3h, 95%. 
Scheme 4.1 Synthesis of the meso-ester and carboxylic acid functionalized BODIPYs 
4-1 – 4-8: (a) i) BF3•Et2O, CH2Cl2, RT, 3h; ii) DDQ, RT, 1h; iii) Et3N, BF3•Et2O, RT, 
1h; (b) i) 2,4-dimethylpyrrole, -78 
o
C, 4h; ii) Et3N, BF3•Et2O, BF3•OEt2, -78 
o
C to RT, 
2h; (c) piperidine, AcOH, toluene, reflux, 12h; (d) 10 % Pd/C, 1 atm H2, RT, 4h; (e) 
tert-butanol, DCC, anhydrous diethyl ether, RT, 5h; (f) HCl, CH3NO2, 0 
o
C to RT, 4h; 
(g) LiI, ethyl acetate, reflux, 8h. 
Scheme 6.1 Reagents and conditions: 1) n-BuLi, THF, -78゜C, 2 hours; Ar-CHO, 
-78゜C to RT, overnight; 2) NaH, MeI, THF/DMF (4:1), O゜C to R.T.; 20% for 6-5 
in two steps from 6-3; 3) p-toluenesulfonic acid, acetone/H2O (2:1), reflux for 6 hours; 
95% for 6-6, 18% for 6-13 in three steps from 6-10; 4) i) 2-ethylpyrrole, TFA, DCM, 
RT, 3 hours; ii) DDQ, DCM, 2 hours; 5) TEA, BF3·OEt2, DCM, RT 0.5 hour; 20% 
for 6-8 in two steps from 6-6 and 25% for 6-15 from 6-13; 6) BF3·OEt2, DCM, 20 
min; 7) DDQ, DCM, 0.5 hour; 28% for 6-1 and 45% for 6-2 in three steps from 6-6 
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Chapter 1: Introduction 
Near-infrared (NIR) dyes, which defined as chromophores with 
absorption and emission located at near-infrared region (650 nm - 900 nm) are 
attracting increasingly more interest of a vast scientific community among 
chemists, physicists and biologists，as these dyes open unique and meaningful 
opportunities in the fields of both materials science and bio-imaging 
applications. In respect to materials science, NIR dyes are most potential and 
perspective organic chromophores that serve as alternatives to conventional 
solid inorganic materials, due to their low cost, minimum pollution and 
excellent light harvesting feature (since nearly 50% of the energy from the sun 
reaching the earth is in the form of NIR radiation).
1
 In addition, NIR 
fluorescent dyes are favorable for in vivo bio-imaging since light in NIR 
wavelength region would induce minimum photo-damaging to bio-tissues, 
minimal auto-absorption and auto-fluorescence from the bio-molecules, and 
deep tissue penetration, resulting in low background noise and high 
signal-to-noise ratios.
2
 However, compared to chromophores with absorption 
and emission within the visible region, various problems have been 
encountered in the design and synthesis of the red-shifted far-red and NIR 
counterparts, such as undesirable dye aggregation, photo-bleaching, and low 
fluorescence quantum yields.
3
 Chemical modification to highly absorbed and 
fluorescent dye-core to push the absorption and emission to NIR region was 
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the most conventional method to synthesize NIR dyes. In recent years, 
fundamental chemistry studies on the 
4,4-difluoro-4-borata-3a,4a-diaza-s-indacene (abbreviated as BODIPY) family 
have facilitated several promising strategies to obtain NIR BODIPY dyes. 
1.1 Overview on BODIPYs  
1.1.1 Fundamental Chemistry of BODIPYs  
BODIPY is one of the most popular families amongst the highly 
fluorescent dyes, which was first described by Treids and Kreuzer in 1968 and 
has gained ever-growing success ever since.
4 
The excellent stability, high 
fluorescence yield, negligible triplet state formation, intense absorption profile, 
good solubility, and chemical robustness make them suitable for a wide range 
of applications bio-molecular labels,
5














 and sensitizers for solar cells.
12
 When being 
described as a boradiaza-s-indacene, BODIPY can be taken in analogy with 
the all carbon tricyclic s-indacene, and the numbering of substituents follows 
the rules set for s-indacene (Scheme 1.1). The 8-position is often specified by 
meso-, the 3,5-positions are usually referred to α, while β is used to denote the 
2,6-positions, and all these positions are possible sites for functionalization. 
When drawing the resonance structures of BODIPY core, zwitterionic forms 
with the positive and negative charges delocalized at different positions can be 
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indicated. Simple consideration of these delocalized structures reveal that, the 
1, 3, 5, 7, 8 positions bear some positive charges, which tend to be 
electrophilic-attacked; while the 2, 6-postions bear the least positive charges, 
so they should be most susceptible to electrophilic attack (Scheme 1.1) and 
tend to be nucleophilic-attacked instead.
13
 All these structural considerations 
about BODIPY backbone is instructive and meaningful to the synthesis and 
modification of BODIPY framework, which will be demonstrated in the 





Scheme 1.1 a) IUPAC numbering system of BODIPY core in analogue with s-indacene. 
b) The different zwitterionic resonance structures of BODIPY core.  
1.1.2 Basic procedures to synthesize BODIPYs 
 
Scheme 1.2 Typical synthetic routes of symmetric BODIPY dyes. 
The fundamental studies on BODIPY in recent few decades had afforded 
various synthetic pathways toward these fluorophores, which allowed the 
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creation of a perfect fit between the structure of the dye and its desired 
spectroscopic and photophysical characteristics. The conventional synthetic 
pathways to BODIPY dyes can be divided into two categories according to the 
symmetrical characteristic of the resulting BODIPY structures. Starting from 
commercially available substituted pyrrole derivatives, the construction of the 
intermediate dipyrromethene unit was largely based on the well-known 
condensation reaction that was developed originally for the synthesis of 
certain types of porphyrin structure. A highly electrophilic carbonyl compound 
(for example, acid anhydride, acyl chloride, or aldehyde) is used to form the 
methane bridge between two pyrrole units, and when using aldehyde for the 
condensation reaction, aromatic aldehyde is necessary (to the best of our 
knowledge, aliphatic aldehydes have not been reported in this reaction). The 
pyrrole units are usually substituted at one of the positions adjacent to the 
nitrogen atom to avoid polymerization and/or porphyrin formation. An excess 
of a non-substituted pyrrole (usually as solvent) is needed to obtain 
satisfactory yields of the corresponding naked dipyrromethene.
14
 Such 
synthetic procedures rapidly lead to the isolation of symmetric BODIPY dyes 
after complexation with BF3·OEt2 in the presence of a base, such as a tertiary 
amine,
15
 as shown in Scheme 1.2. 
A large number of BODIPY dyes have been synthesized from readily 
available pyrroles using this synthetic method, which provided direct and 
convenient methods to access symmetrically meso-aromatic units substituted 
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BODIPYs. The rotation of the aromatic units at the meso- position would be 
restricted by the pyrrole fragments, and the resultant orthogonal geometry 
minimizes the electronic coupling between the BODIPY core and the meso- 
substituents, thus inducing very little effect on the electron density and optical 
properties of the chromophores. Upon this consideration, this synthetic 
strategy would allow the connection of selective groups directly onto the 
BODIPY framework without drastic change of their spectral features, which is 
very important for the functionalization of BODIPY dyes to formulate 
chemical sensors. 
 
Scheme 1.3 General synthetic route of asymmetric BODIPY dyes. 
Asymmetric BODIPY dyes are usually obtained by condensation of a 
carbonyl-containing pyrrole (also named acylpyrrole) with another pyrrole 
units that is not substituted at the 2-position under acidic condition, followed 
by complexation with boron trifluoride salt in the presence of a base (Scheme 
1.3). Unlike the previous synthetic method, one-pot reaction is usually not 
allowed here, since the condensation reaction generates many by-products and 
the excess amount of acid used is not favorable for the nest step reaction. 
Many BODIPY-based biological labels
16
 are prepared by following a similar 
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procedure. An active carboxylate group can be introduced at the 8-position by 
following a similar procedure. This synthetic route is useful for the preparation 
of reasonably large batches of dyestuff, although it tends to be expensive in 
terms of solvent wastage. Purification is best carried out by column 
chromatography followed by recrystallization. 
1.2 Strategies toward BODIPY-based far-red and NIR dyes 
BODIPY can also be considered as an example of “rigidified” 
mono-methine cyanine, which is generated by the complexation of a 
dipyrromethene unit to boron trifluoride (Scheme 1.4). The greatly restricted 
flexibility leads to unusually high fluorescence quantum yields from the 
dipyrromethene-boron framework. The π-electrons delocalize along the 
organic backbone and can be further extended by substitution or fusion of 
aromatic units to one or both pyrrole fragments. Obtaining dyes with 
fluorescence in the far-red or NIR spectral region requires the presence of an 
extended delocalization pathway. Under these considerations, recent 
developments in BODIPY chemistry have allowed diverse modifications on 
the core structure to extend the -conjugation and to generate red-shifted 
BODIPY dyes. These strategies toward far-red and NIR BODIPYs can be 
summarized and grouped into the following three categories: 1) 
functionalization at the α-, β- and meso- sites of the BODIPY core to extend 
π-conjugation and to generate a “push-pull” structure; 2) employment of 
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π-extended pyrrole units instead of the simple pyrrole or fusion of aromatic 
units to extend the -conjugation at the [a] bond, [b] bond and the “zig-zag” 
edge of the BODIPY; 3) replacement of the meso- carbon by ‘aza’-type 





Scheme 1.4 Structural considerations of the BODIPY core and the schematic 
modification strategies toward far-red and NIR BODIPYs. 
1.2.1 α, β and meso- Substituted BODIPYs 
1.2.1.1 α-Aryl substituted BODIPYs  
 
Fig 1.1 Examples of α- aryl and heteroaryl-substituted BODIPYs. 
The most straightforward method to extend the electron delocalization of 
BODIPY is to introduce aromatic units at the 3, 5-positions (α-sites). Direct 
attachment of phenyl substituents at these two positions (e.g. 1-1, Fig 1.1) can 
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somehow extend the conjugation system, but the bathochromic shift is 
limited.
17
 Heterocyclic aromatic units such as pyrrole (1-2) and thiophene (1-3) 
at the 3,5-positions could induce more significantly spectral red shift (Fig 1.1), 
for example, the 3,5-dithienyl BODIPY (1-3) exhibited a red shift of ∼60 nm 
in absorption and emission compared to the 3,5-diphenyl analogue (1-1). 
18
 
Moreover, increasing the number of thiophene rings in the substituents 
led to progressive red shift of the absorption/emission spectrum (Fig 1.2).
19
 
Several unsymmetrical 3,5-dioligothienyl BODIPY dyes (1-4 and 1-5) have 
been synthesized by attaching the additional thiophene units through 
palladium-catalyzed cross-coupling reactions, with the most progressive one 
(1-5) exhibiting absorption maximum at 677 nm and emission maximum at 
769 nm (Fig 1.2). 
 
Fig 1.2 α- Oligothienyl substituted BODIPYs. 
The possible energy loss from the excited state via thermal rotation of the 
aromatic substituents may cause the reduced fluorescence quantum yields (Ф) 
of the 3,5-diaryl substituted BODIPYs. In order to avoid the free rotation of 
the 3,5-diphenyl substituents, Burgess et al. synthesized a series of rigid 
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Fig 1.3 Conformationally restricted BODIPYs. 
 
Scheme 1.5 Synthesis of the phenyl-substituted pyrroles with a heteroatom or ethylene 
bridge, and representative synthesis of the conformationally restricted BODIPYs 
1-6a/1-6b. 
These dyes have relatively rigid conformations caused by the heteroatom 
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(1-6) or ethylene (1-7) bridge linkers that preclude free rotation of the 
substituted-phenyl molecular fragments. They were synthesized by 
condensation of 4-iodobenzoyl chloride with the corresponding pyrrole 
intermediates, which were prepared in several steps as described in Scheme 
1.5. The resulted dyes absorb and fluoresce more intensely at longer 
wavelengths, and their fluorescence quantum yields are generally higher 
compared to the un-restricted structure. Oxidative dehydrogenation of 1-7a by 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) only gave the 
half-oxidized structure 1-8, and there was no fully oxidized product even 
under longer reaction time. 
 
Scheme 1.6 Synthetic procedure more extended restricted structure. 
Using the similar synthetic approach, a NIR BODIPY dye 1-9 bearing 
3,4,4a-trihydroxanthene moieties was synthesized (Scheme 1.6).
21
 The 
combined extension of conjugation and restricted bond rotation resulted in a 
pronounced red shift of the absorption/emission spectra to NIR region. The 
new BODIPY 1-9 was stable, non-cytotoxic, and suited to labelling living 
cells for imaging assay. 
11 
 
1.2.1.2 Alkenyl and alkynyl substituted BODIPYs and related structures 
 
Fig 1.4 Examples of 3,5- alkenyl and alkynyl substituted BODIPYs. 
Alkenyl- and alkynyl- substitution at the 3,5-positions had been proved to 
be another efficient strategy toward -extended BODIPYs. It was found that 
the halogen atoms at the 3,5-positions of the BODIPY core showed similar 
reactivity to heterocyclic imidoyl chlorides. This opens the door for 
derivatization using transition metal catalyzed coupling reactions. Thus, a 
series of 3,5- alkenyl and alkynyl substituted BODIPY dyes (e.g., 1-10 – 1-12) 




Fig 1.5 3,5- Distyryl substituted “push-pull” type BODIPYs. 
Alternatively, 3,5- alkenyl substituted BODIPYs can also be obtained by 
condensation of 3,5-dimethyl BODIPYs with aromatic aldehydes because the 
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3,5- methyl substituents are acidic enough to participate in Knoevenagel 
condensation reactions.
24-26
 Using this protocol, a third functional group that 
attached to the aromatic aldehyde moiety can be introduced to the conjugated 
structure. In particular, attachment of electron-donating dialkylamino group or 
alkoxy group (1-13 – 1-16, Fig 1.5) generated a “push-pull” structure and 
resulted in even more pronounced spectral changes by activation of an 
intramolecular photophysical process, such as charge transfer and electron 
transfer. The dialkylamino-functionalized BODIPY derivatives 1-13, 1-14, 
1-15 exhibit small solvato-chromism and considerable positive 
solvato-fluorochromism. The fluorescence intensity increases significantly 
with decreasing solvent polarity. Protonation of the dialkylamino groups 
induced a noted blue shift of spectrum accompanied with a significant 
enhancement in fluorescence intensity, leading to optical properties that are 
very similar to those of non-functionalized styryl-BODIPY 1-10. The spectral 
change and the solvato-chromism profiles made this type of BODIPY suitable 
as pH sensor. 
New strategies to access polymethine-substituted BODIPYs at both the α- 
and β- sites were carried out by Osuka and Shinokubo et al.. They applied the 
directly iridium-catalyzed borylation to the meso-mesityl substituted 
dipyrromethane and boron dipyrrin (BODIPY) dyes.
27
 The regio-selective 
borylation enabled a variety of functionalizations at the α- and β- positions 
through rhodium-catalyzed Heck type addition the borylated compounds to 
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2,4-pentadienoate esters, and the resulted dimethine ester substituted 
BODIPYs (1-17, 1-18) exhibited substantial red shift in both absorption and 
emission spectra (Fig 1.6). The 3,5-substituted BODIPY 1-17 exhibited higher 
absorption coefficient and fluorescence quantum yield, sharp fluorescence 
peak, and smaller Stokes shift, compared to the 2,6-substituted BODIPY 1-18. 
These findings revealed that the properties of BODIPY dyes can be finely 
tuned not only by extended conjugation but also by means of the position of 
modification. 
 
Fig 1.6 Dimethine ester substituted BODIPYs. 
The meso-polymethine-substituted BODIPYs (1-19 – 1-21, Fig 1.7) were 
first reported by Kovtun et al. and the synthesis was realized by the reaction of 
meso- methyl- 3,5-diphenylboradipyrromethene with a number of 
hemicyanine derivatives.
28
 The cyanine-like chromophoric system bearing a 
BODIPY structure made these dyes exhibiting intense long-wavelength 
absorption band belonging to the polymethine fragment and weaker 
short-wavelength band stemming from the dipyrromethene unit. Upon 
protonation the long-wavelength band disappears (for example dye 1-21) and 
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the short-wavelength absorption increases. This unique type of dye 
represented rare example to combine the structure of BODIPY and cyanine in 
one molecule, and the spectral change via protonation made the dyes potential 
for sensing applications. 
 
Fig 1.7 meso-Polymethine-substituted BODIPYs. 
Similar modification and functionalization can be also performed at the 
3,5-positons. In 2012, the same group prepared a series of conjugation 
extended BODIPY dyes bearing polymethine units at the α-position by 
condensation of 3,5-dimethyl boron dipyrromethene with various 
hemicyanines, yielding the corresponding mono- and di-substituted derivatives 
(1-22 – 1-23, Fig 1.8).29 The spectral characteristics of the mono-substituted 
dyes were similar to those of meso-substituted analogues, suggesting the 
modality of cyanine-like chromophoric system. While for the 
3,5-polymethine-disubstituted BODIPYs, the long-wavelength electronic 
transition induced the peripheral system changing from dipyrromethane type 
into polymethine (drawn in bold), which highly delocalized the conjugation 
system. As a consequence, extremely red-shifted absorption (up to 972 nm in 
15 
 
DMF) was observed for these derivatives. 
 
Fig 1.8 α-Polymethine-substituted BODIPYs. 
1.2.2 Fusion of aromatic units at the [a] bond, [b] bond and the “zig-zag” 
edge 
Fusion of aromatic units to the BODIPY core has tended to be an 
efficient strategy to introduce pronounced bathochromic shift. Aromatic units 
can be fused at the [a] bond, [b] bond and the “zig-zag” edge of the BODIPY 
core, respectively (Scheme 1.4). Fusion of aromatic units at these positions all 
resulted in red shift of their absorption/emission spectra, but their impacts on 
the photo-physical properties of the BODIPY structure such as absorption and 
emission intensity, energy level of frontier orbitals and stability showed some 
distinctions.  
1.2.2.1 Aromatic units [a]-fused BODIPYs  
The first example of benzo-[a]-fused BODIPY was reported by Ono et 
al..
30
 Isoindole fragments that unmasked by a retro-Diels-Alder reaction were 
used instead of simple pyrrole fragments (Method 1, Scheme 1.7). This 
synthetic method provided an indirect route to obtain aromatic units [a]-fused 
16 
 
BODIPY derivatives. Related dyes can be also synthesized through 
condensation of ortho- diacetophenone with an ammonium salt, followed by 
boron complexation (Method 2, Scheme 1.7).
31
 The resulting derivatives 
known as isoindole-BODIPYs (1-24 – 1-26) showed pronounced red shift in 




















































Scheme 1.7 Two synthetic approaches for benzo-[a]-fused BODIPYs: a) 
trifluoroacetic acid, DDQ, 
i
Pr2NEt, BF3·OEt2 in CH2Cl2; b) 220 
O
C, 30 min. 
 
Fig 1.9 Examples of benzo-[a]-fused BODIPYs 
In 2012, a facile one-pot synthesis of asymmetric isoindole-BODIPYs 
was developed by Hao et al. based on nucleophilic substitution (SNAr) reaction 
of the in situ formed chlorinated dipyrromethene with pyrrole moieties.
32
 
These asymmetric isoindole-BODIPY dyes (e.g. 1-27 – 1-29, Fig 1.10) 
17 
 
showed sharp absorption and fluorescence, high fluorescence quantum yields, 
and high photo-stability. The emission wavelength was finely tunable over a 
wide range (from 592 to 714 nm) by simple variation of substituent groups 
and through functionalization. 
 
Fig 1.10 Examples of asymmetric benzo-[a]-fused BODIPYs. 
 
Fig 1.11 Phenanthro-fused BODIPYs. 
More extended conjugation system can be constructed by direct 
condensation of β-phenanthropyrrole with aromatic aldehydes, as a 
consequence a series of highly annulated phenanthro-BODIPYs with strong 
absorbance and fluorescence (Φ > 0.8) in long-wavelength region were 
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generated (e.g., 1-30 – 1-31, Fig 1.11).33 Dye 1-30c with an electron-donating 
dimethylamino group at the phenyl-ring showed pH-dependent spectral 
properties, making it applicable as a pH probe. 
1.2.2.2 Aromatic units [b]- fused BODIPYs  
 












































Scheme 1.8 Synthetic route for KFLs: a) N3CH2COOEt, 20% NaOEt, EtOH, 0 
o
C to rt, 
2 h; toluene, reflux, 1−1.5 h; b) NaOH, EtOH/H2O, reflux, 0.5−1 h; c) TFA, CH(OEt)3, 
50 
o
C, 10 min; d) TFA, 50 
o
C, 10 min; e)TFA, POCl3, 50 
o
C, 10 min; f) BF3Et2O 
complex, TEA, halogenated solvent, reflux, 15 min; g) TFA/TFA anhydride, 80 
o
C, 1 h; 
h) BF3Et2O complex, TEA, toluene, reflux, 0.5-1 h. 
Aromatic units can also be fused at the [b] bond of BODIPY framework 
through proper synthetic approach, numerous aromatic units [b]-fused 
BODIPY derivatives have been synthesized and studied so far. One of the 
most famous example was known as Keio Fluos (KFLs, Fig 1.12), which was 
firstly reported by Suzuki et al..
34
 As shown in Scheme 1.8, furo-pyrroles were 
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first synthesized and then condensed with furopyrrole-aldehyde to give the 




Fig 1.13 Examples of KFLs with different substituents on the furan rings. 
The simple KFL dye exhibited a significant spectral red shift with 
retention of extremely sharp absorption and fluorescence bands and 
outstandingly bright fluorescence emission (Φ = 0.96 at 583 nm) in 
comparison with normal BODIPYs. After introduction of strong electron 
acceptor “CF3” to the meso- site and electron donor “4-MeO-Ph” to the 
furo-site, the spectral wavelength was pushed to NIR region owing to the 
constructed ‘push-pull’ motif. In respect to a typical ‘push-pull’ structure, the 
basic phenomena of color chemistry have suggested that the optical 
wavelength relies on the strength of electron donors and acceptors,
35
 thus 
chemical modification of the KFL dyes allowed easy and fine tuning of 
absorption/emission peaks without negatively influencing their optical 
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properties (bandwidth, quantum yield etc.) over a wide range. By introduction 
of different donors and acceptors, numerous related KFLs have been 
synthesized based on this concept (Fig 1.13).
36
 The excellent features of KFLs 
made them potential to substitute or to complement existing commercially 
available fluorescent dyes and to be used as new standard dyes in the vis-NIR 
region. 
Using similar synthetic approach, thiophene-fused BODIPY derivatives 
(e.g. 1-39 – 1-41, Fig 1.14) were obtained by replacement of the oxygen atoms 
in furan ring with sulfur atoms. The more electron-rich profile of the 
fused-thiophene rings induced a more pronounced bathochromic shift 
compared to KFLs.
 
These thiophene-KFL dyes with absorption and emission 
at NIR region were applied for the improved singlet oxygen generation when 
bromine atoms were introduced.
37 
 
Fig 1.14 Examples of thiophene-KFLs. 
Some other sets of aromatic units [b]-fused BODIPY derivatives were 
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also synthesized and investigated in details, their optical properties exhibited 
some distinctions with the KFL families. The bis-naphthobipyrrolylmethene 
derived BODIPY 1-42 and the biphenyl-fused BODIPY 1-43 served as two 
representatives (Fig 1.15).
38, 39
 The extremely bathochromic spectral shift of 
these dyes was mainly due to the construction of highly extended conjugation 
configuration instead of the ‘push-pull’ motif which commonly existed in 
KFLs.  
 
Fig 1.15 Structures of Bis-naphthobipyrrolylmethene derived BODIPY and 
biphenyl-fused BODIPY. 
1.2.2.3 BODIPYs with fusion at the “zig-zag” edge  
 
Fig 1.16 BODIPY dyes with aromatic units fused at the “zig-zag” edge. 
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Intramolecular oxidative cyclodehydrogenation was recently developed 
as an efficient way to fuse an electron-rich aromatic unit to the “zig-zag” edge 
of the BODIPY core.
40
 After fusion of perylene, porphyrin, or anthracene 
moieties to the “zig-zag” edge, the obtained BODIPY dyes (e.g. 1-44 – 1-47, 
Fig 1.16) exhibited largely red-shifted absorption spectra even beyond 1000 
nm accompanied with good photo- and chemical stability.  
The absorption spectra of these “zig-zag” edge-fused BODIPYs showed 
more complicated spectra due to the plural transitions between molecular 
orbitals in these low-symmetry molecules, and the broad absorption band in 
long-wavelength region somehow gave the evidence for intra-molecular 
charge transfer character or aggregation profiles due to the highly extended 
-conjugation. For these reasons, these dyes always exhibited low 
fluorescence quantum yield. 
1.2.2.4 Benzo-[a] or [b]-fused bis-BODIPY structures 
Fusion pathway that can avoid multi-direction transitions would help to 
maintain the simple absorption profile. Therefore, in 2012, Uno et al. 
synthesized a series of benzene-[a]-fused bis-BODIPYs 1-47 – 1-50 via a 
retro-Diels-Alder strategy (Scheme 1.9).
41
 These dimers exhibited sharp and 
strong absorption/emission bands in the red to NIR region and kept good 
transparency in the visible region, making them to be promising candidates for 
selective NIR dyes. The anti-dimers showed absorption and emission at longer 
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wavelength region compared to the corresponding syn-dimers due to the more 
delocalized LUMO orbital (caused by the LUMO interaction between the two 
BODIPY moieties) and lower LUMO energy level of anti-dimers. However, 
the stability of fully benzo-[a]-fused BODIPYs 1-49 and 1-50 was not so good, 
which decomposed within 20 hours in solution. The instability of these two 
compounds may be caused by their increased HOMO energy level after 
fusion. 
 
Scheme 1.9 Benzo-[a]-fused-bis-BODIPYs and representative synthetic scheme: a) 
p-TsOH, AcOH, rt; b) LiAlH4, THF, reflux; c) chloranil, BF3OEt2, i-Pr2NEt, CH2Cl2, rt; 
d) 160 °C, 30 min. 
1.1.1. Aza-BODIPYs 
Aza-BODIPYs are BODIPY derivatives with the meso-carbon atom 
replaced by an imine type nitrogen atom. The 1,3,5,7-tetraaryl aza-BODIPY 
dyes was synthesized by the reaction of a pyrrole with a nitrosopyrrole, which 
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was prepared either in a separate step or in situ. Addition reaction between the 
chalcones and nitromethane, or cyanide, followed by a condensation reaction 
with ammonium acetate provided the aza-dipyrromethenes, and subsequent 
























Scheme 1.10 Synthetic route for aza-BODIPYs: a) CH3NO2, NEt3, MeOH, reflux 10 h; 
b) KCN, acetic acid, ethanol, 35 °C; c) NH4OAc, BuOH, reflux, 24 h; d) BF3·OEt2, 
i-Pr2NEt, CH2Cl2, 25 °C, overnight. 
Aza-BODIPYs are attractive due to their largely red-shifted 
absorption/emission spectra relative to conventional BODIPYs and 
unmodified excellent properties of BODIPY including high molar extinction 
coefficients, narrow spectral bands, high fluorescence quantum yields and 
good stability. The conventional 1,3,5,7-tetraaryl aza-BODIPY 1-52 showed 
absorption at 650 nm and emission 673 nm (Fig 1.16).
25b
 Introduction of an 
electron-donating group at the 3,5-phenyl ring (e.g. 1-53) 
42b,43
 and replacing 
the phenyl rings with thiophene rings (e.g. 1-54)
44,45
 both resulted in 
significant bathochromic shift (Fig 1.17). Moreover, modifications can be 
conducted by attachment of alkynyl groups onto the α-phenyl substituents or 
by substitution at the β- sites (e.g. 1-55) to generate further red shift.45  
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Similar with conventional BODIPYs, conformational restriction would 
also serve as an strategy to get derivatives with stronger fluorescence and 
larger conjugation extension for aza-BODIPYs. Thus, in 2005, Carreira et al. 
reported the conformational restricted aza-BODIPY structure by restricting the 




Fig 1.17 Examples of aza-BODIPYs. 
 
Scheme 1.11 Synthesis of conformationally restricted aza-BODIPY 1-56: a) NaNO2, 
HOAc/Ac2O; b) Et3N, BF3·Et2O. 
 
Fig 1.18 Examples of conformationally restricted aza-BODIPYs. 
The aza-BODIPY 1-56 was prepared by simple two-step reactions from 
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the rigidified pyrrole (Scheme 1.11). It exhibited largely red-shifted absorption 
spectrum and emission spectra due to more efficient -conjugation.46 At the 
same time, the dye maintained moderate fluorescence quantum yield and good 
stability. By using the similar synthetic approach, a series of asymmetric 
aza-BODIPYs 1-57 – 1-60 with tunable optical properties were also prepared 
by the same research group (Fig 1.18).
47 
Another conformationally restricted system is the B,O-chelated 
aza-BODIPY (e.g. 1-62, Scheme 1.12).
48
 The conformation restriction caused 
by the B,O- chelation led to a bathochromic shift in both the absorption and 
emission spectra and induced a dramatic increase in the quantum yield from 
0.07 for 1-61 to 0.51 for 1-62. 
 
Scheme 1.12 Synthesis of the B,O chelated aza-BODIPY. 
Similar to conventional BODIPYs, aza-BODIPYs with extended 
-conjugation can be also realized by fusion of aromatic units. A series of 
benzo- or naphtho [a]-fused aza-BODIPYs were synthesized by reacting 
aryl-magnesium bromides with phthalonitriles or naphthalenedicarbonitriles 
followed by complexation (Scheme 1.13).
49
 The representative benzo- and 
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1,2-naphtho-[a]-fused 3,5-diaryl aza-BODIPY dyes (1-63 and 1-64) displayed 
markedly red-shifted absorption and emission bands in the NIR region (> 700 
nm). 
 
Scheme 1.13 Structure of benzo- and 1, 2-naphtho-[a]-fused aza-BODIPYs and 
outline of typical synthesis of [a]-fused aza-BODIPYs. 
1.3 Applications of NIR BODIPY dyes 
1.3.1 For Dye Sensitized Solar Cells (DSSCs) 
As mentioned above, BODIPYs are interesting chromophores with high 
fluorescence quantum yield and absorptivity, their photo-stability is 
significantly better than many other sensitizers proposed.
50
 Recent 
developments in BODIPY chemistry have allowed diverse modification on the 
core structure. Through these modifications, many characteristics of the parent 
chromophore can be altered in the desired direction, for example, through 
simple chemical transformations it is easy to make these dyes to absorb 
essentially all colors of the rainbow.
51
 Strong electron donor and acceptor 
groups can be easily placed on the chromophore, and solubility and 
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aggregation characteristics of the dyes can also be modulated as needed for 
BODIPY derivatives.
52
 In addition, calculations at various levels of the 
theory
53
 suggested that excitation of the BODIPY chromophore results in 
significant reorganization of the electron distribution, setting up the scene for 
efficient electron transfer to nanocrystalline titania from the S1 state of the dye. 
Thus, optimization of the BODIPY derivatives is promising to provide better 
sensitizers for use in DSSCs. 
 
Fig 1.19 a) Structures of BODIPY-based sensitizers; b) normalized absorption 
spectrum of sensitizers PS1 to PS6; c) current-voltage curves of BODIPY based 
DSSCs. Reproduced from ref. 56 with permission from The Royal Society of Chemistry. 
 In 2005, Fukuzumi et al. reported the first rationally designed example 
of a BODIPY based sensitizer.
54
 And a few more recent articles presented the 
performance of the BODIPY-sensitizers in both liquid electrolyte
52
 and solid 
state based
55 
DSSCs, and the overall efficiency (η) was unsatisfactory. Thus, 
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in 2011, Akkaya et al. set out to synthesize different BODIPY based 
sensitizers (Fig 1.19 a)) upon the considerations of tuning the most important 
parameters including the absorption range, anchoring groups, and the direction 
of charge reorganization on excitation. These BODIPY sensitizers exhibited 
impressive panchromatic nature (Fig 1.19 b)), and in the best case example, an 
overall efficiency of a modest 2.46% was achieved (Fig 1.19).
56
  
1.3.2 For Bio-imaging Applications 
1.3.2.1 In vivo imaging for metal ions 
The important role of metal ions in environmental and biological settings 
has motivated the rapid development of NIR fluorescent probes for these 
species. However, bio-imaging of metal ions still remains as a challenge, since 
most of the existing probes showed too poor water solubility to be membrane 
permeable and were often characterized in non-aqueous phase. In respect to 
BODIPY-based far-red and NIR fluorescent probes for metal ions, only very 
few were applied for bio-imaging in living cells. Peng et al. reported that the 
fluorescent sensor 1-67 can be used for selective imaging of Cd
2+
 in living 
cells based on the ICT mechanism (Fig 1.20). 
N,N-bis(pyridin-2-ylmethyl)-benzenamine was chosen as Cd
2+
 receptor (and 
the ICT donor) and was incorporated to the BODIPY core through a vinyl 
group.
57
 The free sensor 1-67 exhibits emission at 656 nm with a quantum 
yield of 0.12 in Tris-HCl (0.01M) (acetone-water 9:1, v/v, pH = 7.4). Upon 
addition of CdCl2, the emission maximum showed a blue shift to 597 nm (Φ = 
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0.59) with a well-defined iso-emission point at 673 nm. The increased 
emission intensity at 597 nm and the intensity ratio (R (F597/F697)) upon the 
gradual addition of Cd
2+
 allowed the detection of Cd
2+
 by both normal 
fluorescence and ratiometric fluorescence methods (Fig 1.20). This probe 




 in living cells. 
 
 
Fig 1.20 Ratio fluorescence (F597/F697) images of Cd
2+
 in DC cells (Leica TCS-SP2 
confocal fluorescence microscope, 20× objective lens): (a) DC cells incubated with 
1-67 (5 μM); (b) DC cells incubated with 1-67 and then further incubated with 5 μM 
CdCl2. Reprinted with permission from ref. 57. Copyright (2007) American Chemical 
Society. 
Oka and Suzuki et al. described a novel NIR fluorescent probe 1-68 for 
Ca
2+
 based on Keio Fluors, in which the Ca
2+
 recognition group BAPTA 
(O,O’-bis(2-aminophenyl) ethyleneglycol-N,N,N’,N’-tetra acetic acid) was 
attached at the meso- site (Fig 1.21).
58
 The absorption band of probe was not 
essentially influenced by the presence or absence of Ca
2+
, however, an 
extraordinarily high on/off fluorescence signal (120 fold) was observed. The 
probe displayed almost no fluorescence (Φ < 0.002) due to the PET process 
between the chelating moiety and the fluorophore. Upon binding to Ca
2+
 the 
fluorescence was dramatically enhanced due to the weakened PET. The 
addition of ATP (a reagent leading to an increase in Ca
2+
 concentration) and 
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the stimulation by ionomycin (a reagent causing a cytosolic Ca
2+
 increase) 
both caused a significant increase in the fluorescence emission with 
time-related changes, indicating the probe was useful for monitoring 
intracellular calcium concentration. The real-time dual-colour imaging of 
intracellular Ca
2+
 was also realized using this probe (Fig 1.21).  
 
 
Fig 1.21 Real-time single- or dual-colour Ca
2+
 imaging: (a) pseudocoloured images of 
sensor 1-68-loaded HeLa cells with ATP stimulation (100 μM) at 30 s. Images were 
captured at 15 s, 45 s, and 120 s; scale bar, 20 mm. (b) Time course of fluorescence 
change of sensor 1-68. The arrowhead indicates the timing of ATP addition. (c) 
Pseudocoloured images of HeLa cells loaded with both Fluo-4 and 1-68 with ATP 
stimulation (100 μM) at 30 s.  (d) Time course of fluorescence change of Fluo-4 
(blue) and sensor 1-68 (red). Reproduced from ref. 58 with permission from The Royal 
Society of Chemistry. 
1.3.2.2 Bio-imaging for small molecules 
Very recently, Han et al. developed a NIR reversible and ratiometric 
fluorescence sensor 1-69 based on Se-BODIPY for the redox cycle between 
hypobromous acid oxidative stress and hydrogen sulfide repair (Fig 1.22).
59
 
The present probe, only responds to HBrO and then efficiently reacts with H2S 
in its oxidized form. In its reduced form, the probe showed absorption at 672 
nm and fluorescence at 711 nm with low quantum yield due to the heavy metal 
effect. After “selenide” is oxidized to “selenoxide” by HBrO, the fluorescence 
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of the probe was blue shifted to 635 nm because the weaker electron-donating 
ability of ‘‘selenoxide’’ than ‘‘selenide’’. The fluorescence intensity at 635 nm 
was remarkably increased by 230 folds since the heavy atom effect of Se was 
weakened by the binding of an oxygen atom (Fig 1.22 I).  
 
Fig 1.22 I) Structure of diMPhSe-BOD (1-72) and the detection mechanism for the 
HBrO/H2S induced redox cycle. II) Confocal fluorescence images of the redox cycles 
between HBrO and H2S in RAW264.7 cells: (a) control; (b) probe-loaded cells 
incubated with H2O2 (20 μM), EPO (105 U mL
-1), and KBr (50 μM) for 30 min; (c) 
cells in (b) incubated with H2S (50 μM) for 20 min; (d) (c) was treated with a second 
dose of H2O2 (20 μM), EPO (105 U mL
-1) and KBr (50 μM) for 30 min; (e) overlay 
of images showing fluorescence from 1-72 and Hoechst dye; (f) overlay of 
bright-field, 1-72, and Hoechst dye images. Reproduced from ref. 59 with permission 
from The Royal Society of Chemistry. 
The oxidized form of the probe displayed rapid response to H2S, and the 
fluorescence intensity recovered quickly to the original level. The detection 
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limits for HBrO and H2S were determined to be 50 nM and 0.1 mM, 
respectively. Real-time imaging showed that the probe was able to monitor 
intracellular HBrO/H2S redox cycle replacement. The ratiometric cell image 
observed an enhanced ratio between the short-wavelength fluorescence and 
long-wavelength fluorescence upon the addition of HBrO (generated by 
combining H2O2 (20 μM), EPO (105 U mL
-1), and KBr (50 μM) to the 
probe-loaded cells). After incubated with H2S, the ratio recovered to original 
level, and the probe mainly localized in the cytoplasm of the living cells (Fig 
1.22 II). 
 
Fig 1.23 Reaction-based detection for Cys and Hcy using probe 1-73 and the 
bio-imaging profiles. Reprinted with permission from ref. 50. Copyright (2013) 
American Chemical Society. 
Fluorescent probes for biological thio-species were also studied. 
Ravikanth et al. developed a red fluorescent probe 1-70 for specific detection 
of cysteine (Cys) and homocysteine (Hcy) in living cells based on the 
3,5-bis(acrylaldehyde) BODIPY scaffold (Fig 1.23).
60
 The free probe showed 
intense absorption band at 596 nm in buffer media. Upon addition of Cys the 
absorption band at 596 nm was decreased gradually, and a new band at 552 
nm increased with a clear isosbestic point at 568 nm, due to the formation of a 
34 
 
hexahydro-1,4-thiazepine derivative (Fig 1.23). Blue shift was also observed 
in fluorescence spectra. After addition of Cys, the fluorescence band at 612 nm 
decreased slowly, and a new band appeared at 567 nm with an isoemissive 
point at 598 nm. Similar change was observed in the case of Hcy. This probe 
possessed practical applicability for imaging Cys in living cells. The living 
HepG2 cells incubated with the probe exhibited bright intracellular red 
fluorescence. By contrast, the cells pretreated with Cys followed by incubation 
with the probe exhibited bright yellow-green intracellular fluorescence (Fig 
1.23).  
1.4 Objectives 
In light of this background, the recent developments of BODIPY 
chemistry have allowed diverse modifications on the core structure to generate 
extended conjugation configuration to afford derivatives which exhibit 
absorption or emission at NIR radiation region. However, when considering 
the methodologies reported so far, most of the modification was taken by 
attachment of substituents at the periphery of BODIPY core, or fusion of 
aromatic units at the [a] or [b] bond of the structure. However, fusion of 
aromatic units at the ‘zig-zag’ edge, which was proved to be an extremely 
efficient approach to push the absorption to long-wavelength region, was still 
largely unexplored. On the other hand, most of the reported NIR BODIPY 
dyes suffer from the following shortcomings: unmatched absorption spectrum 
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with the radiation spectrum of solar light, large hydrophobicity, 
water-insoluble, low fluorescence quantum yield with small stokes shift and 
poor photo-stability, making their applications in materials science and 
bio-technology largely unsatisfactory. In order to afford perspective NIR 
BODIPY candidates, the aim of this thesis is to explore novel synthetic and 
modification methodologies that may generate NIR BODIPY derivatives with 
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Chapter 2: Naphthalene and Anthracence Fused BODIPYs: 
Synthesis and Impacts of the Electronic Structures on the 
Intramolecular Cyclization and Intermolecular Coupling  
2.1 Introduction  
BODIPYs are fascinating dyes with some notable features, such as an 
excellent stability, intense absorption profiles, and insensitivity to the polarity 
of the environment.
1
 These chromophores generally exhibited absorption and 
fluorescent emission located between 470 and 550 nm, which is within the 
visible light-radiation wavelength region.
2
 Considering the increasing interest 
in the preparation of near-infrared (NIR) absorption as well as NIR emission 
dyes
3











 and optical 
limiting at telecommunication wavelength,
9
 promotion of the absorption and 
emission of BODIPYs to the far-red and even to the NIR spectral region is 
crucial and necessary. To achieve this goal, various structural modifications to 
the BODIPY skeletons at the periphery have been developed and extensively 
studied. These modifications were conducted to extend the -conjugation and 
narrow down the energy gap, and the typical methods employed so far include: 
1) fusion of aromatic units to the BODIPY skeleton;
10
 2) functionalization at 
the α and/or meso-position to generate a “push-pull”motif,11 and 3) 





The photo-physical properties of BODIPYs can be altered as desired 
indeed after these structural modifications. However, their insufficient 
solubility and stability caused by the large molecular size and low band gap 
still remained as severe shortcomings. The extensive research progress on 
polycyclic aromatic hydrocarbon (PAH)-based NIR dyes has proved that band 
gap and photo-physical features of a molecule depended not only on the 
molecular size, but also on the edge structure.
13
 Thus, edge modification on 
BODIPY skeleton could serve as another efficient approach to achieve NIR 
BODIPY derivatives.  
 
Scheme 2.1 Synthetic route of perylene-fused BODIPY. 
 Recently, fusion of PAH units onto the porphyrin at the ‘zig-zag’ edge 
has attracted considerable interest and the fused hybrid molecules showed 
intensified NIR absorption and emission.
14
 BODIPY, porphyrin’s little sister 
(which can be regarded as a half of porphyrin), also provides a nice ‘zig-zag’ 
geometry for fusion of aromatic units. However, despite the structural 
similarities, this fusion mode has never been implemented in BODIPY family 
until 2011, our group firstly reported the N-annulated perylene-fused BODIPY 
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structure 2-1 through the intramolecular oxidative cyclodehydrogenation 
strategy.
15
 The synthetic pathway is quite straightforward as shown in Scheme 
2.1, and the generated perylene-fused BODIPY 2-1 gave intense absorption 
band between 600 nm- 900 nm, together with excellent photo-stability.  
 
Fig 2.1 Structures of porphyrin and anthracene fused BODIPYs. 
The bathochromic spectral shift of the fused-BODIPY can be further 
enhanced by the design of a larger conjugation system. In 2011, C. Jiao in our 
group designed and synthesized porphyrin fused mono- (2-2) and di-BODIPY 
(2-3) dyes (Fig 2.1), which possessed extremely extended π-systems and 
enhanced NIR absorption at even 1040 nm.
16
 Anthracene, an electron-rich 
aromatic hydrocarbon which possesses a zig-zag edge that potentially matched 
with BODIPY core, was also fused to the BODIPY core, and the resulting 
structure 2-4 (Fig 2.1) showed intense absorption band that covered the UV, 
visible, and a partial of NIR region.
 17 
During the cyclization process promoted 
by FeCl3, intermolecular dehydrogenation coupling was also observed with the 
formation of a considerable amount of anthracene-fused BODIPY dimer 2-5 
(Fig 2.1). The existence of competition between the intramolecular 
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cyclodehydrogenation and the intermolecular coupling process was therefore 
indicated.   
 
Scheme 2.2 Oxidative dehydrogenation of aromatic units substituted BODIPYs 
without electron donating groups. 
Theoretically speaking, these two reaction processes are highly 
dependent on the steric hindrance and the electronic structures of the 
precursors. For perylene-fused BODIPY 2-1, no dimer was observed during 
the oxidative dehydrogenation due to the steric hindrance of the bulky groups. 
In addition, the fused BODIPY dyes were not afforded for the BODIPY 
precursors (2-6 and 2-7) without electron donating groups attached on the 
aromatic substituents (Scheme 2.2); alternatively, inseparable BODIPY 
oligomers via intermolecular coupling together with other decomposed 
BODIPY side products were obtained.
16, 17
 However, the detailed impacts of 
electronic structures on the cyclization and dimerization in aromatic-BODIPY 
system are still not clear. In order to get better insight into this point, fusion 
process should be systematically studied among aromatic-BODIPYs with 
differential electronic structures. Herein, we design and synthesize a series of 
BODIPY precursors with anthracene or naphthalene moiety substituted at 
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meso-site (Fig 2.2).  
 
Fig 2.2 1) Schematic design concept on the anthracene-fused BODIPYs; 2) Structures 
of naphthalene substituted or fused BODIPYs. 
The design concept is based on the following considerations: 1) Electron 
donating groups have been proved to be necessary for the oxidative 
cyclodehydrogenation in BODIPY system. In respect to meso-anthracene 
substituted BODIPY precursor, promotion of the fusion process need the 1, 
8-positions to be activated, and introduction of alkoxy groups to the para- 
sites (4, 5-positons of anthracene) has been proved as an effective method. 
However, attachment of electron donating groups at other positions of the 
anthracene unit, which can also activate the fusion site, has never been 
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reported so far. Thus, compound 2-8 with tetra-methoxy groups attached at the 
bay site (2, 3, 6, 7-positions of anthracene) is designed (Fig 2.2). The 
employment of four methoxy groups would induce much higher reactivity to 
the 1, 8-positions, meanwhile the reactivity of the β position in BODIPY 
fragment tend to be unchanged due to the negligible electronic coupling 
between the BODIPY core and perpendicularly localized meso-substituent. 
This would make the oxidative cyclodehydrogenation more favorable. 2) The 
essence of activating some position in a cyclization system is to increase its 
electron density, and the electron donating ability and the position of the 
functional groups located should play significant roles for the activation.  
For a meso-naphthalene substituted BODIPY backbone (2-11), the 
8-position of naphthalene core can be activated at different levels by varying 
the electron donating groups or by changing their localization at ortho-, meta-, 
para- positions. Therefore, we designed and investigated the oxidative 
cyclization of a series of naphthalene substituted BODIPYs (2-12 – 2-16). 
Among these precursors, di-tert-butyl groups and di-alkoxy groups were 
employed for comparison in order to tell the effect of electron donating ability 
on activating the fusion site; and di-alkoxy groups attached at different 
positions of naphthalene were used to explain the position-related activating 
effect. The oxidative cyclodehydrogenation process of all these BODIPY 
precursors was then investigated under the same reaction condition. All the 




C NMR and high 
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resolution mass spectroscopy (HR MS). Their geometries, electronic structures 
and photophysical properties were investigated to provide a fundamental 
understanding on their reactivity and physical properties. 
2.2 Results and discussion  
2.2.1 Synthesis 
The synthetic pathways are depicted in Scheme 2.2. Tetra-methoxy 
anthracene fused BODIPY dye 2-10 was synthesized through a four-step 
sequence, among which construction of the anthracene mono-aldehyde was 
the key step. Condensation reaction between the veratrole and 
4-tert-butylbenzaldehyde promoted by concentrated sulfuric acid (w.t. 84%) 
gave the triphenyl methane derivative 2-19.
18
 After reacting with 2.0 
equivalent of dichloromethyl methyl ether in the presence of a strong Lewis 
acid TiCl4 in anhydrous DCM, the anthracene mono-aldehyde 2-20 was 
formed.
19
 Acid-catalyzed condensation of the obtained aldehyde 2-20 with 2 
equiv of 2-ethyl pyrrole afforded the corresponding dipyrromethane derivative 
in good yield. Due to high reactivity, this dipyrromethane was used for the 
next step without further purification. Subsequent oxidation by 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) and complexation with 
BF3·OEt2 afforded the meso-anthracene- substituted BODIPY 2-9 with an 
overall 54% yield in three steps. After being treated with 2.5 equiv FeCl3, the 
fully fused BODIPY dye 2-10 was obtianed in 45% yield. Unlike the reported 
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example of anthracence fused-BODIPY dye 2-4, dimerization of 2-10 was not 
observed due to the highly activated 1,8-postions of anthracence subunit and 
the realitively unchanged reactivity of β-postions of BODIPY core. Detailed 
investigation on oxidative behavior of the naphthalene-BODIPY precursors 
can provide further instructions for the impacts of electronic structures on the 
cyclo-dehydrogenation and intermolecular coupling.  
As shown in Scheme 2.2, two methods were adopted to synthesize the 
naphthalene aldehyde derivatives. The 3,7-di-tert-butyl-naphthaldehyde (2-23) 
was prepared via lithiation of the mono-brominated naphthalene followed by 
reaction with anhydrous DMF.
20
 The aldehydes with strong electron-donating 
groups (2-27, 2-31, 2-34, 2-36) were prepared by treating the corresponding 
naphthalene compounds with the mixture of POCl3 and anhydrous DMF.
21
 
Excess amount of POCl3, higher temperature and longer reaction duration 
were required for the naphthalene di-aldehyde 2-36. Through a similar 
condensation-oxidation-complexation sequence to that for the 
anthracene-substituted BODIPY 2-9, the naphthalene-substituted BODIPY 
dyads 2-12, 2-13, 2-14, 2-15, 2-16 were obtained in 55%, 57%, 45%, 52%, 
45% yield, respectively. Their behaviors in the oxidative 
cyclodehydrogenation process promoted by FeCl3 were quite different owing 
to the distinct electronic properties of the naphthalene subunits. Treatment of 
dyad 2-12 with excess FeCl3 in nitromethane and DCM did not generate the 
target compound 2-24, even at high reaction temperature with long reaction 
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duration, and an unseparable mixture containing the dimerized 2-12 was 
obtained instead.  
 
Scheme 2.3 Synthetic pathways for anthracene and naphthalene substituted or fused 
BODIPYs. Reagents and conditions: a) 4-tert-butyl-benzaldehyde, 95% H2SO4, 0-5゜
C, 2 h, 36%; b) dichloromethyl methyl ether, TiCl4, DCM, r.t., overnight, 67%; c) i) 
corresponding pyrroles, TFA, DCM, r.t., 2 h; ii). DDQ, r.t., 1.5 h; iii). TEA, BF3·OEt2, 
2 h; 54.4% for 2-9, 55% for 2-12, 57% for 2-13, 45% for 2-14, 52% for 2-15, 45% for 
2-16; d) FeCl3, DCM, r.t., 0.5 h, 35% for 2-10, 42% for 2-17; e) CHCl3, Br2, r.t., 12 h, 
90%; f) n-butyllitium, -78゜C, 2 h, DMF, r.t., 12 h, 76%; g) C8H17Br, K2CO3, DMF, 60
゜C, 8 h, 66% for 2-30, 68% for 2-33; h) POCl3, DMF, 60゜C, 2 h; 64% for 2-31, 59% 
for 2-34, 42% for 2-36; i) Me2SO4, toluene, 80゜C, 87%. 
For BODIPY 2-13, the stronger electron-donating methoxy groups were 
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supposed to activate the 8-position and bulky 3,5-di-tert-butylphenyl groups 
were chosen to surmount the solubility and aggregation problem of the high 
conjugated target compound 2-28. Unfortunately, neither the intramolecular 
nor the intermolecular coupling reaction took place in the presence of FeCl3. 
The failure of the cyclization was attributed to the low activity of the 
8-position, and the steric hindrance induced by the bulky group served as the 
main obstacle for the intermolecular coupling. Observation was then moved to 
precursor 2-15 in which electron donating alkoxy groups are attached onto 
2,6-positions of naphthalene subunit and two 3, 5-di-tert-butylphenyl groups 
are linked to the α-positions of BODIPY unit. After treated with FeCl3, the 
color change, mass spectroscopy, and UV-vis-NIR absorption spectra (Fig 2.4 
b) indicated the existence of fused target compound 2-35, however, separation 
of the mixture turned out to be very difficult due to the extremely low yield 
and the formation of many by-products with similar polarity. In order to 
simplify the oxidative reaction, a symmetrical naphthalene-bridged BODIPY 
dimer 2-16 was designed and synthesized. In this molecule, the two most 
reactive sites of the naphthalene unit were occupied by the BODIPY units and 
the possibility for intermolecular coupling was hindered by steric hindrance. If 
the oxidative reaction can take place in this compound, it would be most likely 
to undergo the desirable cyclization to afford 2-37. However, only 
decomposition of the starting material 2-16 was observed when it was treated 
with FeCl3. Putting the electron donating groups at the 2,7-positions was the 
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most efficient way to activate the 8-position of naphthalene ring, and thus the 
precursor 2-14 was designed and synthesized. The 2-ethylhexyl chains were 
chosen to surmount the solubility and eliminate the aggregation of the 
fused-BODIPY. The interesting thing is that cyclization and dimerization 
proceeded spontaneously when compound 2-14 was oxidized by FeCl3, and 
only the naphthalene fused BODIPY dimer 2-17 was obtained.  
Based on these synthetic experimental results, we can see that electronic 
structure of the aromatic unit at the meso- site of BODIPY can be finely tuned 
by varying substituents with different electron-donating ability or by changing 
their localization. The tunable electron density and reactivity of the fusion 
sites led to different oxidative behaviors: 1) when the fusion position of the 
aromatic showed low reactivity and no steric hindrance exist, intermolecular 
coupling dominated like compound 2-12; 2) the intramolecular oxidative 
cyclodehydrogenation and intermolecular coupling can took place 
spontaneously if the reactivity of fusion site was tuned at a proper level, like 
2-14; 3) the extremely high reactivity of the fusion site would make the 
cyclization dominate, like 2-9. 
2.2.2 Photophysical and electrochemical properties  
2.2.2.1 Photophysical and electrochemical properties of 
anthracene-substitued and fused BODIPYs 
The UV-vis-NIR absorption spectra of dyes 2-9 and 2-10 recorded in 
DCM are shown in Fig 2.2, the red-yellow colored solution of unfused 
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precursor 2-9 displays superposition of the BODIPY monomer and anthracene 
subunit. The intense absorption band located at 518 nm (ε = 76368 M-1·cm-1) 
is quite similar with that of simple BODIPY structure without 
meso-anthracene substituent, which suggests that the electronic coupling 
between the BODIPY core with the anthracene subunit is negligible owing the 
orthogonal geometry. The fluorescence of dye 2-9 was very weak for that the 
electron rich anthracene group functionalizes as a strong electron donor and 
the constructed D-A motif induced serious fluorescence quenching. After 
oxidative cyclodehydrogenation, the conjugation is highly extended with 
π-electrons delocalized along the planar backbone and the HOMO-LUMO 
energy gap is extremely narrowed. UV-Vis–NIR spectroscopic measurement 
clearly demonstrates that fused compounds 2-10 shows a broad absorption 
spectra that cover the entire visible and a part of the NIR spectral regions (Fig 
2.2), a significant bathochromic shift was observed compared to its precursor 
2-9 with absorption maximum at 768 nm (ε = 17144 M-1·cm-1); and the 
existence of a strong absorption band at 606 nm resulted in a blue color for 
dye 2-10 in solution (Fig 2.2 b)).  

























































Fig 2.2 a) Normalized UV-vis-NIR absorption spectra of compound 2-9 and 2-10 in 
DCM; b) Solvent dependent absorption spectra of fused structure 2-10. 
Solvent dependent absorption behavior of dyad 2-10 was also studied by 
measuring its absorption spectra in various solvents with different polarity. As 
shown in Fig 2.2 b), when the polarity of the solvents increase (from hexanes 
to toluene, to dichloromethane and to methanol) the spectral transition reveals 
a gradually blue-shift. This unusual negative solvato-chromic effect must be 
related to the unique H-aggregation of the planar structure 2-10 in polar 
solvents. 













Fig 2.3 Cyclic voltammogramms of compounds 2-9 and 2-10 in anhydrous DCM with 
0.1 M Bu4NPF6 as supporting electrolyte, AgCl/Ag as reference electrode, Au disk as 
working electrode, Pt wire as counter electrode, and scan rate of 50 mV/s. Fc
+
/Fc was 
used as external reference. 
The electrochemical properties of compounds 2-9 and 2-10 were 
investigated by cyclic voltammetry (CV) in anhydrous DCM (Fig 2.3) and the 
data are collected in Table 2.1. The cyclic voltammogram of 2-9 exhibited one 
reversible oxidative wave and one reversible reduction wave with half-wave 
potential Eox
1/2
 at 0.74 V and Ered
1/2
  -1.45 V (vs Fc
+
/Fc), respectively. For the 
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fused compound 2-10, two reversible oxidation waves with Eox
1/2
 at 0.62 V 
and 0.93 V together with one reversible reduction wave with Ered
1/2
at -1.0 V 
(vs Fc
+
/Fc) were observed. The HOMO (highest occupied molecular orbital) 
and LUMO (lowest unoccupied molecular orbital) energy levels were deduced 
from the onset potentials of the first oxidation (Eox
onset
) and the first reduction 
wave (Ered
onset
), according to equations: HOMO = -(4.8+ Eox
onset
) eV and 
LUMO = -(4.8+ Ered
onset





Thus the HOMO and LUMO energy levels of compounds 2-9 and 2-10 can be 
calculated from the cyclic voltammogram accordingly. For compound 2-9, the 
HOMO locates at -5.45 eV and the LUMO goes to -3.28 eV (Table 2.1). In 
comparison, the fused structure 2-10 has a slightly higher lying HOMO energy 
level (-5.35 eV) and a much lower lying LUMO energy level (-3.94 eV). 
Electrochemical energy gaps of 2.17 eV for 2-9 and 1.41 eV for 2-10 were 
thus obtained which are in agreement with their optical band gaps estimated 
from the onset of the lowest energy absorption band (1.90 eV for 2-9 and 1.28 
for 2-10) (Table 2.1). In the fused system with high electron density, the 
HOMO energy level is usually too high to make the dye easy to oxidize in air. 
For dye 2-10, although the highly electron-rich anthracene moiety is also 
involved, the existence of the electron withdrawing ‘BF2’ moiety in the 
BODIPY fragment can lower the HOMO energy at an adequate level (-5.35 
eV) to effectively improve the oxidation resistance, making compound 2-10 























2-9 0.74 - -1.45 -5.45 -3.28 2.17 2.25 
2-10 0.62 0.93 -1.0 -5.35 -3.94 1.41 1.46 










 Obtained from cyclic voltammograms. Eg
opt
 Obtained from the low 
energy absorption onset in the absorption spectra. 
2.2.2.2 Photophysical and electrochemical properties of 
naphthalene-substituted and fused BODIPYs 
Optical properties of the naphthalene-substituted and fused BODIPY 
derivatives 2-12, 2-13, 2-14, 2-15, 2-16 were also measured as shown in Fig 
2.4. Dyes 2-12 and 2-14 exhibited absorption spectra with similar shape and 
nearly identical maximum wavelength (λabs
max





 for 2-12; λabs
max
 = 516 nm, ε = 0.91×105 M-1·cm-1 for 2-14) since the 
alteration of meso-substituents has no significant effect on the electronic 
properties of the BODIPY skeleton. Unlike the anthracene-substituted 
BODIPY 2-9, intramolecular charge transfer is much weaker in the 
naphthalene-substituted BODIPY system because of the lower 
electron-donating ability of naphthalene subunits, thus compounds 2-12 and 
2-14 exhibited bright fluorescence located at 538 nm with quantum yield () 
of 0.78 and 0.45, respectively. For compounds 2-13, 2-15 and 2-16, similar 





 = 569 nm, ε = 1.37×105 M-1·cm-1 for 2-13, λabs
max







 for 2-15, λabs
max
 = 565 nm, ε = 1.09×105 M-1·cm-1 for 2-16), 
and the bathochromic red-shift (about 50 nm) in spectrum was owning to the 
phenyl-substituents at the α-positions of BODIPY skeleton.  



































Fig 2.4 a) Absorption spectra of naphthalene substituted BODIPY derivatives 2-12, 
2-13, 2-14, 2-15, 2-16 and the fused BODIPY dimer 2-17; b) Absorption spectra of the 
mixture after 2-15 was treated with FeCl3. 
Compounds 2-13, 2-15 and 2-16 displayed fluorescence at around 600 
nm with Φ of 0.21, 0.66, 1.00, respectively. The fluorescence quantum yield of 
2-15 was much higher than that of 2-13 and the di-BODIPY 2-16 emitted 
extremely bright fluorescence. The unusual fluorescent behavior of 2-15 and 
2-16 must be related to the more seriously restricted rotation of the 
di-alkoxy-naphthalene unit at the meso- position. As mentioned above, upon 
treating by FeCl3, no cyclization product was observed for 2-13; however, for 
2-15 a mixture with a longer absorption between 650 and 800 nm (Fig 2.4 b) 
was generated, indicating the formation of the desired ring-fused product. 
When comparing the absorption spectra of the naphthalene-fused BODIPY 
dimer 2-17 with its precursor 2-14 (Fig 2.4 b)), a much broader absorption 
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band that covers the UV-vis and partially NIR region was observed, with an 
intense and broad absorption band from 600 nm to 850 nm. As result, the 
compound appeared a deep green color in both solution and solid state.  





























Fig 2.5 a) Cyclic voltammograms of 2-12, 2-14, 2-17 in DCM; b) Cyclic 
voltammograms of 2-13, 2-15, 2-16 in DCM. For all the CV measurement the dye was 
dissolved in anhydrous DCM with 0.1 M Bu4NPF6 as supporting electrolyte, AgCl/Ag 
as reference electrode, Au disk as working electrode, Pt wire as counter electrode, and 
scan rate of 50 mV/s. Fc
+
/Fc was used as external reference. 
The electrochemical properties of meso-naphthalene substituted 
BODIPYs 2-12, 2-13, 2-14, 2-15 and 2-16, together with fused BODIPY 
dimer 2-17, were investigated by cyclic voltammetry in DCM solution 
containing 0.1 M tetra-n-butylammonium hexafluorophosphate as the 
supporting electrolyte. Considering the structural similarity, comparison can 
be taken among dyes 2-12, 2-14 and 2-17, as shown in Fig 2.5 a. Both 2-12 
and 2-14 exhibited one quasi-reversible oxidation wave and one reversible 
reduction wave with half-wave potentials at 0.95 V, -1.52 V for 2-12 and 0.90 
V, -1.62 V for 2-14 (vs Fc
+
/Fc) respectively, the fused BODIPY dimer 2-17 
displayed one reversible oxidation wave with Eox
1/2
 at 0.34 eV and two 
reversible overlapped reduction waves with Ered
1/2
at -1.37eV. The HOMO 
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energy levels of -5.61 eV, -5.57 eV, -5.05 eV and LUMO energy levels of 
-3.36 eV, -3.29 eV, -3.59 eV were then estimated for 2-12, 2-14 and 2-17 
(Table 2.2), respectively, based on the onset potential of the first oxidation and 
reduction wave. The higher HOMO energy level and lower LUMO energy 
level of 2-17 than 2-14 indicated that fusion of naphthalene unit at the zig-zag 
edge of BODIPY can effectively extend the π-delocalization, resulting in an 
efficiently narrowed energy gap. The cyclic voltammograms of the BODIPY 
dyes 2-13, 2-15, 2-16 with α-phenyl substituents are shown in Fig 2.5 b. 
Compounds 2-13 and 2-15 displayed two oxidation waves and one reversible 
reduction wave with half-wave potentials at 0.68 V, 1.04 V, -1.48 V for 2-13; 
0.75 V, 1.13 V, -1.47 V for 2-15. One reversible oxidation wave and one 
reversible reduction wave with half-wave potentials at 0.78 V, -1.46 V for dye 
2-16. The HOMO energy level of -5.42 eV, -5.46eV, -5.48 eV and the LUMO 
energy level of -3.40 eV, -3.42 eV, -3.43 eV were then estimated for 2-13, 
2-15, 2-16, respectively (Table 2.2). The closely located HOMO and LUMO 
energy levels of these three dyes indicated their similar electronic properties. 
Electrochemical energy gaps of 2.25 eV for 2-12, 2.02 eV for 2-13, 2.28 eV 
for 2-14, 2.04 eV for 2-15, 2.05 eV-for 2-16 and 1.46 eV for 2-17 were then 
obtained, which are in agreement with their optical band gaps estimated from 
the onset of the lowest energy absorption band (2.28 eV for 2-12, 2.03 eV for 























2-12 0.95 - -1.52 -5.61 -3.36 2.25 2.28 
2-13 0.68 1.04 -1.48 -5.42 -3.40 2.02 2.03 
2-14 0.90 - -1.62 -5.57 -3.29 2.28 2.30 
2-15 0.75 1.13 -1.47 -5.46 -3.42 2.04 2.05 
2-16 0.78 - -1.46 -5.48 -3.43 2.05 2.03 
2-17 0.34 - -1.37 -5.05 -3.59 1.46 1.48 





are the half-wave potentials for respective redox waves 
with Fc/Fc
+ 
as reference. HOMO and LUMO energy levels were calculated from the 
onset of the first oxidation and reduction waves according to equations: HOMO = -(4.8 
+ Eox
onset






 was obtained from cyclic 
voltammograms. Eg
opt
 was obtained from the lowest energy absorption onset. 
2.3 Conclusion 
In summary, oxidative cyclodehydrogenation of several meso-anthracene 
and meso-naphthalene substituted BODIPYs were studied in details. The 
reaction has proved to be highly dependent on the electron density of the 
fusion site, as among the set of naphthalene-substituted BODIPYs 2-12, 2-13, 
2-14, 2-15 and 2-16, only the fused structure of 2-14 can be obtained in high 
yield. The observation of fused-BODIPY dimer 2-5 in previous work 
indicated the existence of competition between intramolecular 
cyclodehydrogenation and intermolecular coupling. This competition is finely 
controllable by tuning the electronic properties and the structural geometries 
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of the precursors. BODIPY precursors with subunits less electron-rich 
prefered intermolecularl coupling as for dye 2-12; upon gradually increasing 
the electron-donating ability of the substituents, the possibility for 
intramolecular cyclization increased as for 2-15; when the electron-donating 
ability of the subunit was increased to a certain level as 2-14, cyclization and 
coupling would take place spontaneously; further enhancement in 
electron-donating ability of the subunits made the intramolecular cyclization 
more favorable, as for anthracene-substituted BODIPY 2-9 no fused BODIPY 
dimer was generated during oxidative cyclization. In respect to the 
geometrical impacts, attachment of bulky groups at the α-positions of 
BODIPY skeleton can effectively block intermolecular coupling owning to 
large steric hindrance, as for dyads 2-13, 2-15 and 2-16, no BODIPY dimer 
was generated during the oxidative reaction. Restricted rotation of the 
meso-subunits can be realized for dyes 2-14, 2-15 and 2-16 when the ‘OR’ 
groups are properly localized, resulting in high fluorescence quantum yields. It 
was also helpful for intramolecular cyclization, since it was more favorable for 
dye 2-15 than 2-13 that possessed similar electronic features. The fused 
BODIPY dyes 2-10 and 2-17 exhibited lower band gap and NIR absorption, 
and the suitable HOMO and LUMO energy levels led to excellent thermal and 
photo-stability. All these features are attractive for some technical applications 
such as NIR laser absorbing dyes. However, further modifications to avoid the 
intramolecular charge transfer and to improve the fluorescence quantum yield 
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are necessary for biological applications.  
2.4 Experimental Section 
2.4.1 General Experimental Methods 
All reagents were purchased from commercial suppliers and used as 
received without further purification. Anhydrous dichloromethane (DCM), N, 
N-dimethylformaldehyde (DMF) was distilled from CaH2. Toluene and THF 





C NMR spectra were recorded on Bruker DPX 300 or DRX 500 
NMR spectrometer with tetramethylsilane (TMS) as the internal standard. The 
chemical shift was recorded in ppm and the following abbreviations were used 
to explain the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m 
= multiplet. EI-mass spectra were recorded on Agilent 5975C DIP/MS mass 
spectrometer. MALDI-TOF mass spectra were measured on a Bruker Autoflex 
MALDI-TOF instrument using 1,8,9- trihydroxyanthracene as a matrix. 
UV-vis absorption and fluorescence spectra were recorded on Shimadzu 
UV-1700 spectrometer and RF- 5301 fluorometer, respectively. The solvents 
used for UV-vis and fluorescence measurements are of HPLC grade. The 
electrochemical measurements were carried out in anhydrous and degassed 
DCM containing 0.1 M tetra-n-butylammonium hexafluorophosphate 
(Bu4NPF6) as the supporting electrolyte at a scan rate of 0.05 V/s at room 
temperature. A gold disk was used as working electrode, platinum wire was 
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used as counting electrode, and Ag/AgCl (3 M KCl solution) was used as 
reference electrode. The potential was calibrated against the 
ferrocene/ferrocenium couple. 
2.4.2 Material Synthesis and Characterization Data 




Synthesis of compound 2-19: A solution of veratrole (30 mmol, 4.14g) and 
4--tert-butyl-benzaldehyde (10 mmol, 1.62 g) in DCM (5 mL) was added 
dropwise to 84% sulfuric acid (10 ml) while the temperature was kept at 0゜C. 
The suspension was stirred for 1h at room temperature. The reaction was then 
quenched with water, neutralized by ammonia and extracted with DCM. The 
organic layer was washed with water and brine, dried over anhydrous MgSO4. 
The solvent was then removed under reduced pressure and the residue was 
purified by column chromatography (silica gel, hexane: DCM = 4:1) to give 
the crude product, which was then recrystallized in hexane to give 2-19 as a 
white solid (1.52 g, 36 %). 
1
H NMR (300 MHz, CDCl3) δ = 7.29 (d, J = 8.4 
Hz, 2H), 7.03 (d, J = 8.2 Hz, 2H), 6.78 (d, J = 8.3 Hz, 2H), 6.68 (d, J = 2.0 Hz, 
2H), 6.61 (dd, 
3
J = 8.2 Hz, 
4
J = 2.0 Hz, 2H), 5.40 (s, 1H), 3.86 (s, 6H), 3.77 (s, 
6H), 1.30 (s, 9H) ppm. 
13
C NMR (125 MHz, CDCl3) δ = 148.99, 148.70, 
147.39, 141.15, 136.99, 128.80, 125.08, 121.37, 112.81, 110.82, 55.83, 55.81, 




Synthesis of compound 2-20: To a solution of 2-19 (750 mg, 1.79 mmol) and 
dichloromethyl methyl ether (1.11 g, 9.63 mmol) in DCM (25 ml) was added a 
solution of TiCl4 (0.73 ml, 6.7 mmol) in dry DCM (2 ml) at 0゜C. The 
reaction mixture was kept at room temperature for 12 h before the addition of 
cold water (20 ml) and extracted with DCM (30 ml × 3). The organic layer 
was washed with water (30 mL × 2) and dried over anhydrous Na2SO4. The 
solvent was removed and the residue was purified by column chromatography 
(silica gel, hexane: DCM = 1:1) to give compound 2-20 as a light yellow solid 
in 67% yield (550 mg).
 1
H NMR (300 MHz, CDCl3) δ = 11.42 (s, 1H), 8.44 (s, 
2H), 7.61 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.4 Hz, 2H), 6.83 (s, 2H), 4.10 (s, 
6H), 3.73 (s, 6H), 1.45 (s, 9H) ppm. 
13
C NMR (75 MHz, CDCl3) δ = 192.17, 
151.81, 150.89, 148.53, 142.30, 135.70, 129.83, 129.08, 126.24, 125.42, 
120.28, 105.17, 100.78, 55.92, 55.33, 34.73, 31.35 ppm. HR-MS (APCI): m/z 
= 459.2159 ([M+H]), calcd for C29H30O5:458.2093; C29H30O5: 459.2166.  
Synthesis of compound 2-9: To a solution of compound 2-20 (300 mg, 0.655 
mmol) and 2-ethylpyrrole (1.64 mmol, 156 mg) in degassed anhydrous DCM 
(50 ml) was added four drops of TFA. The reaction mixture was stirred at 
room temperature for 3 h under nitrogen atmosphere. Then DDQ (141 mg, 
0.79 mmol) was added and the solution was stirred at room temperature for 
another 1 h under nitrogen atmosphere. Et3N (3 ml, excess) and BF3·OEt2 (4 
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ml, excess) were successively added. After 4 h the solvents were removed 
under reduced pressure, and the residue was purified by column 
chromatography (silica gel, DCM: hexane = 1:6) to give a purple waxy solid 
product 2-9 (230 mg, 54.4% in three steps).
 1
H NMR (300 MHz, CDCl3) δ = 
7.62 (d, J = 8.4 Hz, 1H), 7.40 (d, J = 8.4 Hz, 1H), 6.95 (s, 1H), 6.83 (s, 1H), 
6.42 (d, J = 4.2 Hz, 2H), 6.24 (d, J = 4.2 Hz, 2H), 3.75 (d, J = 8.4 Hz, 6H), 
3.16 (q, J = 7.6 Hz, 2H), 1.47 (s, 4H), 1.38 (t, J = 7.6 Hz, 3H) ppm.
 13
C NMR 
(75 MHz, CDCl3) δ = 163.75, 150.53, 149.57, 148.90, 141.37, 136.06, 135.84, 
135.28, 130.47, 130.23, 126.76, 125.66, 125.51, 123.16, 117.34, 104.11, 
103.47, 55.89, 55.52, 34.78, 31.47, 22.17, 12.52 ppm. HR-MS (MALDI-TOF): 
m/z = 676.3289 ([M]), calcd for C41H43BF2N2O4: 676.3278. 
Synthesis of compound 2-10: To a solution of 2-9 (80 mg, 0.118 mmol) in 
degassed anhydrous DCM (50 mL) was added a solution of FeCl3 (100 mg, 
0.60 mmol) in nitromethane (2.0 mL). The reaction mixture was carried out at 
room temperature for 10 min and then quenched by addition of a saturated 
NaHCO3 solution. The organic layer was washed with saturated brine and 
dried over anhydrous Na2SO4. The solvent was removed under vacuum and 
the residue was purified by column chromatography (silica gel, DCM: hexane 
= 1:4) to give a blue solid product 2-10 (27.7 mg, 35%). 
1
H NMR (300 MHz, 
CDCl3) δ = 7.63 (d, J = 8.4 Hz, 1H), 7.47 (d, J = 8.4 Hz, 1H), 7.32 (s, 1H), 
7.16 (s, 2H), 4.34 (s, 3H), 3.86 (s, 3H), 3.31 (q, J = 7.5 Hz, 2H), 1.50 (s, 5H) 
ppm. 
13
C NMR (75 MHz, CDCl3) δ = 156.90, 156.25, 152.63, 151.60, 147.44, 
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134.70, 131.28, 127.25, 124.70, 119.87, 111.23, 108.72, 61.23, 55.81, 34.90, 
31.44, 22.21, 13.65 ppm. HR-MS (MALDI-TOF): m/z = 672.2985 ([M]), 
calcd for C41H39BF2N2O4: 672.2971. 
General procedure for synthesis of BODIPYs: To a solution of 
corresponding aldehyde (0.655 mmol) and 2-ethylpyrrole (1.64mmol, 156mg) 
in degassed anhydrous DCM (50 mL) was added four drops of TFA. The 
reaction mixture was stirred at room temperature for three hours under 
nitrogen atmosphere. Then DDQ (0.79 mmol, 141mg) was added, the solution 
was stirred at room temperature for another 1 h under nitrogen atmosphere. 
Et3N (3 mL, excess) and BF3·OEt2 (4 mL, excess) were successively added. 
After 4 h the solvents were removed under reduced pressure, and the residue 
was purified by column chromatography (silica gel, DCM: hexane = 1:6). 
Compound 2-12: Yield 55%. 
1
H NMR (300 MHz, CDCl3) δ = 7.85 – 7.76 (m, 
3H), 7.57 (m, 2H), 6.55 (d, J = 4.2 Hz, 2H), 6.27 (d, J = 4.2 Hz, 2H), 3.18 – 
3.07 (m, 4H), 1.41 (s, 9H), 1.37 (t, J = 7.6 Hz, 6H), 1.26 (s, 9H) ppm. 
13
C-NMR 75MHz δ = 164.2, 149.4, 147.4, 142.8, 136.0, 132.4, 131.9, 131.5, 
131.1, 128.7, 128.3, 125.8, 125.1, 121.7, 117.7, 35.6, 35.4, 31.8, 22.8, 13.4 
ppm. HR-MS (MALDI-TOF): m/z = 486.3021 ([M]), calcd for 
C31H37BF2N2:486.3012. 
Compound 2-13: Yield 57%. 
1
H NMR (300 MHz, CDCl3) δ = 7.72 (d, J =1.7 
Hz, 4H), 7.57 – 7.43 (m, 4H), 7.36 (t, J = 8.1 Hz, 1H), 6.93 (m, 2H), 6.61 (d, J 
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= 4.2 Hz, 2H), 6.47 (d, J = 4.2 Hz, 2H), 4.08 (s, 3H), 4.03 (s, 3H), 1.35 (s, 36H) 
ppm. 
13
C NMR (75 MHz, CDCl3) δ = 159.88, 158.41, 157.14, 150.22, 142.63, 
137.46, 136.66, 132.21, 130.11, 129.17, 127.17, 124.03, 123.61, 120.77, 
119.61, 117.37, 106.52, 104.74, 56.52, 56.39, 34.91, 31.48 ppm. HR-MS 
(APCI): m/z = 755.4584 ([M+H]), calcd for C49H57BF2N2O2: 754.4481; 
C49H58BF2N2O2: 755.4562.  
Compound 2-14: Yield 45%. 
1
H NMR (500 MHz, CDCl3) δ = 7.84 (d, J = 8.9 
Hz, 1H), 7.70 (d, J = 9.0 Hz, 1H), 7.16 (d, J = 8.9 Hz, 1H), 7.02 (d, J = 9.0 Hz, 
1H), 6.86 (s, 1H), 6.48 (d, J = 3.5 Hz, 2H), 6.23 (d, J = 3.6 Hz, 2H), 3.88 (d, J 
= 5.3 Hz, 2H), 3.81 – 3.73 (m, 2H), 3.18 – 3.07 (m, 4H), 1.64 (t, J = 5.9Hz, 
1H), 1.52 (d, J = 5.7 Hz, 1H), 1.36 (t, J = 7.6 Hz, 8H), 1.32 – 1.22 (m, 6H), 
1.13 (s, 8H), 0.87 (m, 6H), 0.81 (t, J = 6.6 Hz, 3H), 0.73 (t, J = 7.4 Hz, 3H) 
ppm. 
13
C-NMR (126 MHz, CDCl3) δ = 162.94, 158.18, 155.23, 139.26, 135.50, 
135.40, 130.51, 129.49, 129.13, 123.83, 116.87, 116.58, 115.79, 111.19, 
104.46, 71.55, 70.43, 39.35, 39.02, 30.50, 30.28, 28.96, 28.87, 23.72, 23.57, 
22.94, 22.85, 22.03, 13.96, 12.66, 11.08, 10.96 ppm. HR-MS (MALDI-TOF): 
m/z = 630.4162 ([M]), calcd for C39H53BF2N2O2: 630.4163. 
Compound 2-15: Yield 52%. 
1
H NMR (300 MHz, CDCl3) δ = 7.87 (d, J = 9.0 
Hz, 1H), 7.75 (d, J = 1.1 Hz, 4H), 7.65 (d, J = 9.1 Hz, 1H), 7.45 (t, J = 1.7 Hz, 
2H), 7.37 (d, J = 9.1 Hz, 1H), 7.19 – 7.10 (m, 2H), 6.54 (s, 2H), 6.46 (s, 2H), 
3.96 (dd, J = 8.8 Hz, 5.7 Hz, 4H), 1.53 (s, 2H), 1.36 (s, 36H), 1.27 (s, 6H), 
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1.19 (s, 8H), 0.97 (s, 8H), 0.79 (d, J = 8.1 Hz, 6H) ppm. 
13
C NMR (75 MHz, 
CDCl3) δ = 159.61, 156.04, 153.12, 150.16, 139.55, 137.48, 132.37, 129.56, 
129.38, 126.85, 123.67, 123.51, 120.50, 120.38, 117.82, 115.05, 106.35, 72.47, 
70.54, 39.49, 39.43, 34.92, 31.51, 30.62, 30.30, 29.69, 29.12, 28.92, 23.96, 
23.68, 23.06, 22.90, 14.09, 11.15, 11.06 ppm. HR-MS (MALDI-TOF): m/z = 
950.6630 ([M]), calcd for C63H85BF2N2O2: 950.6672. 
Compound 2-16: Yield 45%. 
1
H NMR (300 MHz, CDCl3) δ = 7.91 (d, J = 9.2 
Hz, 2H), 7.77 (d, J = 0.9 Hz, 8H), 7.48 (t, J = 1.7 Hz, 4H), 7.36 (d, J = 9.3 Hz, 
2H), 6.62 (t, J = 3.9 Hz, 4H), 6.51 (m, 4H), 3.94 (d, J = 5.5 Hz, 4H), 1.38 (s, 
72H), 1.18 (s, 18H), 0.79 (d, J = 7.4 Hz, 12H) ppm. 
13
C NMR (75 MHz, 
CDCl3) δ = 159.83, 153.24, 150.25, 139.14, 137.51, 132.31, 129.25, 128.37, 
123.65, 120.65, 117.05, 115.72 , 72.13, 39.44, 34.94, 31.51, 30.32, 28.90, 
23.70, 22.91, 14.05, 11.07 ppm. HR-MS (MALDI-TOF): m/z = 1498.0401 
([M]-F), calcd for C100H130B2F3N4O2: 1498.0332. (Chemical formula of 
compound 2-16 was C100H130B2F4N4O2, for BODIPY dyes the fluoride is easy 
to be removed during the mass spectroscopic measurement, especially for 
di-BODIPY structures). 
General procedure of the oxidative cyclodehydrogenation reaction for 
naphthalene-substituted BODIPYs: To a solution of meso- 
naphthalene-substituted BODIPY precursor (0.079 mmol) in degassed 
anhydrous DCM (30 mL) was added a solution of FeCl3 (32.5 mg, 0.198 
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mmol, 2.5 equiv) in nitromethane (1.0 mL). The reaction mixture was carried 
out at room temperature until the starting materials disappearing and then 
quenched by addition of a saturated NaHCO3 solution (5 mL). The organic 
layer was washed with saturated brine and dried over anhydrous Na2SO4. The 
solvent was removed under vacuum and the residue was purified by column 
chromatography (silica gel, DCM: hexane = 1:4). For the di-BODIPY 
structure 2-16, more FeCl3 was used (5.0-10.0 equiv). Upon treatment with 
FeCl3, only the BODIPY precursor 2-14 can afford the fused-BODIPY 
structure in good yield. 
Compound 2-17: Yield 35 %. 
1
H NMR (500 MHz, CDCl3) δ = 8.04 (d, J = 
8.8 Hz, 2H), 7.91 (d, J = 9.0 Hz, 2H), 7.49 (s, 2H), 7.30 (d, J = 8.8 Hz, 4H), 
7.15 (s, 2H), 4.28 (d, J = 4.3 Hz, 4H), 3.23 (q, J = 7.5 Hz, 4H), 3.07 (q, J = 7.0 
Hz, 4H), 2.01 (m, 2H), 1.68 (m, 6.5, 8H), 1.46 (t, J = 7.5 Hz, 6H), 1.29 (d, J = 
7.3 Hz, 12H), 1.25 (s, 12H), 1.12 – 1.06 (m, 8H), 1.02 (t, J = 7.5 Hz, 6H), 0.92 
(t, J = 7.1 Hz, 6H), 0.70 (m, 12H) ppm. 
13
C NMR (126 MHz, CDCl3) δ = 
164.32, 161.21, 159.42, 154.57, 136.94, 134.82, 133.76, 131.41, 130.71, 
130.34, 126.80, 126.30, 122.92, 122.85, 113.86, 113.76, 113.38, 110.98, 
108.97, 77.28, 77.03, 76.78, 74.37, 71.92, 39.84, 38.98, 30.80, 30.21, 29.26, 
28.72, 24.07, 23.57, 23.10, 22.79, 22.21, 20.93, 14.64, 14.07, 13.83, 12.91, 
11.29, 10.64 ppm. HR-MS (MALDI-TOF): m/z = 1254.7885 ([M]-F), calcd 




1. HR-Mass (MALDI-TOF) spectra of 2-9 (a), 2-10 (b), 2-12 (c), 2-13 (d), 
2-14 (e), 2-15 (f), 2-16 (g), 2-17 (h). 
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2. 1H NMR and 13CNMR spectra of compounds 2-9, 2-10, 2-12, 2-13, 
2-14, 2-15, 2-16 and 2-17:  
1
H NMR (300 MHz, CDCl3) spectrum of compound 2-9:   
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H NMR (300 MHz, CDCl3) spectrum of compound 2-10:  
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H NMR (300 MHz, CDCl3) spectrum of compound 2-12: 
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C NMR (75 MHz, CDCl3) spectrum of compound 2-13:  
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C-NMR (126 MHz, CDCl3) spectrum of compound 2-14:  
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C-NMR (75 MHz, CDCl3) spectrum of compound 2-15:  
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C-NMR (75 MHz, CDCl3) spectrum of compound 2-16: 
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Chapter 3: Benzene-fused BODIPYs: Synthesis and the 
Impact of Fusion Mode 
3.1 Introduction  
In the design of narrow HOMO-LUMO gap molecules, decreasing the 
LUMO energy level while maintaining a moderate increment of the HOMO 
levels is important for the stability towards air oxidation.
1
 Therefore, how to 
efficiently expand the conjugation system is the key issue to afford NIR dyes. 
In respect to BODIPYs, direct dimerization and oligmerization at the 2,6- or 
3,5-positions of the skeleton seems to be the most straightforward approach.
2
 
However, the resulting chromophores often suffered from steric congestion 
caused by neighboring substituents, resulting in a twisted non-coplanar 
conformation. Alternatively, fusion of aromatic structures might serve as a 
more efficient way to construct fully ring-fused, planar π-conjugated structure, 
which can be taken at [a], [b] bond or ‘zig-zag’ edge of the BODIPY skeleton 
(Fig 3.1). Several derivatives having the fused structures at the [a] bond have 
been reported,
3
 and the [b] bond-fused derivatives are still limited to only a 
few examples by replacement of the pyrrole rings with 
benzofuro[3,2-b]pyrrole, thianaphtheno[3,2-b]pyrrole, and biphenyl-fused 
pyrrole units.
4
 Indole can also be regarded as a benzannulated pyrrole. 
However, to the best of our knowledge, replacement of pyrrole rings in the 






   
Fig 3.1 a) Schematic [a] and [b] fusion mode on BODIPY scheleton; b) structures of 
the BODIPY derivatives synthesized in this study. 
In addition, fusion of aromatic units at ‘zig-zag’ edge of BODIPY 
skeleton through oxidative cyclodehydrogenation has now been proved as an 
efficient method to extend the -conjugation of BODIPY backbone. The 
resulting dyes exhibited extremely bathochromic shift in absorption spectrum 
together with excellent photo- and air- stability, making this structural 
modification quite impressive.
6
 However, our previous research has clearly 
demonstrated that this fusion process was highly dependent on the electronic 
structures of the meso-aromatic substituents, and only aromatic that adequately 
activated by electron rich groups can be successfully fused onto the ‘zigzag’ 
edge of BODIPY skeleton. As a consequence, ‘D-A’ profile was constructed, 
and the accompanied intramolecular charge transfer would seriously quench 
fluorescence of the chromophore. Thus, exploration of novel synthetic 
pathway for the annulation of aromatic units without electron donating groups 
onto the ‘zigzag’ edge was highly desirable to eliminate intramolecular charge 
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transfer. Therefore, in this chapter convenient synthetic routes will be reported 
to replace the pyrrole with indole to achieve indole-based BODIPY 3-1, and 
bisindole-based BODIPY 3-2, which can also be regarded as benzo[b]-fused 
BODIPYs (Fig 3.1). Meanwhile, a novel strategy to prepare BODIPY 3-3 with 
one benzene unit fused at the [b] bond and one benzene ring fused at the 
zigzag edge will also be demonstrated. Their geometries, electronic structures 
and photophysical properties are investigated to afford a fundamental 
understanding on these new benzene-fused BODIPY dyes. A tetramethyl- 
BODIPY dye 3-4 was also prepared for comparison.
7
 
3.2 Results and discussion 
3.2.1 Synthesis 
The asymmetry benzo[b]-fused BODIPY 3-1 was synthesized through a 
two-step synthetic route (Scheme 3-1). The alkylation-condensation between 
2-amino-benzophenone and 2-bromoacetylphenone gave 
2-benzoyl-3-phenylindole 3-5 in 72% yield.
8
 Compound 3-5 was then reacted 
with 2,4-dimethylpyrrole in the presence of POCl3, followed by addition of 
triethylamine (TEA) and complexation with BF3·OEt2 to afford the 
benzo[b]-fused BODIPY 3-1 as a deep red solid in a total yield of 42%. This 
method likely can be used to prepare a series of benzo[b]-fused BODIPY 
derivatives since the alkylation-condensation sequence between o-amino 





 The symmetric BODIPY 3-2 was prepared through the 
condensation of indole derivatives with the corresponding aldehyde. The 
Suzuki coupling reaction of N-tosyl-3-iodoindole 3-7 with phenylboronic acid 
gave the N-tosyl-3-phenylindole 3-8 in 88% yield. After hydrolysis, the 
resulting 3-phenylindole 3-9 was reacted with benzaldehyde in the presence of 
concentrated hydrochloric acid to produce the key intermediate 3-10.
9
 Without 
further purification, this intermediate was dissolved in anhydrous DCM 
followed by oxidization with DDQ and complexation with borontrifluoride to 
afford the dibenzo[b]-fused BODIPY 3-2 as a blue dye in an overall 20% 
yield.  
 
Scheme 3.1 Synthetic procedures. Reagents and conditions: (a) DMF, 90 
o
C, 16 h, 72%; 
(b) 2,4-dimethylpyrrole, POCl3, DCM, r.t., 12 h; (c) BF3•OEt2, TEA, DCM, 2h, 42% 
for 3-1 from 3-5, 20% for 3-2 from 3-9, 24% for 3-3 from 3-13; (d) phenylboronic acid, 
Pd(PPh3)4, Na2CO3, toluene, 110 
o
C, 24 h,  81%; (e) 10% NaOH, DMSO, EtOH, 50
 o
C, 
94%; (f) benzaldehyde, 37% HCl, MeOH/EtOH, r.t., 12h; (g) DDQ, DCM, reflux, 2h; 
(h) i: LDA, THF, -78 
o
C, 2h; ii: 2-iodobenzoylchloride, r.t., 12h, 21%; (i) Cu, DMF, 140 
o
C, 3h, 95%. 
To synthesize compound 3-3, we attempted the condensation of a fused 
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indole-ketone intermediate 3-13 with pyrrole for the first time. Compound 3-7 
was treated with strong base LDA for lithiation at the 2-position, then reacted 
with 2-iodobenzoyl-chloride to generate 3-11. This compound was then 
treated with activated copper for intra-molecular Ullmann coupling reaction to 
give 3-12,
10
 after hydrolysis, affording the key intermediate benzene-fused 
keto-indole 3-13. Using a similar synthetic methodology to BODIPY 3-1, the 
BODIPY 3-3 was successfully prepared as a pink-red solid in an overall yield 
24% from 3-13. The structures of all these compounds were unambiguously 
identified by NMR spectroscopy and mass spectrometry. 
3.2.2 Photophysical properties  


















 Abs of 3-1
 Abs of 3-2
 Abs of 3-3
 Abs of 3-4
 PL of 3-1
  
Fig 3.2 UV-vis-NIR absorption spectra of 3-1 – 3-4 and normalized emission spectra of 
3-1 in DCM. Inset is the photograph of the solutions of 3-1 – 3-4.  
The UV-vis-NIR absorption spectra of compounds 3-1 – 3-4 and the 
normalized emission spectrum of 3-1 are shown in Fig 3.2. BODIPY 3-1 
shows a relatively broad absorption band with maximum at 512 nm (log ε = 
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4.62, ε: molar extinction coefficient in M-1cm-1), with a slight red-shift by 12 
nm relative to 3-4 (λmax = 500 nm, log ε = 4.90). It exhibits an emission band 
centered at 655 nm with a fluorescence quantum yield of ca. 10% in DCM. 
Interestingly, a very large Stokes shift of 143 nm was observed, which makes 
this dye attractive for bio-imaging application after modification at the 
3-methyl site.
11
 BODIPY 3-2 displays an even broader absorption band 
(covering from 500 nm to 700 nm) with a more red-shifted λmax of 568 nm. 
However, no fluorescence was observed. BODIPY 3-3 exhibits three 
absorption bands, an intense band at 391 nm with a relatively large coefficient 
(log ε = 5.0), a band at 518 nm, which is similar to that of BODIPY 3-1, and a 
broad band ranging from 600 nm to 1100 nm, indicating a highly extended 
π-delocalization caused by fusion of a benzene ring at the zigzag edge of the 
BODIPY core. By assuming an average UV-vis width of 4000 cm
-1
 at 
half-height using the SWizard program,
12
 UV-vis-NIR absorption spectrum of 
BODIPY dyes 3-1, 3-2, 3-3 can also be calculated by time-dependent density 
functional theory (TD-DFT) calculations, which are in agreement with the 
experimental observation.  
3.2.3 Electrochemical properties 
The electrochemical properties of 3-1, 3-2 and 3-3, together with 3-4 for 
comparison, were investigated by cyclic voltammetry in DCM solution 
containing 0.1 M tetra-n-butylammonium hexafluoro-phosphate as the 
supporting electrolyte. As shown in Fig 3.6, compounds 3-4, 3-1 and 3-2 all 
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exhibit one quasi-reversible oxidation wave and one reversible reduction wave 
with half-wave potentials at 1.05 V, -1.68 V for 3-4, 1.11 V, -1.24 V for 3-1, 
and 1.20 V, -0.70 V (vs Fc
+
/Fc) for 3-2, respectively. The half-wave potentials 
of the oxidation waves of these three compounds only show slight difference, 
while the reduction potentials exhibit positive shift from 3-4 to 3-1 then to 3-2, 
indicating that fusion of one benzene ring at the [b] bond of BODIPY can 
efficiently decrease the LUMO energy level, but shows less impact on the 
HOMO energy level. HOMO energy levels of -5.68 eV, -5.79 eV, -5.88 eV 
and LUMO energy levels of -3.32 eV, -3.69 eV, -4.19 eV were estimated for 
3-4, 3-1 and 3-2, respectively, based on the onset potential of the first 
oxidation and reduction wave. 














Fig 3.3  Cyclic voltammograms of 3-1- 3-4 in DCM with 0.1 M Bu4NPF6 as 
supporting electrolyte, AgCl/Ag as reference electrode, Au disk as working electrode, 
Pt wire as counter electrode, and scan rate of 50 mV/s. Fc
+
/Fc was used as external 
reference. 
Compound 3-3 displays one reversible oxidation wave with a half-wave 
potential of 0.78 V and two reversible reduction waves with half-wave 
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potentials of -0.85 V and -1.61 V. The HOMO energy level was estimated to 
be -5.44 eV, 0.33 eV higher than that of 3-1, while the LUMO energy level is 
-4.08 eV, 0.39 eV lower than that of 3-1. Thus, the fusion of a benzene unit at 
the zigzag edge of BODIPY can effectively extend the π-delocalization, 
resulting in an efficiently narrowed energy gap. Electrochemical energy gaps 
of 2.36 eV for 3-4, 2.10 eV for 3-1, 1.69 eV for 3-2 and 1.36 eV for 3-3 were 
then calculated which are in agreement with their optical band gaps estimated 
from the onset of the lowest energy absorption band (2.40 eV for 3-4, 2.23 eV 




























3-4 1.05 -1.68 - -5.68 -3.32 2.36 2.40 
3-1 1.11 -1.24 - -5.79 -3.69 2.10 2.23 
3-2 1.20 -0.70 - -5.88 -4.19 1.69 1.76 
3-3 0.78 -0.85 -1.61 -5.44 -4.08 1.36 1.28 





are the half-wave potentials for respective redox waves with Fc/Fc
+ 
as 
reference. HOMO and LUMO energy levels were calculated from the onset of the first 
oxidation and reduction waves according to equations: HOMO = -(4.8 + Eox
onset
) eV 
and LUMO = - (4.8 + Ered
onset
) eV. a) Obtained from cyclic voltammograms. b) 
Obtained from the low energy absorption onset in the absorption spectra. 
3.2.4 TD-DFT calculations and electronic Structures 
In order to gain better insight into the molecular geometries, electronic 
structures, and optoelectronic properties, time-dependent density function 
theory (TDDFT at B3LYP/6-31G*) calculations were performed for 
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Fig 3.4 Calculated geometry and frontier molecular orbital profiles and HOMO, 
LUMO energy level of 3-1, 3-2 and 3-3. Hydrogen atoms are omitted for clarity. 
The geometries of 3-1, 3-2 and 3-3 were fully optimized in gas phase 
using the default convergence criteria without any constraints and confirmed 
by frequency calculations，and the optimized structures and frontier molecular 
orbital profiles are shown in Fig 3.7. For molecules 3-1 and 3-2, the phenyl 
substitutions at meso- and β-positions are nearly perpendicular to the BODIPY 
plane, and the HOMO and LUMO are homogenously delocalized along the 
fused BODIPY system. 3-3 shows a nearly planar structure. The HOMO 
coefficients are mainly delocalized on the indole-fragment and the fused 
benzene ring at the zigzag edge, while the LUMO coefficients are 
homogenously dispersed along the whole conjugation system. The same 
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tendency to the cyclic voltammetry was observed for the calculated HOMO 
and LUMO energy levels of 3-1, 3-2 and 3-3. The HOMO energy level of 3-1 
(-5.47 eV) and 3-2 (-5.40 eV) are almost same, while a much lower LUMO 
level than that of 3-1 (-2.79 eV) was calculated for 3-2 (-3.21 eV). Meanwhile, 
a higher HOMO energy level (-5.19 eV) and a lower LUMO energy level 
(-3.25 eV) than those of 3-1 was also calculated for 3-3. 
3.3 Conclusion 
In summary, BODIPY derivatives with one or two benzene rings fused at 
different positions (‘zig-zag’ edge and [a] or [b] bond) were successfully 
prepared for the first time using new synthetic methods. The impacts of 
benzene-ring fusion at different positions were investigated by 
absorption/emission spectroscopy and electrochemical measurements assisted 
by DFT calculations. Compound 3-2 represents the first example of 
dibenzo[b,g]-fused BODIPY, and the synthetic method likely can be applied 
for the synthesis of other [b,g]-fused BODIPYs. Dye 3-3 shows NIR 
absorption due to the highly extended p-conjugation, and the new synthetic 
approach opens the door to introducing an aromatic unit without an 
electron-donating group onto the zigzag edge of the BODIPY core, which is 
essential to avoid intra-molecular charge transfer caused by the 
electro-donating groups. Dye 3-1 exhibits long wavelength fluorescence with a 
large Stokes shift, which makes it attractive for bio-imaging application, and 
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this research is underway in our laboratories. 
3.4 Experimental Section 
3.4.1 General Experimental Methods 
All reagents were purchased from commercial suppliers and used as 
received without further purification. Anhydrous dichloromethane (DCM), N, 
N-dimethylformaldehyde (DMF) was distilled from CaH2. Toluene and THF 





C NMR spectra were recorded on Bruker DPX 300 or DRX 500 
NMR spectrometer with tetramethylsilane (TMS) as the internal standard. The 
chemical shift was recorded in ppm and the following abbreviations were used 
to explain the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m 
= multiplet. EI-mass spectra were recorded on Agilent 5975C DIP/MS mass 
spectrometer. MALDI-TOF mass spectra were measured on a Bruker Autoflex 
MALDI-TOF instrument using 1,8,9- trihydroxyanthracene as a matrix. 
UV-vis absorption and fluorescence spectra were recorded on Shimadzu 
UV-1700 spectrometer and RF- 5301 fluorometer, respectively. The solvents 
used for UV-vis and fluorescence measurements are of HPLC grade. The 
electrochemical measurements were carried out in anhydrous and degassed 
DCM containing 0.1 M tetra-n-butylammonium hexafluorophosphate 
(Bu4NPF6) as the supporting electrolyte at a scan rate of 0.05 V/s at room 
temperature. A gold disk was used as working electrode, platinum wire was 
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used as counting electrode, and Ag/AgCl (3 M KCl solution) was used as 
reference electrode. The potential was calibrated against the 
ferrocene/ferrocenium couple. 







 were synthesized according to a literature 
procedure. 
Synthesis of compound 3-1: To a solution of 3-5 (297 mg, 1 mmol) and 
2,4-dimethylpyrrole (114 mg, 1.2 mmol) in degassed anhydrous DCM (40 mL) 
was added POCl3 (0.2 mL, 2.1 mmol) under Ar atmosphere. The solution was 
stirred at room temperature for 24 h until the completed consumption of 3-5 
(monitored by TLC), then poured into 100 mL of a saturated NaHCO3 solution. 
The organic layer was wash with brine and water, dried over anhydrous 
Na2SO4. The solvent was removed under vacuum to afford a crude product 3-6 
as a brown solid. The crude product 3-6 was then dissolved in degassed 
anhydrous DCM (30 mL) and Et3N (0.8 mL, excess), and then BF3·OEt2 (0.9 
mL, excess) were successively added under argon atmosphere. The resulting 
mixture was stirred at room temperature for 2 h. After removing the solvent 
under reduced pressure, the residue was purified by column chromatography 
(silica gel, DCM: hexane = 1: 3) to afford pure product 3-1 (176 mg, 42%) as 
a deep-red solid.
 1
H NMR(CDCl3, 300 MHz): δ 7.83 (d, J = 8.6 Hz, 1H), 7.36 
(m, 1H), 7.17 (d, J = 8.2 Hz, 1H), 7.10 (m, 1H), 7.04 (m, 4H), 6.97 (m, 4H), 
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6.84 (m, 2H), 6.25 (s, 1H), 2.76 (s, 3H), 1.38 (s, 3H) ppm. 
13
C NMR (CDCl3, 
75 MHz): δ 166.2, 149.8, 145.5, 145.1, 138.2, 136.6, 134.7, 133.4, 132.4, 
130.9, 130.2, 129.7, 128.7, 127.9, 126.8, 126.5, 123.0, 121.8, 115.6, 30.4, 16.3. 
HR MS (EI): m/z = 422.1759 [M
+
] and 402.1696 [M
+
-F]; calcd. for 
C27H21BF2N2: 422.1766 (error: -1.62 ppm). 
Synthesis of compound 3-8: A mixture of compound 3-7 (1.59 g, 4 mmol), 
phenylboronic acid (585 mg, 4.8 mmol), toluene (80 mL), and Na2CO3 
aqueous solution (2 M, 8 mL) was degassed by bubbling through argon stream 
for 15 min. Then Pd(PPh3)4 (231 mg, 0.20 mmol) was added and the mixture 
was further degassed for 10 min. The reaction was heated at 110 
o
C for 24 h. 
After cooling down to room temperature, the mixture was poured into water 
and extracted with DCM. The organic layer was washed by water and brine, 
dried over anhydrous Na2SO4. The solvent was removed under vacuum and 
the residue was purified by column chromatography (silica gel, EA: hexane = 
1: 10) to afford pure product 3-8 (1.22 g, 88%) as a white solid. 
1
H NMR 
(CDCl3, 300 MHz): δ 8.06 (d, J = 8.2 Hz, 1H), 7.79 (t, J = 7.9 Hz, 3H), 7.70 (s, 
1H), 7.61 (m, 2H), 7.46 (m, 2H), 7.39-7.21 (m, 5H), 2.3 (s, 3H) ppm. 
13
C 
NMR (CDCl3, 75 MHz): δ 145.7, 136.2, 133.7, 130.6, 130.0, 129.6, 128.6, 
128.2, 127.6, 125.6, 124.7, 124.2, 123.7, 121.1, 114.5, 22.2. MS (ESI): m/z = 
347.24 [M
+
]; calcd. for C21H17NO2S: 347.10. 
Synthesis of compound 3-8: To a solution of 3-8 (695 mg, 2.0 mmol) in 
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EtOH (100 mL) and DMSO (12.5 mL), 10% aq. NaOH (5.0 mL) was added 
slowly. The reaction mixture was stirred at 50
 o
C for 100 min until no more 
starting material existing (monitored by TLC), the solution was concentrated 
under vacuum, poured into water (100 mL), and extracted with EtOAc. The 
combined organic layer was dried over anhydrous Na2SO4, the solvent was 
removed under reduced pressure to give the crude product 3-9 (360 mg, 94%) 
as s white solid. TLC analysis shows that the product obtained was sufficiently 
pure to be used without further purification. To a solution of compound 3-9 
(150 mg, 0.78 mmol) and benzaldehyde (41 mg, 0.39 mmol) in 15 mL of 
methanol, ethanol (2.6 mL) and concentrated hydrochloride acid (1.0 mL) 
were successively added at 0
 o
C under argon atmosphere. The resulting 
mixture was allowed to slowly warm to room temperature, and stirred at this 
temperature overnight. The mixture was concentrated under vacuum and 
poured into ice-water (40 mL), the white precipitate was isolated by filtration, 
dried under vacuum, and then dissolved in degassed anhydrous DCM (30 mL). 
After an addition of DDQ (106 mg, 0.47 mmol), the solution was stirred under 
refluxing condition for 2 h under argon atmosphere. After cooling, Et3N (1.0 
mL, excess) and BF3·OEt2 (1.2 mL, excess) were successively added. The 
mixture was then stirred at room temperature for 2h. The solvent was removed 
under reduced pressure, and the residue was purified by column 
chromatography (silica gel, DCM: hexane = 1:6 to 1:2) to afford pure product 
3-2 (40 mg, 20%) as a deep blue solid. 
1
H NMR (CDCl3, 500 MHz): δ 7.92 (d, 
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J = 8.3 Hz, 2H), 7.46 (m, 2H), 7.21 (d, J = 8.5 Hz, 2H), 6.94-6.87 (m, 10H), 
6.80 (m, 4H), 6.69 (m, 1H), 6.49 (m, 2H) ppm. 
13
C NMR (CDCl3, 125 MHz): 
δ 153.4, 149.6, 144.4, 136.6, 133.7, 133.6, 132.7, 132.0, 131.0, 129.7, 129.3, 





-F]; calcd. for C35H23BF2N2: 520.1922 (error: 3.22 ppm). 
Synthesis of compound 3-11: LDA (4.55 mL, 2M solution in 
heptane/THF/ethylbenzene, 9.07 mmol, 1.2 eq) was slowly added to a 
well-stirred solution of compound 3-7 (3.0 g, 7.56 mmol) in dry THF at -78゜
C under a nitrogen atmosphere. The solution was stirred for 1.5 h and after 
that a solution of 2-iodo-benzoyl chloride (2.41g, 9.06mmol) in dry THF (3 
mL) was added dropwise. The reaction mixture was allowed to slowly warm 
to room temperature and the stirring was proceeded until no more starting 
material 3-7 was detectable by TLC. Then the reaction mixture was 
concentrated under vacuum, poured into water (40 mL), and extracted with 
DCM. The combined organic layer was dried over anhydrous Na2SO4, the 
solvent was removed under reduced pressure and the crude product was 
purified by column chromatography (silica gel, DCM: hexane = 4:1) to give 
pure product 3-11 (1.95 g, yield 21%) as a light yellow solid. 
1
H NMR (CDCl3, 
300 MHz): δ 8.02 (m, 2H), 7.80 (d, J = 8.2 Hz, 2H), 7.46-7.09 (m, 8H), 2.28 (s, 
3H) ppm. 
13
C NMR (CDCl3, 75 MHz): δ 188.8, 146.2, 142.8, 140.5, 137.8, 
136.8, 134.9, 133.7, 132.5, 130.5, 128.7, 128.5, 128.3, 125.5, 124.1, 115.6, 
95.6, 22.3 ppm. MS (ESI): m/z = 649.70 [M
+




Synthesis of compound 3-12: A solution of compound 3-11 (0.50 g, 0.80 
mmol) and activated copper powder (0.150 g, 2.39 mmol) in anhydrous DMF 
(15 mL) was heated at 140 
o
C for 3 h. After cooling, the reaction mixture was 
poured into water (200 mL) and extracted with diethyl ether. The organic layer 
was washed with water and brine, dried over anhydrous Na2SO4, the solvent 
was removed under reduce pressure to afford 3-12 (283 mg, 95%) as a dark 
orange solid. 
1
H NMR (CDCl3, 300 MHz): δ 8.25 (d, J = 8.6 Hz, 1H), 7.97 (d, 
J = 8.4 Hz, 2H), 7.66 (d, J = 7.9 Hz, 1H), 7.46 (m, 1H), 7.42(m, 1H), 
7.37-7.11 (m, 5H), 7.07 (m, 1H) ppm. 
13
C NMR (CDCl3, 75 MHz): δ 181.0, 
146.3, 143.4, 143.1, 137.6, 136.5, 136.1, 135.4, 134.3, 130.6, 129.5, 129.2, 
128.0, 125.4, 124.8, 123.3, 122.4, 120.7, 116.4, 22.3 ppm. MS (ESI): m/z = 
374.18 [M
+
+H]; calcd. for C22H15NO3S: 373.08. 
Synthesis of compound 3-13: To a solution of 3-12 (150 mg, 0.402 mmol) in 
EtOH (20 mL) and DMSO (2.5 mL), 10% aq. NaOH (1.0 mL) was added 
slowly. The reaction mixture was stirred at 50゜oC for 40 min, concentrated 
under vacuum, poured into water (100 mL), and extracted with EtOAc. The 
combined organic layer was dried over anhydrous Na2SO4, filtered and 
evaporated under reduced pressure. The crude product was recrystallized from 
hexane to give the pure product 3-13 (0.06 g, 68%) as a dark red solid. 
1
H 
NMR (d6-DMSO, 300 MHz): δ 12.04 (br, 1H), 7.83 (d, J = 4.8Hz, 1H), 
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7.38-7.26 (m, 4H), 7.24 (d, J = 4.2Hz, 1H), 7.16 (t, J = 4.2Hz, 1H), 7.02 (t, J = 
4.1Hz, 1H) ppm. 
13
C NMR (d6-DMSO, 125 MHz): δ 183.6, 143.0, 134.2, 
133.9, 126.7, 126.2, 123.12, 121.8, 121.4, 120.6, 119.3 ppm. MS (ESI): m/z = 
220.01 [M
+
+H]; calcd. for C15H9NO: 219.07. 
Synthesis of compound 3-3: To a solution of compound 3-13 (40 mg, 0.183 
mmol) and 2,4-dimethylpyrrole (21 mg, 0.22 mmol) in degassed anhydrous 
DCM (20 mL) was added POCl3 (0.2 mL). The solution was stirred at room 
temperature for 24 h and then TEA (1 mL) was added to neutralize the 
solution. The solvent was removed under vacuum and the residue was 
somehow purified by column chromatography (Al2O3, hex: DCM = 1:1) to 
give the crude product 3-14 as a deep brown solid. The crude product 3-14 
was then dissolved in degassed anhydrous DCM (20 mL). Et3N (0.8 mL, 
excess) and BF3·OEt2 (1.0 mL, excess) were successively added. The resulting 
mixture was further stirred for 2h, concentrated under vacuum and then 
purified by column chromatography (silica gel, EA: hexane = 1:9) to afford 
pure product 3-3 (15 mg, yield 24%) as a deep brown solid. 
1
H NMR (CDCl3, 
500 MHz): δ 7.35 (m, 2H), 7.21 (d, J = 3.8 Hz, 1H), 7.09 (m, 1H), 6.83-6.98 
(m, 3H), 6.55-6.60 (m, 1H), 6.34 (s, 1H), 2.71 (s, 3H), 2.47 (s, 3H) ppm. 
13
C 
NMR (CDCl3, 125 MHz): δ 171.6, 148.1, 147.4, 146.5, 144.2, 138.2, 138.1, 
137.4, 133.2, 129.3, 128.2, 128.1, 126.2, 125.1, 124.8, 121.9, 121.4, 115.6, 
29.7, 16.7 ppm. HR MS (EI): m/z = 344.1295 [M
+
]; calcd. for C21H15BF2N2: 




1. HR-Mass (EI) spectra of 3-1 (a), 3-2 (b), 3-3 (c). 
(a) HR-Mass (EI) spectra of 3-1. 
A:\24oct12_eihr\1024wu-ny1001-c1-AV 24/10/2012 05:05:59 PM NY1001
EIHR
1024wu-ny1001-c1-AV #1 RT: 3.55 AV: 1 NL: 3.20E6
T: + c Full ms [ 400.08-434.48]



































430.9728416.9760 420.4682 424.1813408.4625 428.9739418.4523411.9736 415.4243 431.9783427.4217
1024wu-ny1001-c1-AV#1 RT: 3.55
T: + c Full ms [ 400.08-434.48]
m/z= 421.90-422.42







 422.1759  2896877.0   100.00  422.1766    -1.62    17.5 C 27 H 21 N 2 11B 1 F 2
 
(b) HR-Mass (EI) spectra of 3-2. 
A:\24oct12_eihr\1024wu-ny1002-c1-AV 24/10/2012 05:32:51 PM NY1002
EIHR
1024wu-ny1002-c1-AV #1 RT: 4.87 AV: 1 NL: 3.69E6
T: + c Full ms [ 500.19-533.98]

































530.9697528.9749522.2010518.1869505.9717 532.2187514.9737513.2177509.9748 523.9673 526.9861507.9697
1024wu-ny1002-c1-AV#1 RT: 4.87
T: + c Full ms [ 500.19-533.98]
m/z= 520.04-520.36







 520.1939  2190730.0   100.00  520.1939    -0.08    29.0 C 39 H 24 N 2
 520.1922     3.22    24.5 C35H23N2 11B1F2
 
(c) HR-Mass (EI) spectra of 3-3. 
A:\24oct12_eihr\1024wu-ny1003-c1-AV 24/10/2012 04:32:21 PM NY1003
EIHR
1024wu-ny1003-c1-AV #1 RT: 3.95 AV: 1 NL: 5.71E6
T: + c Full ms [ 325.02-359.98]


































342.1180332.1609 353.1134351.1022327.0921 329.1057 337.3823
341.1107 354.9792326.0532 333.1688 350.3907339.0983 347.1809 359.9787357.0838
1024wu-ny1003-c1-AV#1 RT: 3.95
T: + c Full ms [ 325.02-359.98]
m/z= 343.93-344.34











2. 1H-NMR and 13C-NMR spectra of compounds 3-1, 3-2, 3-3:  
1
H NMR spectrum of 3-1 (300 MHz, CDCl3, RT): 
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H NMR spectrum of 3-2 (500 MHz, CDCl3, RT): 
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H NMR spectrum of 3-3 (500 MHz, CDCl3, RT): 
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Chapter 4: meso-Ester and Carboxylic Acid Substituted 
BODIPYs with Far-red and Near-Infrared Emission for 
Bio-imaging Applications 
4.1 Introduction  
The remarkably technological advances in bio-imaging and sensing area 
have asked for biocompatible fluorescent probes with excitation and emission 
in far-red and near-infrared (NIR) region (650-900 nm), since they avoid the 
use of light which may cause photo-toxicity and auto-fluorescent background.
1
 
Although numerous synthetic far-red and NIR fluorophores with exceptional 
brightness existing, some of them tend to be water-insoluble and membrane 
impermeable due to their hydrophobic character,
2
 some others show poor 
photo-stability and undesired aggregation (such as cyanine, squaraine 
derivatives),
3
 while the other some exhibit unspecific binding to cellular 
components due to lack of appropriate binding sites.
4
 
BODIPY has been recognized as a well-known fluorophore which is 
attracting increasing attentions in various bio-applications because of its 
outstanding photophysical properties, such as excellent environmental stability, 
large molar absorption coefficients, and sharp fluorescence spectrum with high 
fluorescence quantum yield.
1b, 1c, 1d
 For example, recently the pH-activatable 
fluorescence probes including a BODIPY dye have been developed for the 
detection of cancers and real-time monitoring of therapy.
5
 Moreover, new 
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probes generated by combining a BODIPY-based pH-sensing unit with a 
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Fig 4.1 Reported and current strategies towards functional BODIPYs with 
long-wavelength absorption and emission. 
However, the undesirable optical property for most BODIPY dyes with 
absorption and emission locating in less than 600 nm is still one of the severe 
limitations in bio-imaging applications. In recent few decades, a large number 
of far-red and NIR BODIPYs have been synthesized via various chemical 
modification methods (Fig 4.1): 1) functionalization at the α-, β- and meso- 
sites of BODIPY core to extend π-conjugation and to generate a push-pull 
structure;
7 
2) employment of π-extended pyrrole units instead of the simple 
pyrrole to extend the conjugation configuration at the a or b bond of BODIPY;
 
8
 3) replacement of the meso- carbon by imide type nitrogen atom;
9
 and 4) 
oxidative fusion of aromatic units at the zig-zag edge to largely extend the 
π-conjugation.10 Unfortunately, most of the generated BODIPYs showed low 
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fluorescence quantum yields with small Stokes shift and tended to be too 
hydrophobic and membrane impermeable. Moreover, the introduction of 
binding site (such as carboxylic acid) which is essential to connect with some 
specific bio-probes to these π-extended BODIPY systems was also a big 
synthetic challenge. Herein, we propose a new design concept by introduction 
of an ester group to the meso-position of the BODIPY (Fig 4.1) based on the 
following considerations: 1) the ester group is an electron-withdrawing group 
and it is easy to generate a push-pull type structure and to extend 
π-conjugation by functionalization at the α-position of the BODIPY core, thus 
it is possible to easily push the absorption and emission wavelength to the 
far-red or NIR region; 2) the ester group can be hydrolyzed to form carboxylic 
acid  group, which is an important binding site for various biomolecules and 
bio-components
11
 and also a versatile functional group for further conjugation; 
3) hydrophilic groups such as oligo(ethylene glycol) ether can be easily 
introduced by condensation reaction at the α-positions of the BODIPY to 
ensure the compounds sufficient hydrophilicity and membrane permeability.
12
 
To the best of our knowledge, such type of BODIPY dyes has never been 
reported, although there are some BODIPYs with an ester or carboxylic group 
linked by an alkyl or phenyl spacer.
13
 In this work, a series of meso-ester 
substituted BODIPY dyes 4-1 – 4-6 and two meso-carboxylic acid 
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Fig 4.2 Chemical structures of the meso-ester and COOH substituted BODIPYs 
reported in this work. 
These new dyes exhibited tunable absorption and emission spectra in the 
far-red or even the NIR region with acceptable fluorescence quantum yields 
and large Stokes shifts. Most of them have appropriate hydrophilicity and are 
membrane permeable. The successful conversion of the ester group to the 
carboxylic group provides many opportunities for further conjugation and 
specific binding studies. Our work started from the synthesis of the simplest 
meso-ester BODIPY 4-1, to the more π-conjugated dye 4-2, then to the 
push-pull type dyes 4-3 – 4-6 with oligo(ethylene glycol) ether groups, and 
finally to the meso-COOH substituted BODIPY dyes 4-7 and 4-8, with the aim 
to tune their absorption/emission wavelength, fluorescence quantum yield, 
Stokes shift, hydrophilicity, and to introduce specific binding sites. 
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Time-dependent density functional theory (TD-DFT) calculations were 
conducted to get more insight to their optical properties. At the end, cell 
staining experiments were performed to probe their potentials for bio-imaging 
and bio-labeling applications. 
4.2 Results and discussion  
4.2.1 Synthesis 
The meso-ester substituted BODIPYs 4-1 and 4-2 were prepared in 20% 
and 28% yield, respectively, by condensation of ethyl glyoxalate (4-9) with 
2-ethyl pyrrole (4-10) or 2-(3,5-di-tert-butylphenyl)pyrrole (4-11)
 10a
 in the 
presence of trifluoroacetic acid (TFA) in dichloromethane (DCM) followed by 
oxidative dehydrogenation with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
(DDQ) and complexation with BF3•Et2O (Scheme 1).
14
 Attempted hydrolysis 
of the ester groups in 4-1 and 4-2 by strong bases (e.g. KOH, NaOH and LiOH) 
in high-polar solvents (THF, MeOH and water) at room temperature
 
all 
resulted in decomposition of the starting materials presumably due to the 
nucleophilic attack to the B-F bonds.
15
 Meanwhile, further modification and 
functionalization of these two molecules are too hard to proceed. Thus, a 
slightly structural change was performed upon the replacement of the 2-ethyl 
pyrrole by 2,4-dimethylpyrrole, and then functionalization can be realized by 
condensation with corresponding aldehyde at the 3,5-methyl sites of the 
resulting BODIPYs. On the other hand, in attempt to access meso-COOH 
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substituted BODIPYs, rationalization of the hydrolysis reaction was taken 
upon the benzyl (Bn)-, tert-butyl and methyl protected ester groups, which 
will be discussed successively (Scheme 4.1). 
 
Scheme 4.1 Synthesis of the meso-ester and carboxylic acid functionalized BODIPYs 
4-1 – 4-8: (a) i) BF3•Et2O, CH2Cl2, RT, 3h; ii) DDQ, RT, 1h; iii) Et3N, BF3•Et2O, RT, 1h; 
(b) i) 2,4-dimethylpyrrole, -78 
o
C, 4h; ii) Et3N, BF3•Et2O, BF3•OEt2, -78 
o
C to RT, 2h; 
(c) piperidine, AcOH, toluene, reflux, 12h; (d) 10 % Pd/C, 1 atm H2, RT, 4h; (e) 
tert-butanol, DCC, anhydrous diethyl ether, RT, 5h; (f) HCl, CH3NO2, 0 
o
C to RT, 4h; 
(g) LiI, ethyl acetate, reflux, 8h. 
Palladium catalyzed reduction was a preferable approach to achieve 
carboxylic acid group from benzyl-ester, since it is a neat and tidy reaction 
with very high yield.
16
 Thus, benzyl-ester substituted BODIPY was chosen as 
the first choice. Benzyl-2-chloro-2-oxoacetate 4-14 was obtained by adding 
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one equivalent of benzyl alcohol (4-12) drop-wise to the solution of oxalyl 
chloride (4-13) in dry chloroform.
17
 The solution was then stirred at room 
temperature (RT) for 2 hours and the resulting compound 4-14 was then 
directly used for the subsequent condensation reaction with 2,4- 
dimethylpyrrole at -78 
o
C without further purification. After complexation 
with BF3•OEt2, compound 4-15 was separated in a total yield of 45%. For this 
condensation reaction, low temperature was quite necessary, since the high 
reactivity of benzyl-2-chloro-2-oxoacetate generated many by-products at RT, 
resulting in a much lower overall yield of 13%. The sufficient reactivity of 
3,5-methyl groups in 4-15 made functionalization at these positions realistic. 
Condensation of 4-15 with 4-(diphenylamino)benzaldehyde 4-16 gave the 
π-extended BODIPY 4-17 in 47% yield.18 Hydrogenation of 4-17 was catalyst 
by 10% Pd/C in 1 atm H2 atmosphere,
16
 and the thin-layer chromatography 
(TLC) analysis indicated that the benzyl group was assuredly removed. 
However, UV/Vis absorption spectrum and MALDI-TOF analysis of the 
product demonstrated that the double bonds linked to the 3,5-positions of 
BODIPY were also hydrogenated at the same time and gave the major product 
4-18. Alternatively, the benzyl group in 4-15 was removed by similar 
hydrogenation to give the meso-COOH substituted BODIPY 4-19 in nearly 
quantitative yield. However, the subsequent condensation of compound 4-19 




Since the tert-butyl ester group was quite easily to hydrolyze under acid 
conditions, meso- tert-butyl ester substituted BODIPY could serve as another 
choice. Condensation between tert-butyl-2-chloro-2-oxoacetate and 
2,4-dimethylpyrrole at low temperature (-78 
o
C) followed by oxidation and 
complexation produced the meso- tert-butyl ester substituted BODIPY 4-20 in 
very low yield (< 5%) since tert-butyl group was easy to be removed under an 
acidic condition. On the other hand, esterification of 4-19 in excessive amount 
of tert-butanol using N,N'-dicyclohexylcarbodiimide (DCC) as dehydrate 
reagent gave 4-20 in 85% yield. Subsequent condensation with corresponding 
oligo(ethylene glycol) ether substituted benzaldehyde and naphthalene 
aldehyde afforded the meso- tert-butyl ester BODIPYs 4-3 and 4-4 in 44% and 
39% yield, respectively. Finally, hydrolysis of 4-3 and 4-4 by HCl (aq.) in 
nitromethane at room temperature
19
 successfully gave the meso-COOH 
BODIPYs 4-7 and 4-8 in 28% and 22% separation yield, respectively. The 
TLC analysis demonstrated that some of the starting material was decomposed; 
moreover, the high polarity of the carboxylic acid led to a significant loss of 
the compound during the column chromatography on silica gel column, 
resulting in low separation yield. The generated meso-COOH substituted 
BODIPYs 4-7 and 4-8 were fully soluble in pure water thanks to the 
carboxylic acid group at the meso-site and the oligo(ethylene glycol) ether 
group localized at the other terminals. 
The six-step synthetic approach toward meso-COOH substituted 
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BODIPYs 4-7 and 4-8 was tedious and the overall yield was low. In order to 
simplify the synthesis, we finally developed a more convenient approach with 
fewer steps and much higher overall yield. The meso- methyl ester substituted 
BODIPY 4-22 was synthesized from methyl-chorooxalate (4-21) in 56% yield 
according to the similar procedure with 4-15 (Scheme 1).  Similar 
condensation reaction of 4-22 with the corresponding aldehyde gave the meso- 
methyl ester substituted BODIPYs 4-5 and 4-6 in 51% and 48% yield, 
respectively. The hydrolysis of the meso- COOMe group turned out to be the 
major challenge again. We have tried various conditions, that is to say, using 
strong base resulted in decomposition while using strong acid like HCl or 
organic base like triethylamine and pyridine could not remove the methyl 
group.
20 
Fortunately, after many optimizations, we found that using the Lewis 
acid lithium iodide as reagent and ethyl acetate as solvent under reflux was the 
best condition, which provided the desired meso-COOH substituted BODIPYs 
4-7 and 4-8 in 57% and 48% yield, respectively.
21
 The TLC analysis indicated 
that the conversion yield was nearly quantitative but the separation yield was 
much lower due to the loss during the purification.
 
This approach has made the 
water soluble meso-COOH substituted BODIPYs 4-7 and 4-8 accessible in 
only three steps, and the separation yield of each step is around 50%. The 
structures of all these compounds were unambiguously indentified by NMR 
spectroscopy and mass spectrometry. 
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4.2.2 Optical properties  



































































































Fig 4.3 Normalized absorption (black), and emission (red) spectra of (a) dye 4-1 (λex = 
510 nm) and (b) dye 4-2 (λex = 560 nm) in CH2Cl2. 
The absorption and normalized emission spectra of 4-1 and 4-2 in DCM 
are shown in Fig 4.3 and the data are collected in Table 4.1. For dye 4-1, the 
maximum absorption wavelength (λabs
max
) located at 536 nm, which exhibits a 
bathochromic shift of 40 nm compared to those of the congeners with alkyl 
substituents.
4
 The moderate bathochromic shift can be attributed to the 
inductive effect from the COOEt group, which is consistent with the results on 
the meso-CF3 substituted BODIPY derivative (λabs
max
 = 548 nm).
22
 The 
maximum emission wavelength (λem
max
) is at 592 nm, which is much longer 
than that of meso-CF3 substituted BODIPY. The absorption and emission 
spectra of 4-1 are almost completely apart from each other with a large Stokes 
shift (∆ν = 1765 cm-1). The unusually red-shifted emission and the large 
Stokes shift are likely associated with the remarkable geometrical difference 
between the first singlet excited state and the ground-state (to be discussed in 
the DFT calculation section).
23
 In addition, 4-1 shows high fluorescence 
quantum yields (Φ = 0.63 in methanol and 0.78 in DCM) with good storage 
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and photo-stability. The absorption spectrum of 4-2 was centered at 592 nm 
while the emission maximum located at 653 nm, with a large Stokes shift too 
(∆ν = 1578 cm-1). In comparison to 4-1, the aryl group at the 3, 5-positions of 
BODIPY caused a noteworthy bathochromic shift (60 nm) due to extended 
-conjugation. The fluorescence quantum yield of 4-2 in DCM (Ф = 0.17) is 
much lower than that of 4-1, which can be attributed to non-irradiative energy 
loss arising from the free-rotation of the aryl substituents. 
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Fig 4.4 (a)-(d): absorption (black) and normalized emission spectrum (red) of dyes 4-3 
- 4-6 in methanol; (e)-(f): absorption (solid) and normalized emission spectrum (dash) 
of dye 4-7 and 4-8 in methanol and pure water. 
After functionalization at 3,5-positions by oligo(ethylene glycol) 
ether-substituted styryl or naphthalene vinylene groups, the absorption and 
emission wavelength of dyes 4-6 in methanol displayed remarkably 
bathochromic shift (Fig 4.4 and Table 4.1). The maximum absorption 
wavelength goes to ca. 658 nm for 4-3 and 4-5, with fluorescence at 684 nm 
(Ф = 19%) and 663 nm (Ф = 6%), respectively. Dye 4-3 displays a larger 
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Stokes shift (∆ν = 601 cm-1) than 5 (∆ν = 115 cm-1), but both are significantly 
smaller than that of 4-1 and 4-2. Attachment of naphthalene groups at the 
3,5-methyl position results in an even more noteworthy bathochromic shift, 
with the absorption maximum of 4-4 and 4-6 at ca. 680 nm and fluorescence at 
ca. 728 nm (Ф = 11% for 4-4 and Ф = 6% for 4-6). Large Stokes shifts of 998 
cm
-1
 for 4-4 and 908 cm
-1
 for 4-6 were observed, which are desirable for NIR 
fluorophores. These four dyes show good solubility in high polar solvent such 
as MeOH, DMSO, and even in PBS buffer solution containing 2% DMSO. 
Meanwhile, the storage and photo-stability of these BODIPYs dyes are 
excellent. What’s foremost is that the fluorescence goes to far-red and NIR 
region (above 700 nm) with acceptable quantum yield and large Stokes shift. 
All these excellent features make these dyes considerably attractive for 
bio-imaging applications. 
After hydrolysis, the meso-COOH substituted BODIPYs 4-7 and 4-8 are 
soluble in both methanol and water, and a blue-shift of their absorption and 
emission spectra was observed compared with their corresponding meso-ester 
analogs 4-3 – 4-6 (Fig 4.4 and Table 4.1).  The λabs
max
 of 4-7 centered at 627 
nm in MeOH and 628 nm in pure water, while he λem
max
 located at 642 nm in 
methanol and 646 nm in pure water, with remarkable fluorescence quantum 
yield (Ф = 36% in methanol and Φ = 15% in pure water). This can be regarded 
as a significant progress for BODIPY dyes, especially for fluorophores with 
emission around or above 650 nm. For 4-8, the λabs
max
 goes to 645 in methanol 
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and 641 nm in pure water, with λem
max
 located at 676 nm (Ф = 15 %) and 680 
nm (Ф = 3%), respectively. The prominent features of these two meso-COOH 
substituted BODIPY dyes, namely good water solubility, long wavelength 
absorption and emission, appreciable fluorescence quantum yields in pure 
water, existence of carboxylic acid as a bonding site, and excellent storage and 
photo-stability make them highly attractive for bio-applications. 


















4-1 CH2Cl2 536 4.70 592 1765 0.78 
4-2 CH2Cl2 592 4.40 653 1578 0.17 
4-3 MeOH 657 4.80 684 601 0.19 
4-4 MeOH 680 4.89 729 998 0.11 
4-5 MeOH 658 5.08 663 115 0.06 
4-6 MeOH 682 4.83 727 908 0.06 
4-7 MeOH 627 4.48 642 373 0.36 
   H2O 628 4.36 646 544 0.15 
4-8 MeOH 645 4.78 676 711 0.15 
 H2O 641 4.38 680 895 0.03 
4.2.3 DFT calculations 
To get more insights to the optical properties of these new meso-ester and 
carboxylic acid substituted BODIPY dyes, time-dependent DFT calculations 
were conducted at the B3LYP/6-31G*level of theory for the model 
compounds, as implemented in the Gaussian 09 program package.
24
 TD-DFT 
geometry optimizations for the 1
st
 excited state of compounds 4-1 and 4-5 
(root=1) were conducted using the default SCRF method with the integral 





 UV-vis-NIR absorption spectra were generated assuming an 
average UV-vis width of 3000 cm
-1




Fig 4.5 Calculated frontier molecular orbital profiles and the HOMO/LUMO energy 
levels of 4-1 (1) – 4-8 (8). To simplify calculations, the ethylene glycol ether groups 
were replaced by methoxy groups 
The calculated frontier molecular orbital profiles and energy levels are 
shown in Fig 4.5. For dyes 4-2 – 4-8, while the HOMOs are delocalized 
through the BODIPY core to the aryl substituents, the LUMOs are mainly 
located on the BODIPY core with a partial disjoint feature, indicating an 
intramolecular push-pull character, which also explains the large red shift in 
the absorption spectra. TD DFT calculations also predicted that dyes 4-1 – 4-8 
would show absorption maximum at 423, 505, 596, 634, 592, 631, 594, 634 
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nm (under vacuum), respectively, and this trend is in consistence with the 
experimental data. 
 
Fig 4.6 Calculated geometry of the ground state (S0) and the first excited state (S1) for 
molecules 4-1 (1) and 4-5 (5). To simplify calculations, the ethylene glycol ether 
groups in molecule 4-5 were replaced by methoxy groups. 
The much larger Stokes shift observed for 4-1 and 4-2 in comparison to 
other dyes (4-3 – 4-8) is also an interesting feature. To further understand the 
origin of this difference, the ground state (S0) and the first singlet excited state 
(S1) of the molecules 4-1 and 4-5 were calculated in CH2Cl2 and MeOH, 
respectively. The optimized geometry of 4-1 in the S0 state shows a large twist 
of the ester group from the BODIPY plan with a torsion angle of 64.5
o
, which 
becomes much smaller (1.7
o
) in the S1 state (Fig 4.6). Such significant change 
of the geometry from S0 to S1 state should be ascribed to the large Stokes shift 
observed in 4-1. On the other hand, the torsion angle changes from 87.7
o
 in S0 
state to 61.9
o
 in S1 state for 4-5, and such as small change of the geometry can 
explain the relatively smaller Stokes shift observed for 4-5. The two methyl 
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groups at the meso-positions in molecules 4-3 – 4-8 are supposed to limit the 
free rotation of the ester or carboxylic acid group, thus leading to a small 
Stokes shift. The TD-DFT calculations in solvents revealed that 4-1 in CH2Cl2 
would show S0→S1 absorption and S1→S0 emission at 441 nm and 509 nm, 
respectively (Stokes shift = 3027 cm
-1
), and 4-5 in MeOH would exhibit 
S0→S1 absorption and S1→S0 state emission state emission at  637 nm and 
685 nm, respectively (Stokes shift = 1100 cm
-1
). Such trend is reasonably 
agreed with the experimental data. Therefore, for the future design, it would 
be essential to keep the two β-sites of the BODIPY core un-substituted if a 
larger Stokes shift is required. 
4.2.4 Cell staining test 
Encouraged by the outstanding features of the meso-ester and 
meso-COOH substituted BODIPYs, epi-fluorescent microscope was then 
employed to examine the imaging ability of these dyes in living HeLa cells 
(Fig 4.7). 1µM of each dye was treated in live HeLa cell for 1 hr and image 
was then taken under Cy5, Texas-Red or NIR filter according to the excitation 
and emission wavelength of the dyes. Nucleus of the cell was stained using 
hoechst and image was taken under DAPI filter. Both of images were taken by 
40x objective lens and merged.
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HeLa cells loaded with 4-1 showed a bright red cell profile. Strong 
fluorescence from the cellular cytoplasm was observed for dye-loaded HeLa 
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cells, implying that dye 4-1 can efficiently diffuse into HeLa cells and retain 
within, thus membrane permeability was confirmed. However, dye 4-2 was 
not proper for cell imaging experiment due to its high hydrophobicity and thus 
low solubility in cell growth media. 
While for the BODIPY dyes functionalized at the α-positions (4-3 – 4-8), 
the extended -conjugation induced significant red-shift in absorption and 
emission, meanwhile the coupled oligo(ethylene glycol) ether groups would 
improve the hydrophilicity by forming a hydrophilic terminal within the 
structure. It was found that all of the meso-ester substituted BODIPYs 4-3 – 
4-6 can stain HeLa cells successfully. For 4-3, Texas-red filter was used since 
the emission wavelength is within far-red region. A deep-red cell profile was 
observed, the merge picture indicated that this dye mainly localized in the 
cytoplasm, which is similar with dye 4-1. NIR filter was employed while 
taking the image of HeLa cell stained by 4-4 because of its emission at 727 nm 
(NIR region), also deep-red cell profile was observed with dyes staining 
mainly in cytoplasm. The cell staining tests of dye 4-5 and 4-6 showed similar 
results while Cy5 filter was used for 4-5. The cell imaging results indicate that 
all the four functionalized meso-ester dyes are well cell-membrane permeable 
to let them diffuse into HeLo cells and retain within. The cell profiles with 
deep-red colour were observed upon epi-fluorescent microscopy, implying that 
far-red or even NIR imaging can be realized using these meso-ester substituted 
BODIPYs. Cell staining tests were also conducted for the two water soluble 
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dyes 4-7 and 4-8. The experiment results indicated that 4-7 cannot penetrate 
and stain HeLa cells even if the concentration was raised up to 9 µM. The 
membrane impermeability of compound 4-7 is possibly attributed to the too 
high polarity of this dye and the hindrance coming from the membrane and the 
negatively charged cell components would block its penetration into the cell. 
However, when 1µM of 4-8 was treated in live Hela cell for 1 hr and taken 
image under Cy5 filter, deep-red stained cell profile displayed, implying that 





Fig 4.7 Living HeLa-cell staining with dyes 4-1 – 4-8. 1µM of the dye was treated in 
live Hela cell for 1hr and image was taken under Texas-Red filter (for 4-1, 4-3), NIR 
filter (for 4-4, 4-6) and Cy5 filter (for 4-5, 4-7, 4-8). Nucleus was stained using 
hochest and image was taken under DAPI filter. The scale bar is 10 μm. 
 Altogether, the balance of hydrophobicity and hydrophilicity of the new 
dyes can be adjusted for biological staining purpose by the modification on the 
meso-position and α-positions.  Furthermore, it is also reasonably expected 
that after binding with some specific probes or drug molecules at the 
meso-COOH site, the resulting conjugated compounds would tend to be cell 
membrane permeable, opening the path for targetted bioimaing. 
4.3 Conclusion 
In summary, meso-COOEt substituted BODIPY derivatives 4-1, 4-2 were 
first synthesized and characterized. Motivated by its bright fluorescence with 
large Stokes shift, we have further modified the structure and prepared four 
meso-ester substituted BODIPYs with extended -conjugation (4-3 – 4-6). 
After introduction of oligo(ethylene glycol) ether substituted phenylene 
vinylene or naphthalene vinylene groups, the absorption and emission 
maximum shifted to far-red and NIR region. The resulting meso-ester 
substituted BODIPY dyes also became partially water-soluble with 
appreciable fluorescence quantum yield. Meanwhile, the cell staining tests 
indicate that they are so well membrane permeable to penetrate into living 
HeLa cell. All these features make these dyes attractive for bio-imaging 
applications. Moreover, three different synthetic approaches to access 
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meso-COOH substituted BODIPYs 4-7 – 4-8 were attempted, two of them 
were approved to be feasible including one three-step highly efficient and 
convenient synthetic route. The meso-COOH substituted BODIPYs 4-7 – 4-8 
are soluble in pure water and displayed remarkable fluorescence quantum 
yield at wavelength around or above 650 nm. The carboxylic group can act as 
a versatile binding site to connect some specific probe for bio-targeting and 
sensing applications. In addition, our synthetic strategies can be easily adopted 
to prepare a series of meso-COOH substituted push-pull type BODIPY dyes, 
which have a good potential for dye-sensitized solar cells.
18
 The related 
studies are underway in our laboratory. 
4.4 Experimental Section 
4.4.1 General Experimental Methods 
All reagents were purchased from commercial suppliers and used as 
received without further purification. Anhydrous dichloromethane and DMF 
were distilled from CaH2. Toluene and THF were distilled from 
sodiumbenzophenone immediately prior to use. The 
1
H NMR and 
13
C NMR 
spectra were recorded on Bruker DPX 300 or DRX 500 NMR spectrometer 
with tetramethylsilane as the internal standard. The chemical shift was 
recorded in ppm and the following abbreviations were used to explain the 
multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet. 
EI-mass spectra were recorded on Agilent 5975C DIP/MS mass spectrometer. 
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MALDI-TOF-mass measurements were taken on Bruker Autoflex instrument 
using anthracence-1,8,9-triol as matrix. UV/Vis spectra and fluorescence 
spectra were recorded on Shimadzu UV-1700 spectrometer and RF-5301 
fluorometer, respectively. The solvents used for UV-vis and PL measurements 
are of HPLC grade. Cell staining image were taken under confocal microscopy 
upon living HeLa cell, while the nucleus were stained using hochest and 
image was taken under DAPI filter. Images were taken by 40x objective lens 
and merged. 
4.4.2 Materials Synthesis and Characterization Data 
Compounds R1-CHO
28
 and 2-(3,5-di-tert-butylphenyl)pyrrole (4-11) 
10a, 10b
 
were synthesized according to a literature procedure. 
Synthesis of compound R2-CHO: A slurry of 1-naphthol (3.00 g, 20.8 mmol), 
tosylated triethylene glycol monomethylether (6.1 g, 19.2 mmol), K2CO3
 
(4.00 
g, 25.6 mmol) in acetonitrile was refluxed overnight. The reaction mixture was 
filtered and the isolated organic phase evaporated to dryness in vacuo. The 
crude product was dissolved in EtOAc and filtered through a plug of silica. 
The solvent was removed under vacuum to give 
2,6-bis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)naphthalene as a colorless oil. 
Then the oil was re-dissolved (4.00 g, 13.8 mmol) in dry DMF (15 ml), POCl3 
(8.63 g, 55.1 mmol) was added dropwise, and the resulting mixture was then 
stirred at 80゜C for 8 h under Ar atmosphere. After cooling to room 
temperature, the mixture was washed three times with water, and the organic 
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phase was dried over MgSO4. The solvent was evaporated under reduced 
pressure and the residue was purified by column chromatography (silica gel, 
EA: Hex = 1:3 to 2:1) to give the aldehyde as a light yellow oil (3.57 g, 81%). 
1
H NMR (CDCl3, 500 MHz): δ 10.19 (d, J = 5.75 Hz, 1H), 8.36 (d, J = 4.25 
Hz, 1H), 7.89 (m, 1H), 7.69 (d, J = 3.75 Hz, 1H), 7.56 (d, J = 3.5, 1H), 6.91 
(m, 1H), 4.40 (m, 2H), 4.04 (m, 2H), 3.82 (m, 2H), 3.66-3.72 (m, 4H), 3.54 (m, 
2H), 3.37 (s, 3H) ppm. 
13
C NMR (CDCl3, 125 MHz): δ 192.2, 159.9, 139.5, 
131.9, 129.5, 126.3, 125.5, 125.0, 124.8, 122.5, 103.7, 71.9, 71.0, 70.6, 70.5, 
69.4, 68.2, 59.0 ppm. HR-MS (EI): [M]
+
 = 318.1467, calcd for C18H22O5: 
318.1454. 
Synthesis of compound 4-1: 30 mL of dry DCM in a round bottom flask was 
purged with nitrogen for 10 min. To this solution, ethyl glyoxalate (50% in 
toluene, 204 mg, 1 mmol), 2-ethyl pyrrole (234 mg, 2.2 mmol) and two drops 
of TFA was added. The reaction mixture was stirred for 3 h at room 
temperature. After complete consumption of the aldehyde (monitored by TLC), 
DDQ (248 mg, 1.1 mmol) was added to the reaction mixture. After 60 min, 4 
mL of triethylamine and 5 mL of BF3·OEt2 were added to the mixture. The 
resulting mixture was stirred at room temperature for 1 h. When the reaction 
was completed, the solvent was removed under reduced pressure. The residue 
was purified by column chromatography (silica gel, EtOAc/hexane (1/3, v/v)) 
to give 4-1 as a red solid (64 mg, 20%). 
1
H NMR (500 MHz, CDCl3): δ 7.26 
(d, J = 3.2 Hz, 2H), 6.39 (d, J = 3.2 Hz, 2H), 4.47 (q, J = 6.9 Hz, 2H), 3.04 (q, 
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J = 7.6 Hz, 4H), 1.44 (m, 3H), 1.34 (m, 6H). 
13
C NMR (125 MHz, CDCl3): δ 
166.4, 163.9, 133.1, 130.7, 128.9, 118.5, 62.5, 29.7, 22.3, 14.2, 12.6. HR-MS 
(EI): m/z = 320.1508 ([M]
+
), calcd for C16H19BO2F2N2: 320.1510. 
Synthesis of compound 4-2: 50 mL of dry DCM in a round bottom flask was 
purged with nitrogen for 15 min. To this solution, ethyl glyoxalate (50% in 
toluene, 204 mg, 1 mmol), 2-(3,5-di-tert-butylphenyl) pyrrole
[10a]
 (561 mg, 2.2 
mmol) and two drops of TFA was added. The reaction mixture was stirred for 
3 h at room temperature. After complete consumption of the aldehyde 
(monitored by TLC), DDQ (248 mg, 1.1 mmol) was added to the reaction 
mixture. After 30 min, 4 mL of triethylamine and 5 mL of BF3·OEt2 were 
added to the mixture. The resulting mixture was stirred at room temperature 
for 1 h. When the reaction was completed, the solvent was removed under 
reduced pressure. The residue was purified by column chromatography (silica 
gel, EtOAc/hexane (1/5, v/v)) to give 4-2 as a blue solid (179 mg, 28%). 
1
H 
NMR (500 MHz, CDCl3): δ 7.69 (d, J = 1.9 Hz, 4H), 7.47 (d, J = 1.9 Hz,  
2H), 7.37 (d, J = 3.8 Hz, 2H), 6.64 (d, J = 3.8 Hz, 2H), 4.53 (q, J = 7.6 Hz, 
2H), 1.49 (t, J = 7.6 Hz, 3H), 1.33 (s, 36H). 
13
C NMR (125 MHz, CDCl3): δ 
164.1, 162.0, 150.4, 134.9, 131.8, 130.3, 129.5, 124.3, 123.7, 122.1, 62.6, 34.9, 
31.4. HR-MS (EI): m/z = 640.3999 ([M]
+
), calcd for C40H51BO2F2N2: 
640.4012. 
Synthesis of compound 4-15: To a solution of oxalyl chloride (12.7 g, 100 
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mmol) in anhydrous DCM (50 mL) was added benzyl alcohol (10.8 g, 100 
mmol) in dry DCM (20 mL) via a syringe pump over 0.5 h. The solvent was 
removed in vacuo, affording benzyl-chlorooxalate 4-14 as colorless oil. 
Compound 4-14 was then directly used for the next step reaction without 
further purification. The solution of previously generated colorless oil (2 g, 
10.1 mmol) in anhydrous DCM (20 mL) was then added dropwise to the 
solution of 2,4-dimethylpyrrole (2.4 g, 25.4 mmol) in dry DCM (50 mL) via a 
syringe pump over 1h at -78 
o
C under Ar atmosphere. The resulting mixture 
was then allowed to stir at this temperature for 4 h, after which Et3N (5.6 mL, 
40.4 mmol) was slowly added and the color of the solution turned to 
red-brown. Then BF3·OEt2 (8.0 mL, excess) was added and the solution was 
slowly warmed to room temperature and stirred for two more hours. After 
removing solvent under reduced pressure, the residue was purified by column 
chromatography (silica gel, DCM: Hexane = 1: 6 to 1:2) to afford compound 
4-15 as a dark-red solid (1.76 g, 45%). 
1
H NMR (CDCl3 500 MHz): δ 
7.38-7.43 (m, 5H), 6.03 (s, 2H), 5.38 (s, 2H), 2.52 (s, 6H), 2.02 (s, 6H). 
13
C 
NMR (CDCl3 125 MHz): δ 165.0, 157.6, 141.2, 133.6, 129.2, 129.1, 128.8, 
121.2, 68.6, 14.7, 12.7. HR-MS (EI): m/z = 382.1656 ([M]
+
), calcd for 
C21H21BF2N2O2: 382.1664. 
Compound 4-22: Compound 4-22 was synthesized in 56% yield according to 
the same procedure as compound 4-15, while the methyl-chorooxalate was 
used. 
1
H NMR (CDCl3, 500 MHz): δ 6.06 (s, 2H0, 3.97 (s, 3H), 2.53 (s, 6H), 
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2.11 (s, 6H). 
13
C NMR (CDCl3, 125 MHz): δ 166.4, 158.3, 141.7, 129.5, 129.4, 
121.9, 53.8, 15.4, 13.2. HR-MS (EI): m/z = 306.1337 ([M]+), calcd for 
C15H17BF2N2O2: 306.1351. 
Synthesis of compound 4-20: Synthesis of compound 4-20 using the same 
procedure as 4-15 and 4-22 resulted in a yield of only 4.7%. The procedure 
using compound 4-15 to generate compound 4-20 was described as below. 
Compound 4-15 (500 mg, 1.31 mmol) was dissolved in DCM (10 ml) and a 
small amount of 10% Pd/C powder (5 % mol) was added under Argon 
atmosphere, followed by addition of MeOH (20 mL). The mixture was 
degassed and then filled with H2 gas using a balloon. The resulting mixture 
was then allowed to stir at RT under 1 atm H2 atmosphere for 5 h until no 
starting material exist. Pd/C was removed through filtration and solvent was 
evaporated under vacuum to afford the crude compound 4-19 as a brown-red 
solid in almost quantitatively yield. Without further purification, compound 
4-19 was re-dissolved in mixed solvent of tert-butanol (5 mL) and anhydrous 
diethyl ether (15 mL), then excessive amount of DCC was added fractionally 
in 5 h. The insoluble white solid was removed by filtration, the solvent was 
removed under rotary evaporation, and the residue was purified by column 
chromatography (silica gel, DCM) to afford compound 4-20 as a bright-red 
solid (1.76 g, 45%). 
1
H NMR (CDCl3, 500 MHz): δ 6.05 (s, 2H), 2.53 (s, 6H), 
2.26 (s, 6H), 1.64 (s, 9H). 
13
C NMR (CDCl3, 125 MHz): δ 166.1, 158.1, 141.5, 





), calcd for C18H23BF2N2O2: 348.1821. 
General procedure for the Knoevenagel condensation: In a round 
bottom flask equipped with a Dean stark apparatus, the corresponding 
aldehyde (2.2 eq), piperidine (2 mL) and AcOH (2 mL) were added to a 
solution of BODIPY (1 mmol) in toluene (20 mL). The solution was heated at 
reflux for 12 hours. After cooling to room temperature, the mixture was 
washed three times with water. The organic phase was dried over MgSO4 and 
the solvent was evaporated under reduced pressure. The residue was purified 
by silica gel column chromatography to afford the desired compounds 4-17, 
4-3, 4-4, 4-5 and 4-6. 
Compound 4-17: Yield 47%. 
1
H NMR (CDCl3, 500 MHz): δ 6.96-7.55 (m, 
37H), 6.66 (s, 2H), 5.40 (s, 2H), 2.08 (s, 6H). 
13
C NMR (CDCl3, 125 MHz): δ 
166.3, 154.7, 149.6, 147.8, 139.9, 137.3, 134.5, 130.8, 130.1, 129.8, 129.7, 
129.5, 129.4, 125.8, 124.4, 122.9, 118.2, 117.8, 69.1, 13.6. MS 
(MALDI-TOF): m/z = 892.3717 ([M]
+
), calcd for C59H47BF2N4O2: 892.3760. 
Compound 4-3: Yield 43%. 
1
H NMR (CDCl3, 500 MHz): δ 7.57 (m, 6H), 
7.23 (d, J = 4.8 Hz, 2H), 6.94 (d, J = 2.6 Hz, 2H), 6.68 (s, 2H), 4.18 (t, 4H), 
3.88 (t, 4H), 3.76 (m, 12H), 3.56 (t, 4H), 3.39 (s, 6H), 2.32 (s, 6H), 1.66 (s, 
9H). 
13
C NMR (CDCl3, 125 MHz): δ 164.6, 159.8, 153.9, 139.9, 136.6, 131.0, 
129.6, 129.2, 127.7, 117.4, 117.2, 115.0, 72.0, 70.9, 70.7, 70.6, 69.7, 67.6, 
59.0, 29.7, 28.5, 14.4. MS (MALDI-TOF): m/z = 848.4210 ([M]
+




Compound 4-4: Yield 39%. 
1
H NMR (CDCl3, 500 MHz): δ 8.35 (d, J = 4.25 
Hz, 2H), 8.17 (d, J = 4.25 Hz, 2H), 8.06 (d, J = 8.0 Hz, 2H), 7.95 (d, J = 4.0 
Hz, 2H), 7.73 (d, J = 8 Hz, 2H), 7.49-7.60 (m, 4H), 6.90 (d, J = 8.0 Hz, 2H), 
6.84 (s, 2H), 4.36 (t, 4H), 4.02 (t, 4H), 3.82 (t, 4H), 3.66-3.72 (m, 8H), 3.55 (t, 
4H), 3.37 (s, 6H), 2.38 (s, 6H), 1.69 (s, 9H). 
13
C NMR (CDCl3,125 MHz): δ 
164.6, 155.9, 154.0, 140.0, 133.1, 132.3, 131.2, 127.7, 127.1, 126.2, 125.7, 
125.6, 125.3, 122.9, 119.4, 117.7, 105.3, 85.5, 71.9, 71.0, 70.7, 70.6, 69.7, 
68.0, 59.0, 28.5, 14.4. MS (MALDI-TOF): m/z = 948.4521 ([M]
+
), calcd for 
C54H63BF2N2O10: 948.4544. 
Compound 4-5: Yield 51%. 
1
H NMR (CDCl3, 500 MHz): δ 7.60 (m, 6H), 
7.29 (m, 2H), 7.00 (d, J = 4.35 Hz, 4H), 6.74 (s, 2H), 4.23 (m, 4H), 4.0 (s, 3H), 
3.94 (m, 4H), 3.70-3.80 (m, 12H), 3.62 (m, 4H), 3.45 (s, 6H), 2.22 (s, 6H). 
13
C 
NMR (CDCl3, 125 MHz): δ 166.1, 159.9, 154.1, 139.3, 136.9, 130.8, 129.4, 
129.2, 129.0, 117.5, 117.0, 115.0, 71.9, 70.8, 70.6, 70.5, 69.6, 67.5, 59.0, 52.9, 
12.7. HR-MS (ESI): m/z = 829.3685 ([M+Na]
+
), calcd for C43H53BF2N2NaO10: 
829.3661. 
Compound 4-6: Yield 48%. 
1
H NMR (CDCl3, 300 MHz): δ 8.30 (d, J = 3.75 
Hz, 2H), 8.12 (d, J = 4.05 Hz, 2H), 8.02 (d, J = 7.95 Hz, 2H), 7.90 (d, J = 4.2 
Hz, 2H), 7.66 (d, J = 8.1 Hz, 2H), 7.43-7.56 (m, 4H), 6.85 (d, J = 4.05 Hz, 2H), 
6.79 (s, 2H), 4.32 (m, 4H), 3.95 (m, 7H), 3.77 (m, 4H), 3.63 (m, 8H), 3.50 (m, 
4H), 3.33 (s, 6H), 2.17 (s, 6H). 
13
C NMR (CDCl3, 75 MHz): δ 166.2, 156.0, 
154.3, 139.5, 139.4, 133.4, 132.3, 131.0, 127.1, 126.1, 125.73, 125.70, 125.3, 
125.0, 122.8, 119.2, 117.8, 105.3, 71.9, 71.0, 70.7, 70.6, 69.7, 68.0, 59.0, 53.0, 
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12.8. HR-MS (ESI): m/z = 929.3973 ([M+Na]
+
), calcd for C51H57BF2N2NaO10: 
929.3975. 
Synthesis of meso-COOH substituted BODIPYs: 
Method 1: To a solution of meso-COO-t-Bu substituted BODPYs 4-3 or 4-4 
(0.05 mmol) in CH3NO2 was added concentrated HCl (1.0 mL). The mixture 
was then stirred in an ice-water bath for 4 h, and then diluted by adding DCM 
(50 mL). The solution was dried over Na2SO4 and the solvent was removed 
through rotary evaporation. The residue was purified by column 
chromatography (silica gel, DCM: MeOH = 10:1) to give the expected 
compound. Compound 4-7, yield 28%; compound 4-8, yield 22%. 
Method 2: A mixture of meso-COOMe substituted BODIPYs 4-5 or 4-6 (0.10 
mmol) and LiI (2.0 mmol) in dry ethyl acetate was heated to reflux for 16 h 
under Ar atmosphere. After cooling down to room temperature, a small 
amount of HCl (0.2 ml) was added to quench the reaction. The organic layer 
was dried over Na2SO4 and the solvent was removed under vacuum. The 
residue was purified by column chromatography (silica gel, DCM: MeOH = 




H NMR (CD3OD, 500 MHz): δ 7.77 (d, J = 8.25 Hz, 2H), 
7.61 (d, J = 4.5 Hz, 4H), 7.27 (d, J = 8.25 Hz, 2H), 6.95 (d, J = 4.5 Hz, 4H), 
6.82 (s, 2H), 4.15 (t, 4H), 3.84 (t, J = 5.0 Hz, 4H), 3.69 (m, 8H), 3.53 (m, 4H), 
3.33 (s, 6H), 2.41 (s, 6H). 
13
C NMR (CD3OD, 75 MHz): δ 160.8, 153.9, 140.5, 
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135.7, 132.6, 131.5, 129.9, 118.9, 117.7, 117.5, 116.0, 115.9, 72.8, 71.6, 71.4, 
71.2, 70.7, 68.7, 59.1, 13.3. HR-MS (ESI): m/z = 815.3534 ([M+Na]
+
), calcd. 
for C42H51BF2N2NaO10 : 815.3503. 
Compound 4-8: 
1
H NMR (CD3OD, 500 MHz): δ 8.34 (d, 4H), 8.14 (d, J = 
8.0 Hz, 2H), 8.03 (d, J = 4.25 Hz, 2H), 7.98 (d, J = 8.0 Hz, 2H), 7.64 (t, J = 
4.13 Hz, 2H), 7.53 (t, J = 4.13 Hz, 2H), 7.10 (s , 2H), 7.05 (d, J = 4.25 Hz, 
2H), 4.41 (m, 4H), 4.05 (m, 4H), 3.81 (m, 4H), 3.71 (m, 4H), 3.65 (m, 4H), 
3.53 (m, 4H), 3.36 (s, 6H), 2.47 (s, 6H). 
13
C NMR (CD3OD, 125 MHz): 162.8, 
155.5, 139.2, 132.3, 131.5, 126.9, 126.5, 125.6, 125.0, 124.9, 122.9, 122.3, 
119.8, 116.94, 116.86, 105.1, 71.5, 70.5, 70.2, 70.0, 69.5, 68.0, 57.8, 11.9. 
HR-MS (ESI): m/z = 891.3788 ([M+Na]
+











1. HR-Mass (EI) spectra of 4-1 (a), 4-2 (b) and HR-Mass (ESI) of 4-5 (c), 
4-6 (d), 4-7 (e), 4-8 (f). 
(a) HR-Mass (EI) spectra of 4-1. 
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T: + c Full ms [ 300.01-334.99]
m/z= 319.90-320.41
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(b) HR-Mass (EI) spectra of 4-2. 
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T: + c Full ms [ 300.01-334.99]
m/z= 319.90-320.41
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(c) HR-Mass (ESI) spectra of 4-5. 
 




(e) HR-Mass (ESI) spectra of 4-7. 
 






2. 1H / 13C NMR spectra and HR mass spectra 
1




























































































































































































































































































































































































































































































H NMR spectrum of 4-3 (500 MHz, CDCl3, 298K): 
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H NMR spectrum of 4-4 (500 MHz, CDCl3, 298K): 
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H NMR spectrum of 4-5 (500 MHz, CDCl3, 298K): 
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H NMR spectrum of 4-6 (300 MHz, CDCl3, 298K): 
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H NMR spectrum of 4-7 (500 MHz, CD3OD, 298K): 
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H NMR spectrum of 4-8 (500 MHz, CD3OD, 298K): 
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Chapter 5: Enhancing the Panchromaticity of meso-Ester 
and Carboxylic Acid Substituted BODIPYs by Tuning the 
Donor Groups at the α-methyl site 
5.1 Introduction 
Dye sensitized solar cell (DSSC) has attracted increasing attentions in 
recent few decades, which can serve as a viable alternative to conventional 
solid-state photovoltaic technologies by constructing devices functioning in 
molecular and nano-level.
1
 DSSCs performed better compared to other 
photovoltaic constructs under light diffuse conditions and at high temperature 
and it offered the possibilities to design solar cells with high flexibility in 
shape, color and transparency. Moreover, the key features of low-cost 
investment and fabrication have made this concept highly attractive.
1e
 For the 
DSSCs, the sensitizer is normally considered as an essential component and 
the performance was highly determined by the structural and physical 
properties of the sensitizer including absorption range, anchoring groups and 
the direction of electronic reorganization on excitation. In respect to 
absorption range, near infrared sensitizability and panchromaticity are 
important and challenging goals and these can be attained in principle by 
designing appropriate organic dyes.
2
 Thus, design and synthesis of 
chromophores with panchromatic absorption is highly desirable in this area. 
To date, metal-free organic dyes have been the central topic of development of 
157 
 
DSSCs, amongst which  BODIPY is one of the most popular families.
3
 
BODIPY dyes have certain unique features that could make them highly 
advantageous compared to most other organic dyes:
4
 (i) high absorption 
extinction coefficients and can easily be modified with desired functionalities, 
solubility and aggregation characteristics of the dyes can also be modulated as 
needed upon suitable functionalization; (ii) tunable absorption peak with 
strong absorption cross sections; (iii) inherent asymmetry in charge 
redistribution makes the pinpoints C-8 as the optimal position of charge 
injection; (iv) the directional charge redistribution can be further enhanced 
with strategically placed electron withdrawing and electron-donating groups. 
The first rationally designed example of sensitizer based on BODIPY dye was 
reported a few years ago,
5
 followed by a few more recent articles including 
both liquid electrolyte
6
 and solid state
7
 based DSSCs. In Chapter 4, effective 
approaches have been developed to overcome the challenges in synthesis of 
meso-COOH substituted BODIPYs. How to tune the photophysical features of 
meso-COOH substituted BODIPYs to afford perspective light-harvesting 
chromophores still remained undiscovered. In this chapter, structural 
modification by altering the electron donating subunits at the α-positions of 
meso-COOH BODIPY framework to finely tune the photophysical properties 
and to achieve panchromatic absorption will be discussed in details. Based on 
the work in Chapter 4, BODIPY-based sensitizers with optimal structural and 
physical properties for DSSCs can be easily obtained based on the following 
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considerations: 1) Carboxylic group attached at the meso-site can functionalize 
as an anchor group and an electron-withdrawing group as well, which would 
also activate the α-methyl groups and making functionalization at this position 
easier; 2) donor groups such as triphenylamine can be easily introduced to the 
-positions of BODIPY and the constructed push-pull structure would make 
the absorption spectrum shift to the long-wavelength region, realizing NIR 
sensitizability and panchromaticity; moreover, the non-planar structure of the 
donor groups would suppress the dye aggregation; 3) the well-placed electron 
withdrawing (at meso-site) and electron donating groups (at α-positions) 
push-pull structure will further enhance the directional charge redistribution 




Fig 5.1 Chemical structures meso-COOH substituted push-pull BODIPY sensitizers 
presented in this chapter. 
Herein, we rationally designed and synthesized a series of meso-COOH 
substituted BODIPY dyes 5-1 – 5-4 (Fig 5.1) by varying the electron donating 
groups at the α-position and tuning the absorption band as need. These dyes 
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exhibited broad absorption band, in particular, dyes 5-3 and 5-4 can cover 
almost all the UV-vis and partially NIR region with large absorption 
coefficients, making these dyes promising for DSSCs. 
5.2 Results and Discussion 
5.2.1 Synthesis 
 
Scheme 5.1 Synthetic route of dyes 5-1 – 5-4. a) Pd2(dba)3, PtBu3, sodium 
tert-butoxide, toluene, reflux, 12h, 65%; b) POCl3, DMF, r.t., 80%; c) n-BuLi, THF, 
(CH3)3SnCl, 95%; d) PdCl2(PPh3)2, DMF, 40 
o
C, 70%; e) piperidine, AcOH, toluene, 
reflux, 12h; f) LiI, ethyl acetate, reflux, 8h. 
The Buchwald coupling of diphenylamine 5-5 with 2-bromothiophene in 
the presence of Pd2(dba)3/PtBu3 as catalyst gave compound 5-6 in 65% yield, 
and subsequent formaldehydation  using POCl3 and DMF at 60 
o
C generated 
compound 5-7 in 80% yield (Scheme 5.1).
.9
 Compound 5-7 was further 
quantitatively converted to the corresponding 5-tri-n-butylstannyl analogue 
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5-8 after deprotonation with stoichiometric amounts of n-butyllithium 
followed by quenching with chloro-tri-n-butylsilane. Stille coupling between 
5-8 and the commercially available 5-bromothiophen-2-carboxaldehyde 
afforded 5-9 in 70% yield.
10
 Condensation reaction of the meso-COOMe 
substituted BODIPY 5-10 
11
 with corresponding aldehyde afforded the 
meso-ester substituted BODIPY derivatives 5-1a – 5-4a in 42%, 39%, 40%, 
37% yield respectively. Hydrolysis of the ester group in 5-1a - 5-4a in the 
presence of Lewis acid lithium iodide  gave the desired target compounds 5-1 
– 5-4 in 55%, 52%, 48%, 40% yield, respectively.12  
5.2.2 Optical properties of the sensitizers 5-1 – 5-4 
















































Fig 5.2 a) Absorption spectra of the four precursors 5-1a – 5-4a (in DCM); b) 
Absorption spectra of the four sensitizers 5-1 – 5-4 (in DCM).  
The absorption spectra of dyes 5-1 - 5-4 and their precursors 5-1a – 5-4a 
are shown in Fig 5.2. Dye 5-1 showed an  absorption maximum at 697 nm 
which is almost 200 nm red-shifted compared to 5-10, owing to the extended 
π-conjugation and the push-pull motif. The absorption maxium of 5-2 (λabsmax 
= 699 nm) is almost same to that of 5-1.  Replacement of the bridged phenyl 
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ring by more electron-rich moieties, thiophene or dithiophene, induced more 
significant red shift due to enhanced donor-acceptor interactions, and dyes 5-3 
and 5-4 showed maximum absorption at 774 nm and 732 nm, respectively. 
Similar phenomenon was observed when comparing the absorption spectra of 
the four precursors 5-1a - 5-4a, which may also suggest that the directional 
charge redistribution would be enhanced for more electron donating 
substituents at α-position. Moreover, it’s noteworthy that dyes 5-3 and 5-4 
showed much more intense absorption within 400-600 nm in contrast with 
dyads 5-1 and 5-2, since the typical absorption of thiophene and dithiophene 
subunits well covered this wavelength region. All the four dyes exhibited 
broad absorption band that covered almost all the UV-vis and a part of NIR 
region, especially for dyes 5-3 and 5-4, which make these dyes promising for 
DSSC applications.  
5.2.3 Electrochemical properties 
The electrochemical properties of the BODIPY-based sensitizers 5-1 – 
5-4 were investigated by cyclic voltammetry in DCM solution containing 0.1 
M tetra-n-butylammonium hexafluorophosphate as the supporting electrolyte 
(Fig 5.3). All these BODIPY derivatives exhibited well-resolved oxidation and 
reduction waves. Dye 5-1 showed one reversible reduction wave with 
half-wave potential at -0.67 eV and two reversible oxidation waves with 
half-wave potential at 0.55 V, 1.42 V, respectively. The HOMO and LUMO 
energy level were then calculated as -5.35 eV, -4.13 eV based on the onset of 
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first oxidation and reduction wave, respectively.  















Fig 5.3  Cyclic voltammograms of 5-1- 5-4 in DCM with 0.1 M Bu4NPF6 as 
supporting electrolyte, AgCl/Ag as reference electrode, Au disk as working electrode, 
Pt wire as counter electrode, and scan rate of 50 mV/s. Fc
+
/Fc was used as external 
reference. 
Similarly, sensitizers 5-2, 5-3 and 5-4 all exhibited one reversible 
reduction peak with half-wave potentials at the -0.69 V, -0.66 V and -0.55 V, 
respectively. However, the oxidation waves were more complicated. For dye 
5-2, two reversible and one quasi-reversible peaks were observed with 
half-wave potential at 0.62 V, 1.37 V and 1.72 V, while compounds 5-3 
showed two reversible oxidation peaks with half-wave potential at 0.36 eV, 
1.34 eV. In contrast, three reversible oxidation peaks were observed for dyad 
5-4 with half-wave potential at 0.50 V, 1.04 V and 1.38 V. The HOMO/LUMO 
energy levels and electrochemical gaps of all the four sensitizers obtained 
from the CV measurements and the optical band gaps estimated from the onset 
of the lowest energy absorption band were presented in Table 5.1. The 
163 
 
electrochemical gaps and optical band gaps were in agreement with each other. 















5-1 -5.34 -4.13 0.55, 
1.42 
-0.67 1.23 1.21 
5-2 -5.42 -4.11 0.62, 
1.37, 
1.72 
-0.69 1.31 1.38 
5-3 -5.16 -4.14 0.36, 
1.34 
-0.66 1.02 1.06 
5-4 -5.30 -4.25 0.50, 
1.04, 
1.38 
-0.55 1.05 1.11 
5.3 Conclusion 
In conclusion, a series of push-pull meso-ester and ‘COOH’ substituted 
BODIPY dyes have been synthesized by altering the electron-donor groups at 
the α-position. Due to the constructed push-pull structure, these dyes showed 
panchromatic absorption in the whole UV-vis spectral region and a part of 
NIR region. Their adequately located HOMO and LUMO levels guaranteed 
their good air stability despite the existence of strong electron-donating groups 
in the structure. We believe these findings would be significant for exploring 
their applications for photovoltaic devices, such as DSSCs. 
5.4 Material Synthesis and Characterization Data 
Synthesis of compound 5-7: To a 100 mL round-bottomed flask, anhydrous 
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deoxygenated toluene (20 mL), Pd2(dba)3 (0.091 g, 0.10 mmol), and PtBu3 
(0.25 mmol, 10% weight solution in hexanes, Strem) were added under 
nitrogen. The solution was stirred at room temperature under nitrogen for 20 
min. 5-5 (2.84 g, 7.70 mmol), 2-bromothiophene (3.2 g, 20 mmol), and 
sodium tert-butoxide (3.0 g, 31 mmol) were added. The reaction mixture was 
heated to reflux under nitrogen for 5 h. The solvent was removed by rotary 
evaporation and the crude product was redissolved in 5% ethyl acetate in 
hexanes and was run through a plug of silica gel, eluting with the same solvent. 
The crude product 5-6 was concentrated and then used directly for next step.  
Phosphorus oxychloride (0.98 g, 6.43 mmol) was added dropwise to a 
stirred mixture of 5-6 (2.80 g, 5.84 mmol) and anhydrous 
N,N-dimethylformamide (20 mL) at 0 °C under nitrogen. The reaction mixture 
was stirred at 0 °C for 4 h and then was brought to room temperature for 1 h. 
The reaction mixture was poured into aqueous sodium carbonate, and a 
yellow-orange precipitate formed. The aqueous layer was extracted with ethyl 
acetate, and the organic layer was subsequently washed with aqueous sodium 
carbonate and water. The organic layer was dried with magnesium sulfate, 
filtered, and concentrated by rotary evaporation. Column chromatography over 
silica gel gave 5-7 as a yellow oil (2.37 g, 80 %). 
1
H NMR (400 MHz, CDCl3) 
δ 9.44 (s, 1H), 7.34 – 7.27 (m, 1H), 7.13 (d, J = 7.1 Hz, 4H), 6.79 (d, J = 7.1 
Hz, 4H), 6.08 (d, J = 2.7 Hz, 1H), 3.86 (t, J = 5.8 Hz, 4H), 1.73 – 1.66 (m, 4H), 
1.41 – 1.34 (m, 4H), 1.26 (s, 8H), 0.83 (s, 6H) ppm. 13C NMR (100 MHz, 
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CDCl3) δ 180.98, 166.44, 157.68, 139.06, 138.74, 128.65, 127.21, 115.61, 
109.09, 77.46, 77.14, 76.82, 68.38, 31.64, 29.27, 25.78, 22.67, 14.11 ppm. 
HR-MS (MALDI-TOF): m/z = 479.2451 ([M]
+
), calcd for C29H37NO3S: 
479.2494.  
Synthesis of compound 9: To a solution of compound 5-6 (2.26 g, 5 mmol) in 
THF (20 mL) at -78 °C under nitrogen was added n-butyllithium (3.75 mL, 6 
mmol, 1.6 M in hexanes). The solution was stirred for 5 min. then warmed to 
ambient temperature. The solution was then cooled with an ice/water bath, 
tri-n-butylchlorostannane (35 mL, 130 mmol) was added and the reaction was 
stirred overnight. The mixture was then added to brine. The aqueous layer was 
extracted with methylene chloride. The combined organic layers were dried 
over magnesium sulfate, and the solvent was removed in vacuo to give the 
product 5-8 contaminated with tri-n-butylchlorostannane residue. The product 
was used without further purification.  
To a degassed solution of 5-bromo-2-thiophenecarboxaldehyde (0.42 g, 2.2 
mmol) and compound 5-8 (1.36 g, 2.2 mmol) in DMF (10 mL) was added 
bis(triphenylphosphine)palladium(II) chloride (56 mg, 0.08 mmol). The 
mixture was heated to 80 °C for 10 min, then cooled to 40 °C, and stirred 
under nitrogen for 5 h. The reaction mixture was poured into aqueous sodium 
carbonate, and a yellow-orange precipitate formed. The aqueous layer was 
extracted with ethyl acetate, and the organic layer was subsequently washed 
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with aqueous sodium carbonate and water. The organic layer was dried with 
magnesium sulfate, filtered, and concentrated by rotary evaporation. Column 
chromatography over silica gel gave 5-9 as a red-orange oil (1.76 g, 70%). 
1
H 
NMR (400 MHz, CDCl3) δ 9.68 (s, 1H), 7.48 (d, J = 4.0 Hz, 1H), 7.06 (d, J = 
8.9 Hz, 4H), 6.99 (d, J = 4.1 Hz, 1H), 6.87 (d, J = 3.9 Hz, 1H), 6.76 (d, J = 8.9 
Hz, 4H), 6.18 (d, J = 4.0 Hz, 1H), 3.86 (t, J = 6.5 Hz, 4H), 1.73 – 1.65 (m, 4H), 
1.41 – 1.34 (m, 4H), 1.30 – 1.23 (m, 8H), 0.83 (s, 6H) ppm. 13C NMR (100 
MHz, CDCl3) δ 182.09, 157.16, 156.50, 148.86, 140.26, 139.71, 137.84, 
126.16, 125.87, 123.85, 121.86, 115.38, 113.41, 77.44, 77.12, 76.80, 68.38, 
31.67, 29.35, 25.83, 22.69, 14.12 ppm. HR-MS (MALDI-TOF): m/z = 
561.2361 ([M]
+
), calcd for C33H39NO3S2: 561.2371. 
General procedure for the Knoevenagel condensation: In a round bottom 
flask equipped with a Dean stark apparatus, the corresponding aldehyde (2.2 
eq), piperidine (2 mL) and AcOH (2 mL) were added to a solution of BODIPY 
(1 mmol) in toluene (20 mL). The solution was heated at reflux for 12 hours. 
After cooling to room temperature, the mixture was washed three times with 
water. The organic phase was dried over MgSO4 and the solvent was 
evaporated under reduced pressure. The residue was purified by silica gel 




Compound 5-1a: Yield 42%. 
1
H NMR (400 MHz, CDCl3) δ 7.38 (m, 4H), 
7.10 (m, 2H), 6.70 – 6.44 (m, 6H), 3.90 (s, 3H), 3.00 (s, 10H), 2.09 (s, 6H) 
ppm. 
13
C NMR (100 MHz, CDCl3) δ 166.28, 154.12, 150.93, 138.28, 137.34, 
130.72, 129.50, 127.85, 125.21, 117.33, 115.12, 112.34, 77.65, 77.34, 77.02, 
52.66, 40.29, 12.95 ppm. HR-MS (MALDI-TOF): m/z = 568.2809 ([M]
+
), 
calcd for C33H35BF2N4O2: 568.2821. 
Compound 5-2a: Yield 39%. 
1
H NMR (400 MHz, CDCl3) δ 7.31 (m, 6H), 
7.00 (m, 10H), 6.75 (m, 12H), 6.54 (s, 2H), 3.85 (s, 11H), 2.05 (s, 6H), 1.71 (s, 
8H), 1.46 – 1.25 (m, 24H), 0.86 (s, 12H) ppm. 13C NMR (100 MHz, CDCl3) δ 
166.19, 156.10, 154.01, 149.77, 139.91, 138.67, 136.90, 130.95, 128.95, 
128.48, 127.18, 123.80, 119.62, 117.58, 116.34, 115.49, 77.64, 77.32, 77.01, 
68.32, 52.76, 31.98, 29.67, 26.14, 23.07, 14.41, 12.89 ppm. HR-MS 
(MALDI-TOF): m/z = 1216.6987 ([M]
+
), calcd for C77H91BF2N4O6: 
1216.7000. 
Compound 5-3a: Yield 40%. 
1
H NMR (400 MHz, CDCl3) δ 7.18-6.12 (m, 
26H), 3.85 (m, 11H), 2.03 (s, 6H), 1.68 (s, 8H), 1.38-1.26 (m, 24H), 0.84 (s, 
12H) ppm. 
13
C NMR(100 MHz, CDCl3) δ 166.30, 157.66, 156.50, 153.06, 
140.13, 137.82, 131.20, 130.17, 129.75, 126.28, 126.23, 125.97, 123.86, 
117.65, 115.43, 113.99, 77.69, 77.37, 77.06, 68.30, 52.59, 32.04, 29.71, 26.21, 
23.17, 14.50, 12.90 ppm. HR-MS (MALDI-TOF): m/z = 1228.6114 ([M]
+
), 
calcd for C73H87BF2N4O6S2: 1228.6128. 
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Compound 5-4a: Yield 37%. 
1
H NMR (400 MHz, CDCl3) δ 7.19 (s, 4H), 
7.00 (m, 10H), 6.90 (d, J = 4.0 Hz, 2H), 6.77 (d, J = 3.8 Hz, 2H), 6.71 (d, J = 
8.8 Hz, 8H), 6.53 (s, 2H), 6.23 (d, J = 4.0 Hz, 2H), 3.85 (m, 11H), 2.07 (s, 6H), 
1.69 (d, J = 6.6 Hz, 8H), 1.44 – 1.26 (m, 24H), 0.86 (s, 12H) ppm. 13C NMR 
(100 MHz, CDCl3) δ 156.04, 154.65, 153.11, 141.27, 140.68, 139.86, 138.77, 
131.57, 130.38, 130.16, 129.45, 126.75, 125.36, 124.18, 122.94, 118.01, 
117.57, 115.34, 77.65, 77.33, 77.01, 68.33, 52.77, 32.01, 29.69, 26.16, 23.12, 
14.45, 12.91 ppm. HR-MS (MALDI-TOF): m/z = 1392.5876 ([M]
+
), calcd for 
C81H91BF2N4O6S4: 1392.5883. 
General procedure for hydrolysis: A mixture of meso-COOMe substituted 
BODIPYs (0.10 mmol) and LiI (2.0 mmol) in dry ethyl acetate was heated to 
reflux for 16 h under Ar atmosphere. After cooling down to room temperature, 
a small amount of HCl (0.2 ml) was added to quench the reaction. The organic 
layer was dried over Na2SO4 and the solvent was removed under vacuum. The 
residue was purified by column chromatography (silica gel, DCM: MeOH = 
10:1) to give the target compounds.  
Compound 5-1: Yield 55%. 
1
H NMR (400 MHz, CD3OD) δ 7.36 (m, 6H), 
7.15 (m, 2H), 6.67 (d, J = 8.8 Hz, 6H), 2.91 (s, 12H), 2.33 (s, 6H) ppm. NMR 
(100 MHz, CD3OD) δ 168.00, 151.23, 139.74, 135.61, 132.26, 131.07, 128.41, 
125.20, 115.65, 114.43, 112.15, 67.79, 39.12, 10.08 ppm. HR-MS 
(MALDI-TOF): m/z = 554.2658 ([M]
+
), calcd for C32H33BF2N4O2: 554.2665. 
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Compound 5-2: Yield 52%. 
1
H NMR (400 MHz, CD3OD) δ 7.71 – 7.47 (m, 
4H), 7.29 (m, 4H), 7.13 (m, 2H), 6.90 (d, J = 8.7 Hz, 8H), 6.70 (m, 12H), 3.84 
(d, J = 8.5 Hz, 8H), 2.32 (s, 6H), 1.66 (d, J = 6.5 Hz, 8H), 1.37 (m, 8H), 1.27 – 
1.23 (m, 16H), 0.82 (d, J = 3.5 Hz, 12H) ppm. 
13
C NMR (100 MHz, CDCl3) δ 
167.53, 156.74, 154.64, 150.40, 140.54, 139.30, 137.54, 131.58, 128.58, 
129.10, 127.81, 124.44, 120.27, 118.28, 116.97, 116.12, 77.64, 77.32, 77.01, 
68.92, 32.61, 30.30, 26.77, 15.04, 13.55 ppm. HR-MS (MALDI-TOF): m/z = 
1202.6857 ([M]
+
), calcd for C76H89BF2N4O6: 1202.6843. 
For compounds 5-3 and 5-4, due to their strong stacking, the clear NMR 
spectrum cannot be obtained, even if we tried many ways to disrupt the strong 
-stacking and interaction such as by adding 30% of CS2 as solvent, using 
DMSO or methanol as solvent (solubility of these two compounds were poor 
in methanol and DMSO). Only the signals of the alkyl chains appeared in the 
NMR spectrum. The purification was realized by column chromatography and 
recrystallization from CH3CN for several times, the HR-MS (MALDI-TOF) of 
these two compounds were obtained that were matched with the calculated 
molecular weight. For compound 5-3, yield 48%; HR-MS (MALDI-TOF): m/z 
= 1214.5981 ([M]
+
), calcd for C72H85BF2N4O6S2: 1214.5972. For compound 
5-4, yield 40%; HR-MS (MALDI-TOF): m/z = 1378.5718 ([M]
+






1. HR-Mass (MALDI-TOF) spectra of 5-1 (a), 5-2 (b), 5-3 (c), 5-4 (d). 
(a) HR-Mass (MALDI-TOF) spectra of 5-1. 
 





(c) HR-Mass (MALDI-TOF) spectra of 5-3. 
 




2. 1H-NMR and 13C-NMR spectra of compounds 5-1, 5-2:  
1
H NMR of compound 5-1 (CD3OD, 400 MHz): 
 
13






H NMR of compound 5-2 (CD3OD, 400 MHz): 
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Chapter 6: para- and meta-Quinodimethane Bridged 
BODIPY Dimers: Synthesis, Biradical Character, Physical 
Properties and Selective Reaction with Reactive Oxygen 
Species 
6.1 Introduction  
Diradicals, which represent molecules possessing two ‘unpaired’ 
electrons associated with different atomic centers, are known as common 
intermediates in organic reactions and have received perpetual attentions over 
the years.
1
 The interesting phenomena stem from unpaired electrons have 
made this kind of molecules especially relevant to the multidisciplinary 
frontier of science concerned with weak interatomic/intermolecular 
interactions, and recent research interest was focused on the biradical 
characters in different molecular systems. Among them, -conjugated 
polycyclic hydrocarbons (PHs) bearing a quinoidal structure are one of the 
most famous families.
2
 Quinoidal PHs usually can be drawn as two types of 
resonance structures, a closed-shell Kekulé form and an open-shell biradical 
form, and their intrinsic instability and high reactivity are usually attribute to 
the contribution of the open-shell resonance form in the ground state, which 
can be evaluated by the biradical character index y (0 < y < 1) through 
theoretical calculations on the basis of the natural orbital occupation number 
(NOON)
3
 of the LUMO or experimental measurements.
4
 Quinoidal PHs with 
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pronounced biradical character are commonly identified as open-shell species, 
and their unique optical, electronic and magnetic properties have made them 







 and energy storage devices
8
. However, the open-shell 
structures of these species render them vulnerable to degradation reactions, 
therefore limiting their practical applications. To this end, recent advances in 
the synthesis of open-shell quinoidal PHs emphasized on the stabilization by 
various design concepts, including kinetic blocking of the reactive radical sites 
by  bulk groups,
9
 thermodynamical stabilization by π-electron 
delocalization,
10
 and substitution by electron-withdrawing groups to lower the 
HOMO energy level.
11
 Quinoidal PHs with a small biradical character usually 
behave as close-shell quinoids, and their smaller HOMO–LUMO energy gap, 
unique reactivity, and distinct NIR absorption/emission compared to their 
aromatic analogues making them highly desirable for design of NIR dyes.
12
 In 
addition, the high reactivity of the potential radical sites in the open-shell 
resonance form might allow the formation of covalent bond with some 
specific radical species, and the carbon atom at the binding site would transfer 
from ‘sp2’ to ‘sp3’ hybridization, which would significantly break the 
fully-conjugated system (Fig 6.1), and thereby, inducing a detectable signal in 
optical features to the structure. Thus, a potential method for selective 
detection of some specific radical species based on quinoidal biradicaloids 
would be feasibly. However, to the best of our knowledge, this concept has 
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never been reported so far. Reactive oxygen species (ROS) is one of the most 
important issues of concern among the radical species, since they are 
important mediators in a variety of biological and pathological events, 
including cancer, cardiovascular diseases, inflammatory and 
neurodegenerative diseases.
13
 Therefore  it is essential to measure ROS 
accurately and selectively.  
 
Fig 6.1 Schematic mechanism and design for fluorescence turn-on probes for radical 
species based on p-quinodimethane bridged -conjugated systems. 
To date, many methods have been adopted to detect ROS indirectly by 
measuring NO synthase activity or by testing the effects of anti-ROS 
enzymes,
14
 and directly by spin resonance spectroscopy (ESR),
15
 
chemiluminescence and fluorescence assays.
16
 ROS includes oxygen radicals 
such as superoxide (O2
·-
), hydroxyl radical (HO·), and certain non-radicals 
which are oxidizing agents such as hypochlorous acids (HClO) and hydrogen 
peroxide (H2O2). The conventional fluorescent probes for selective detection 
of ROS were on based on the differential oxidative abilities among the 
species.
16
 However, for benzenoid PH based probes, the detection is highly 
dependent on the radical character of the ROS, that is to say, ROS with higher 
179 
 
radical character was more inclined to be captured. In addition, when highly 
fluorescent moieties are embedded with the benzenoid structure, fluorescence 
turn-on detection can be realized (Fig 6.1). 
 
Fig 6.2 a) Chemical structures of p-QDM and m-QDM bridged BODIPY dimers and 
numbering system of dicyclopentane-fused anthracene; b) the resonance structures of 
the two isomers of BODIPY dimers and the mechanism for sensing hydroxyl radical. 
Herein, we attempted to combine two BODIPY units with a 
p-quinodimethane (p-QDM) or meta-quinodimethane (m-QDM) substructure 
and designed two fully conjugated BODIPY dimers 6-1 and 6-2 based on the 
following considerations: 1) BODIPY is one of the most popular families 
amongst the highly fluorescent dyes, and their notable features, such as an 
excellent stability, intense absorption profiles, and insensitivity to the polarity 
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of the environment made them facilitating as fluorescent probes;
17
 2) our 
previous studies have pointed out that BODIPY is an effective building block 
for stabilization of the highly electron-rich motif.
18
 The electron-withdrawing 
ability of the “BF2” moieties can lower the HOMO energy level of the fused 
dye,
19
 thus prevent the quinoidal BODIPY dimers from oxidative degradation; 
3) both compounds are expected to show significant biradical character and 
thus open the possibility of fluorescence turn on detection of ROS. The 
ground-state geometric and electronic structures of these two BODIPY-dimers 
are of great interest. Our previous studies indicated that the ground state of 
quinoidal PHs was dependent on the substituents and HOMO-LUMO gap.
4b, 
11c, 20
 The two BODIPY fragments can be regarded as electron deficient 
substituents conjugated with a p-QDM or m-QDM unit, and it is interesting to 
understand the impact of the fusion mode on the biradical character of the 
obtained BODIPY dimers. The core structure of these two compounds  can 
be also regarded as an antiaromatic diaza- biscyclopentaanthracene (Fig 6.2 b), 
which is stabilized by the electron-withdrawing “BF2” moieties . The biradical 
forms are supposed to contribute significantly to the ground state due to the 
recovery of the aromaticity of the p-QDM and m-QDM unit, which open the 
opportunities for selective detection of ROS. Both compounds are expected to 
show long-wavelength absorption due to the extended -conjugation, and thus 
they could be also good candidates for stable NIR dyes. In this work, both 
compounds were synthesized. Their ground-state electronic structures and 
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geometries were systematically studied by experimental methods including 
nuclear magnetic resonance (NMR), electron spin resonance (ESR), and 
supported by density functional theory (DFT) calculations. Their 
photophysical properties were investigated by steady-state one-photon 
absorption (OPA), transient absorption (TA), and two-photon absorption (TPA) 
measurements. Their electrochemical properties were probed by cyclic 
voltammetry (CV) and differential pulse voltammetry (DPV). And their 
behaviors upon treatment with different reactive oxygen species (ROS) 
indicated that they can selectively detect hydroxyl radical (HO·) over other 
ROS with significant fluorescence turn-on signal as desired. 
6.2 Results and Discussion  
6.2.1 Synthesis 
The challenges for synthesis of fully-conjugated BODIPY dimers bridged 
by p-QDM or m-QDM come from the various reactive sites of BODIPY 
backbone, thus many uncontrollable side-products would be generated when 
using the general method for constructing fully-conjugated porphyrin dimers, 
oligomers or tapes.
21
 For example, once the BODIPY structure was involved 
in a molecule, reactions under strong Lewis acid condition would result in 
decomposition of BODIPY units; while reactions under strong base, such as 
Grignard reagent, would inducing electrophilic substitution at the ‘Boron’ 
atom.
17a
 Thus, for the synthetic route in a BODIPY system, no reaction 
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promoted by drastic reaction condition should be involved once the BODIPY 
structure was constructed.  
 
Scheme 6.1 Reagents and conditions: a) n-BuLi, THF, -78゜C, 2 hours; Ar-CHO, -78
゜C to RT, overnight; b) NaH, MeI, THF/DMF (4:1), 0゜C to R.T.; 20% for 6-5 in two 
steps from 6-3; c) p-toluenesulfonic acid, acetone/H2O (2:1), reflux for 6 hours; 95% 
for 6-6, 18% for 6-13 in three steps from 6-10; d) i) 2-ethylpyrrole, TFA, DCM, RT, 3 
hours; ii) DDQ, DCM, 2 hours; e) TEA, BF3·OEt2, DCM, RT 0.5 hour; 20% for 6-8 in 
two steps from 6-6 and 25% for 6-15 from 6-13; f) BF3·OEt2, DCM, 20 min; g) DDQ, 
DCM, 0.5 hour; 28% for 6-1 and 45% for 6-2 in three steps from 6-6 and 6-15 
respectively. 
Herein, a facile synthetic approach was developed to construct the 
conjugated BODIPY dimers utilizing an intramolecular Friedel-Crafts 
alkylation reaction as a key step, and the diether dialdehyde 6-6 and 6-13 as 
the key intermediates to construct di-BODIPY precursors 6-8 and 6-13. The 
as-formed lithium reagents of the ethylene glycol protected 
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dibromo-phenyl-dialdehyde 6-3, 6-10 were allowed to react with 
4-tert-butylbenzaldehyde to afford the diols 6-4 and 6-11,
22
 which were then 
directly used for the next step without purification. Methylation
23
 of the 
obtained diols 6-4 and 6-11 after deprotonation by sodium hydride gave the 
ethers 6-5 and 6-12, respectively, and the subsequent acid-promoted 
de-protection
24
 afforded the di-aldehydes 6-6 and 6-13. Acid-catalyzed 
condensation of the obtained di-aldehydes 6-6 and 6-13 with 2-ethylpyrrole 
led to the corresponding dipyrromethane derivatives.
25
 Due to high reactivity, 
the dipyrromethanes were used for the next step without further purification. 
Subsequent oxidation by 2,3-dichloro- 5,6-dicyano-1,4-benzoquinone (DDQ) 
and complexation with BF3·OEt2 afforded the phenyl-bridged di-BODIPY 
precursors 6-8 and 6-15 an overall yield of 20%, 25% respectively in three 
steps, which were then subjected to Friedel−Crafts alkylation reaction 
promoted by BF3·OEt2 to afford compounds 6-9 and 6-16.
26
 The fully 
conjugated dimers 6-1 and 6-2 were finally obtained as dark-green solids by 
oxidation of 6-9 and 6-16 with DDQ. 
6.2.2 Steady-State and Transient Absorption Spectroscopic Measurements 
of the BODIPY dimers 6-1 and 6-2 
The p-QDM bridged BODIPY dimer 6-1 was predicted to have a fully 
conjugated planar motif, while its isomer m-QDM bridged dimer 6-2 was 
supposed to possess a slightly twisted structure owing to the steric hindrance 
between the β-proton in the BODIPY backbone. The better solubility of 6-2 
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than 6-1 in common solvents may serve as an evidence for the assumption. 
The tert-butyl-phenyl substituents attached to the bay region function as bulky 
groups to kinetically block the possible radical sites and to enhance solubility 
as well. Both compounds 6-1 and 6-2 displayed sharp and well resolved 
1
H 
NMR spectra at RT and they are silent in ESR Spectroscopic measurements, 
indicating that they are probably possess a closed-shell structure in the ground 
state.  
























Fig 6.3 UV-vis-NIR absorption spectra of 6-1 and 6-2 in DCM. Insert are the photos of 
the solutions. 
Compounds 6-1 and 6-2 showed well-resolved one-photon absorption 
(OPA) spectra that covered the whole visible and partial near-IR regions with 







), respectively (Fig 6.3 and Table 6.1). The calculated 
electronic transitions of the closed-shell (at RB3LYP/6-31G* level) and 
open-shell singlet biradical (at BS-UB3LYP/6-31G* level) species are shown 
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in Fig. 6.4 and compared with the experimental data. Due to the larger 
contribution from the electronic transitions of ground-state closed-shell 
species, both absorption spectra revealed typical closed-shell BODIPY-like 
spectroscopic features.  
The large bathochromic shifts compared with the BODIPY monomer 
indicated that both are highly extended π-conjugation systems with small 
HOMO-LUMO gaps. Compared with  other conjugated-BODIPY dimer 
structures such as benzo-[b]-fused BODIPY dimer
19b
 and benzo-[a]-fused 
BODIPY dimer,
27
 the NIR absorption of 6-1 and 6-2 are bathochromically 
shifted by 250-350 nm, despite their similar molecular size. Moreover, 
compared with some other large-size NIR dyes with absorption maximum 
beyond 1000 nm, such as bis-BODIPY-fused porphyrin
18b 































, the NIR absorption 
band of 6-1 and 6-2 are much more intense. Therefore, construction of p- and 
m- QDM bridged BODIPY dimer appears to be an efficient method to 
generate NIR dyes with strong absorption. To the best of our knowledge, these 
fully-conjugated BODIPY dimers possess the longest absorption maximum 
ever observed for the neutral BODIPY derivatives and the most intense NIR 
absorbance for dyes with absorption above 1000 nm. The weak absorption 
bands at 627 nm (6-1) and 721 nm (6-2) result in the light-green and cyan 
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color for 6-1 and 6-2 in solution, respectively. In addition, it is also worth 
noting that the intense and sharp near-IR absorption and weak absorption at 
visible region make them almost transparent at lower concentrations in 




































      
Fig 6.4 Experimental absorption spectrum (top) and calculated absorption p of the 
open-shell (middle) and closed-shell (bottom) resonance form of 6-1 (a) and 6-2 (b). 
The fluorescence, temperature dependent absorption and emission 
behaviors of 6-1 and 6-2 were also investigated in details, as shown in Fig 6.5. 
Compound 6-1 gave fluorescence at 1120 nm with a quantum yield of 0.2% 
(Zn2 hexaphyrin as reference) owing to its small HOMO-LUMO gap; while 
compound 6-2 exhibited fluorescence at 1193 nm with an even lower quantum 
yield of 0.02%. The stronger emissive behavior of 6-1 may attribute to its 
lower biradical contribution to the ground state, which will be further 
supported by the DFT calculations (vide infra). Temperature dependent 
emission spectrum reveals that fluorescence enhanced as the temperature 
decreasing (Fig 6.5 b and d), which is normal for common close-shelled 




relaxation. And a slightly enhancement in absorption intensity without 
significant spectral transition was also observed, which further suggested that 
fully-conjugated BODIPY dimers 6-1 and 6-2 have a closed-shell structure in 
the ground state. 





































































































































































W a ve le ng th  (nm )
f)
 
 Fig 6.5 Normalized absorption and fluorescence spectra of 6-1 (a) and 6-2 (c), and the 
temperature dependent absorption spectra of 6-1 (e) and 6-2 (f) as well as the emission 
spectra of 6-1 (b) and 6-2 (d).  
Femtosecond transient absorption (TA) measurements were then carried 
out to explore the excited-state photo-physical properties of 6-1 and 6-2. The 
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TA spectrum of 6-1 exhibited a ground-state bleaching (GSB) signal around 
1110 nm together with moderate excited-state absorption (ESA) bands in the 
480−660 and 750−840 nm spectral regions. For 6-2, a GSB signal was 
observed around 1175 nm and ESA bands appeared in the 480−570 nm and 
640-790 nm spectral regions. The singlet excited-state lifetimes of 6-1 and 6-2 
were estimated to be 25.7 and 22 ps, respectively. The short singlet 
excited-state lifetimes could be correlated to fast non-radiative internal 
conversion process arising from a smaller energy gap between the lowest 
excited state and ground state, which could well explain the weakly 
fluorescent behavior of both isomers.  
 
Fig 6.5 Transient absorption spectra and decay curves of 6-1 (a) and 6-2 (b). 
Recent theoretical and experimental studies on porphyrinoids have 
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indicated that polarizable quinoidal electronic structures
12b
 may be relevant to 
TPA enhancement. Therefore, two-photon absorption measurements were 
conducted for these two p-QDM and m-QDM embedded di-BODIPY 
structures by using open-aperture Z-scan method in toluene in the near-IR 
range from 2000 to 2400 nm, in which one-photon absorption contribution is 
negligible (Fig 6.6, the TPA spectra are plotted at λex/2). 6-1 exhibited TPA 
cross-section σ(2)max = 1300 GM at 2200 nm, which is quite similar to 6-2 
(σ(2)max = 1500 GM at 2300 nm). The large TPA response of these two 
fully-conjugated BODIPY dimers represents the most excellent examples 
among BODIPY derivatives, and it’s comparable with reported porphyrin 
dimers.
12b, 26
 Therefore, the quinoidal BODIPY-dimer structures should play 
important role in the nonlinear optical response. 














































































































































Fig 6.6 Z-scan curves of 6-1 (a, left) and 6-2 (b, left) by photoexcitation in the range 
from 1200 to 1700 nm; and the OPA spectra (solid line and left vertical axis) and TPA 
spectra (blue symbols and right vertical axis) of (a, right) 6-1 and (b, right) 6-2. TPA 
spectra are plotted at λex/2. 
6.2.3 DFT Calculations 
DFT calculations were conducted to understand the geometries and 
electronic structures of both isomers. The structural optimization for 
compound 6-1 calculated at broken-symmetry UB3LYP/6-31G** level of 
theory indicated a planar configuration with π-electrons delocalized across the 
whole rigid conjugated-plane, and the phenyl units are almost perpendicular to 
the π-plane. Nucleus independent chemical shift (NICS(1)zz)30 values for the 
optimized structure calculated at the HF/6-31+G(d,p) level are summarized in 
Fig. 6.7 (c), which reveal disrupted aromatic character for the central benzene 
rings a (-4.16) and b (+2.19). The NICS(0) value for the terminal pyrrole ring 
c is -9.6, which is less negative than that of the pyrrole ring d (-11.77) as well 
as the pyrrole substructure in the indole (-11.3),
19b
 suggesting that pyrrole ring 
c tended to characterize as nonaromatic azafulvene structure. These results 
implied that the resonance form A (Fig 6.7 b), which has a quinoidal structure 
for the central benzene moiety and can be regarded as an antiaromatic diaza- 
biscyclopentaanthracence derivative, should contribute largely to the 
resonance equilibrium in the ground state. The calculated biradical index y of 
6-1 is 0.069 with the singlet-triplet gap (ΔES-T) of -3.49 kcal/mol, which also 




Fig 6.7 (a) DFT optimized structure of 6-1; (b) different resonance structures of 6-1; (c) 
NICS(0) values (ppm) for 6-1 and indole and HOMA values (number in blue color) of 
6-1, calculated at the HF/6-31+G(d,p)// B3LYP/6-31G(d,p) level. 
In contrast, the structural optimization of isomer 6-2 demonstrated a 
slightly twisted structure (Fig 6.7 a)), owing to the steric repulsion between the 
hydrogen atoms at the center. It was found that the energy level of the SB state 
of 6-2 is 3.24 kcal/mol lower than that of the triplet state, and a much higher 
biradical index (0.262) was calculated on the basis of the UB3LYP/6-31G** 
method, indicating that the biradical resonance form contribution of 6-2 is 
larger compared with 6-1. This conclusion can be further manifested from the 
calculated NICS(0) values (Fig 6.8 c)), the central benzene ring a (-6.3) of 6-2 
tends to be more aromatic than that of 6-1 (-4.16), suggesting that structure 
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6-2 has higher tendency to promote the open-shell resonance form. Meanwhile, 
the NICS values of pyrrole ring c (-10.51) and d (-10.33) are almost equal, 
which are both more negative than that of the terminal pyrrole ring c in 6-1, 
implying that both the resonance form A and B contribute to some extent to 
the resonance equilibrium. And the open shell resonance form can be draw as 
C and D according to the NICS(0) values, which is theoretically reasonable. 
  
Fig 6.8 (a) DFT optimized structure of 6-2; (b) resonance structures of 6-2; (c) NICS(0) 
(ppm) and HOMA values  for 6-2 calculated at the HF/6-31+G(d,p)// B3LYP/6-31G(d, 
p) level. 
6.2.4 Electrochemical Properties, Molecular Orbital Profiles and Energy 
Diagram 
Cyclic voltammertry (CV) and differential pulse voltammetry (DPV) (Fig 
6.9) were employed to investigate the electrochemical properties of 6-1 and 
6-2, and both compounds display well-resolved multiple-stage amphoteric 
193 
 
redox behavior. 6-1 gave three oxidation waves at E1/2
ox
 = 0.52, 0.85, 1.22 V 
(vs Fc/Fc
+
, Fc = ferrocene) and two reduction waves at E1/2
red
 = −0.37, −0.72 
V, while 6-2 showed four oxidation waves at E1/2
ox
  = 0.55, 0.70, 0.89, 1.21 
V and two reduction waves at E1/2
red
  = -0.29, -0.66 V. The HOMO and 
LUMO energy levels were determined as -5.26 eV, -4.51 eV for 6-1 and -5.30 
eV, -4.58 eV for 6-2, from the onset potentials of the first oxidation and 
reduction wave. The adequately low HOMO levels that benefit from the 
electron-withdrawing ‘BF2’ moieties of both isomers, have prompted their 
good stability toward air oxidation. Extremely narrowed energy gaps were 
then calculated as 0.75 eV and 0.72 eV for 6-1 and 6-2, respectively, which 
are consistent with those obtained from the optical onset (0.80 for 6-1 and 0.79 
for 6-2). Low energy gaps are usually believed to be a crucial prerequisite for 
the formation of a singlet biradical ground state, however, these two BODIPY 
dimer structures featured as close-shell ground state even with extremely 
narrowed energy gaps.  
















Fig 6.9 Cyclic Voltammetry (CV) and differential pulse voltammetry (DPV) of 6-1 and 
6-2 in CH2Cl2 with 0.1 M Bu4NPF6 as supporting electrolyte, Ag/AgCl as the reference 
electrode, Au disk as the working electrode, Pt wire as the counter electrode, and the 
scan rate at 50 mV/s. 
The calculated (UB3LYP/6-31G**) frontier molecular orbital profiles, energy 
levels and spin density distributions are shown in Fig 6.10. For both isomers, 
while the HOMOs mainly localized at the two BODIPY fragments with a 
partial disjoint feature, LUMOs are delocalized through the whole 
-conjugated framework, the calculated HOMO and LUMO energy levels 
were -4.985 eV, -3.645 eV for 6-1 and -4.945 eV, -3.634 eV for 6-2 
respectively, which showed some discrepancy with the values determined 
from the CV measurements. The spin densities are evenly delocalized over the 
whole π-conjugated framework for both molecules, however the distribution 
was not homogenous. Since the sites with larger spin density may show up 
higher reactive, the spin distribution map can somehow help to predict 
potential reactive sites for the conjugate-BODIPY-dimer structures and 
speculate the possible products after treating with reactive oxygen species, 
which is essential for the ROS detection. Consequently, the meso-position and 
unfused pyrrole units of the BODIPY fragments as well as the position 
kinetically blocked by phenyl groups were determined as the potential reactive 
site with ROS, and the accurate reaction process can be further evidenced by 
the experimental measurements such as, mass spectroscopy, UV and 





Fig 6.10 Calculated spin density distributions of 6-1 (a) and 6-2 (c). The blue and green 
surfaces represent α and β spin densities, respectively. Calculated (UB3LYP/6-31G**) 
HOMO and LUMO profiles for 6-1 (b) and 6-2 (d).  
6.2.5 Selective Fluorescence Turn-on Detection for Hydroxyl Radical over 
Other Reactive Oxygen Species 
The solution of reactive oxygen species includes H2O2, sodium 
hypochlorite and potassium superoxide were prepared from the commercially 
available source. Peroxynitrite was prepared in-house according to established 
procedures.
31
 Hydroxyl radical was generated by Fenton reaction.
32 
6.2.5.1 Titration with Different Reactive Oxygen Species 
The previous experimental results have demonstrated that both 
fully-fused BODIPY dimers 6-1 and 6-2 exhibited excellent NIR absorption 
profiles with extremely poor fluorescence at around 1100 nm. Both isomers 
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were predicted to have some biradical contribution in the ground state, the 
structural features and the spin density distribution determined by DFT 
calculation have convinced that these two dyes possess relatively good 
stability among narrow gap chromophores and potential reactive sites which 
may selectively bind with some specific radical species. Thereby, these 
structures were believed as potential probes for some specific reactive species 
for that reaction on the conjugated-framework would disrupted the whole 
π-system and induce colorimetric and fluorescent changes. The applications of 
these two quinoidal BODIPY dimers for the detection of reactive oxygen 
species were then investigated in details. 























































Fig 6.11 The absorption spectra of 6-1 (a) and 6-2 (b) after treating with 30 equivalents 
of different ROS (6-1 and 6-2 were dissolved in anhydrous THF). 
Firstly, the response of these BODIPY structures to different reactive 
oxygen species were monitored by UV-vis-NIR spectroscopy (Fig 6.11). The 
solution of 6-1 and 6-2 in anhydrous THF displayed differential absorption 
behavior after treating with 30 equivalents of various reactive oxygen species. 
It was found that these fully-conjugated BODIPY structure showed good 
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stability toward the oxygen species including H2O2, NaClO, and ROO-, with 
the initial absorption band centered at around 1100 nm kept at a moderate 
level for even one month in solution state. And the MALDI-TOF analysis 
showed no peaks with larger mass value than the initial di-BODIPY structures 
for all these situations. However, upon treating with oxygen radical species 
(O2
·-
, ONOO-, ·OH), both isomers exhibited dramatic spectral transitions. 
For example, after titration with KO2 and ONOO-, the initial absorption 
band disappears rapidly in 1 hour, while a new intense absorption band at 
around 1500 nm arises. The MALDI-TOF analysis revealed no noteworthy 
distinction with the initial fully-fused di-BODIPY structures, indicating that 
no functional group was added to the framework. Thereby, the significant 
bathochromic shift in spectra is more likely correlated to the formation of 
radical-cation species. Consequently, electron spin resonance (ESR) 
measurements for the resulting solution of both 6-1 and 6-2 displayed a 
featureless broad signal with ge = 2.00261, 2.00278 (Fig 6.12) respectively. To 
better understand the oxidative reaction, oxidation titrations of both isomers 
were then conducted in THF by using various equivalent of KO2 as oxidant 
and the process was followed by UV-vis-NIR absorption spectroscopy. 
Gradually spectral transition were observed as the appearance of new 
characteristic absorption bands in shorter (at around 620 nm for 6-1 and 720 
nm for 6-2) and longer (around 1500 nm) wavelength region with increasing 
intensity while the intensity of initial absorption bands at around 1100 nm 
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decreases upon addition of increment amount of KO2 solution2. Such 
phenomenon commonly attribute to the redistribution of the frontier molecular 
orbital energy level of the radical-cation species, which allowed one electron 
transition at the higher energy and one electron transition at lower energy in 
the new energy diagram. 



























































Fig 6.12 ESR spectrum of 6-1 (a) and 6-2 (b) after treating with KO2 in THF solution 
and measured at room temperature, and chemical oxidation titration curves of 6-1 and 
6-2 by using various equivalent of KO2.  
In addition, after titration with “·OH”, the absorption spectrum of both 
isomers were simplified with all the absorption band at long wavelength 
region disappearing while the absorption band between 500 nm and 600 nm 
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strengthened, and a colorimetric change from light-green to red-brown for 6-1, 
cyan to red-brown for 6-2 were observed. The dramatic alternation of optical 
features clearly indicated the disruption to the fully-conjugated structure of 
both isomers, meanwhile the mass characterization showed two new peaks 
which corresponding to species with addition of one and two hydroxyl groups 
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Fig 6.13 MALDI-TOF spectra of 6-1 (upper) and 6-2 (bottom) after treating with·OH.  
The fluorescent behaviors of 6-1 and 6-2 after treating with different 
ROS were also investigated and shown in Fig 6.14. Both the initial 







nm, after treating with reactive oxygen species including H2O2, KO2, ONOO-, 
ROO- and NaClO, weak fluorescence centered at 664 nm, 658 nm was 
observed for 6-1 and 6-2, respectively. In contrast, noteworthy fluorescence 
with highest intensity amongst all the titration situations was measured for 
both isomers after treating with hydroxyl radical, with a 100 fold and 40 fold 
fluorescence enhancement for probes 6-1, 6-2 separately, suggesting that they 
functionalize as selective fluorescence turn-on probes for hydroxyl radical 
over other ROSs. Colorimetric detection can also be realized on the basis of 
previously mentioned color alternation. 
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Fig 6.14 Fluorescence spectra of 6-1 (a) and 6-2 (b) after treating with ROS. The 
fluorescence intensity of both isomers after treating with different ROS was also 
demonstrated for comparison in histogram.  
6.2.5.2 Considerations on the Additive Reactions with Hydroxyl Radical 
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The multiplicity of the potential reactive sites on the 
conjugated-di-BODIPY frameworks may facilitate many possibilities to the 
addictive reactions with hydroxyl radical species, as ‘OH’ group can be added 
at the kinetically blocked bay sites, the un-substituted sites of the pyrrole 
fragments or the meso-positions of the BODIPY cores, as well as the mixture 
of these potential products. Therefore, confirmation of the resulted structures 
would be difficult, and the UV-vis-NIR absorption features could provide 
useful information. Firstly, ‘OH’ groups attached on the un-substituted 
position of the pyrrole fragments would induce negligible influence to the 
absorption spectra of the conjugated-di-BODIPY structures, thereby, can be 
excluded. However, the construction of covalent bond with ‘OH’ at both the 
meso-positions of BODIPY subunits and the bay-sites of the quinoidal 
fragment would definitely disrupt the conjugation system and induce the 
observed spectral transitions. And if the ‘OH’ groups were attached at the 
bay-site, the absorption and emission spectra of the resulting structure from 
6-1 and 6-2 should show some similarities with the ‘CH’ bridged BODIPY 
dimers 6-9, 6-16 respectively, which were generated by the Friedel-Crafts 
alkylation reaction in the synthetic process.  
As shown in Fig 6.15 a, for 6-1, the absorption spectrum displayed three 
peaks at 638 nm, 519 nm, and 418 nm respectively after titration by hydroxyl 
radical, while for the ‘CH’ bridged BODIPY dimer 6-9 exhibited two intense 
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bands at 542 nm and 424 nm with shoulder peaks accompanied with a weak 
absorption band at 634 nm were observed. In spite of the similar bands 
distribution, the spectral shapes are quite different from each other, which may 
attribute to the impurities in the titration system. In contrast, their emissive 
behaviors displayed high similarities both in spectral shape and band 
distributions, and a slightly shift of 56 nm was observed for the titration 
mixture of 6-1 (660 nm) over 6-9 (604 nm) owing to the electronic distinctions 
between ‘H’ and ‘OH’ groups. Similar phenomena was observed for 6-2, after 
titration by hydroxyl radical, the resulting species (two bands located at 557 
nm, 415 nm) exhibited similar band distributions with the ‘CH’ bridged 
BODIPY dimer 6-16 (two bands at 541 nm, 525 nm) as well as the spectral 
shape. In addition, their fluorescence performance is quite similar to each 
other both in spectral shapes and peak localization, and a shift of 37 nm was 
observed for titration mixture of 6-2 (657 nm) over 6-16 (620 nm).  
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Fig 6.15 UV-vis-NIR absorption spectra and fluorescence spectra of 6-8, 6-9 and the 
titration mixture of 6-1 by hydroxyl radical (a); as well as 6-15, 6-16, and the titration 
mixture of 6-2 by hydroxyl radical (b).  
These results somehow evidenced that addition of ‘OH’ groups mainly 
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took place at sites as described in Fig 6. 16, and the additive reaction process 
can be further followed by both time-dependent absorbing and fluorescent 
titration curves. After adding 20 equivalent of hydroxyl radical, the absorption 
band at long wavelength region gradually decreased and the absorption band 
at around 550 nm increased for both di-BODIPY isomers, accompanying an 
increment in fluorescence intensity. The obvious color change and the 
enhancement in fluorescence intensity at around 650 nm have realized 
selective detection for hydroxyl radical.  


















































































































Fig 6.16 Time-dependent UV-vis-NIR absorption and fluorescence spectra of 6-1, 6-2 
after titration by 20 equivalents of hydroxyl radical, and the possible resulting 




In summary, two novel fully-conjugated quinoidal di-BODIPY isomers 
6-1 and 6-2 were prepared for the first time by an intramolecular 
Friedel-Crafts followed by oxidative dehydrogenation strategy. Their 
electronic structures in the ground state were systematically studied by various 
experimental methods and DFT calculations, and the results clearly 
demonstrated that both isomers featured as closed-shell species in ground state, 
and a much greater biradical character for  6-2 in comparison to 6-1. These 
fully conjugated BODIPY dimers showed intense long-wavelengthabsorption 
beyond 1000 nm, and the adequately located HOMO energy levels induced by 
the electron deficient ‘BODIPY’ subunits guarantee their good stabilities.  
From another perspective, benefiting from the highly fluorescent 
fluorophore embedded quinoidal structure, good stability, biradical 
characteristics, and unique spin distribution, these two BODIPY dimers 
functionalized as fluorescent turn-on probes for selective detection of 
hydroxyl radical over other reactive oxygen species, and gave 40 fold and 100 
fold fluorescence enhancement at around 650 nm for 6-1 and 6-2, respectively. 
This represents the first example of using quinoidal biradicaloids as 
fluorescence turn-on probes, which may open new gate for their applications 
in fluorescent imaging areas.  
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6.4 Experimental Section 
6.4.1 General Experimental Methods  
All reagents were purchased from commercial suppliers and used as 
received without further purification. Anhydrous dichloromethane (DCM) was 
distilled from CaH2, anhydrous THF and toluene were distilled from sodium. 
The 
1
H NMR and 
13
C NMR spectra were recorded in solution of CDCl3 on 
Bruker DPX 300 or DRX 500 NMR spectrometers with tetramethylsilane 
(TMS) as the internal standard. The following abbreviations were used to 
explain the multiplicities: s = singlet, d = doublet, t = triplet, m = multiplet. 
MALDI-TOF mass spectra (MS) were recorded on a Bruker Autoflex 
instrument using anthracene-1, 8, 9-triol as matrix. HR-APCI mass spectra 
were recorded on MicrOTOF-Q II 10269 mass spectrometer. HR-EI mass 
spectra were recorded on Agilent 5975C DIP/MS mass spectrometer. 
UV-vis-NIR absorption spectra were recorded on a Shimadzu UV-1700 and 
UV-3600 spectrometer. Fluorescence spectra were recorded at 5301 
fluorometer. The solvents used for UV-vis and fluorescence measurements are 
of HPLC grade. The electrochemical measurements were carried out in 
anhydrous DCM with 0.1 M tetrabutylammonium hexafluorophosphate 
(Bu4NPF6) as the supporting electrolyte at a scan rate of 0.05 V/s at room 
temperature under the protection of nitrogen.  
The femtosecond time-resolved transient absorption spectrometer used 
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for this study consisted of a femtosecond optical parametric amplifier 
(Quantronix, Palitra-FS) pumped by a Ti:sapphire regenerative amplifier 
system (Quantronix, Integra-C) operating at 1 kHz repetition rate and an 
accompanying optical detection system. The generated OPA pulses had a 
pulse width of ~100 fs and an average power of 1 mW in the range 450 to 800 
nm, which were used as pump pulses. White light continuum (WLC) probe 
pulses were generated using a sapphire window (2 mm thick) by focusing of 
small portion of the fundamental 800 nm pulses, which were picked off by a 
quartz plate before entering into the OPA. The time delay between pump and 
probe beams was carefully controlled by making the pump beam travel along a 
variable optical delay (Newport, ILS250). Intensities of the spectrally 
dispersed WLC probe pulses were monitored by miniature spectrograph 
(Ocean Optics, USB2000+). To obtain the time-resolved transient absorption 
difference signal (ΔA) at a specific time, the pump pulses were chopped at 25 
Hz and absorption spectra intensities were saved alternately with or without 
pump pulse. Typically, 6000 pulses were used excite samples and to obtain the 
TA spectra at a particular delay time. The polarization angle between pump 
and probe beam was set at the magic angle (54.7
o
) using a Glan-laser polarizer 
with a half-wave retarder to prevent polarization-dependent signals. The 
cross-correlation fwhm in the pump-probe experiments was less than 200 fs, 
and chirp of WLC probe pulses was measured to be 800 fs in the 400 -800 nm 
regions. To minimize chirp, all reflection optics were used in the probe beam 
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path, and a quartz cell of 2 mm path length was employed. After completing 
each set of fluorescence and TA experiments, the absorption spectra of all 
compounds were carefully checked to rule out the presence of artifacts or 
spurious signals arising from, for example, degradation or photo-oxidation of 
the samples in question.  
The two-photon absorption spectrum was measured in the NIR region 
using the open-aperture Z-scan method with 130 fs pulses from an optical 
parametric amplifier (Light Conversion, TOPAS) operating at a repetition rate 
of 2kHz generated from a Ti:sapphire regenerative amplifier system 
(Spectra-Physics, Hurricane). After passing through a 10 cm focal length lens, 
the laser beam was focused and passed through a 1 mm quartz cell. Since the 
position of the sample cell could be controlled along the laser beam direction 
(z axis) using the motorcontrolled delay stage, the local power density within 
the sample cell could be simply controlled under constant laser intensity. The 
transmitted laser beam from the sample cell was then detected by the same 
photodiode as used for reference monitoring. The on-axis peak intensity of the 
incident pulses at the focal point, I0, ranged from 40 to 60 GW·cm
-2
. For a 
Gaussian beam profile, the nonlinear absorption coefficient can be obtained by 





where α0 is the linear absorption coefficient, l is the sample length, and 
z0is the diffraction length of the incident beam. After the nonlinear absorption 
coefficient has been obtained, the TPA cross section σ(2) of one solute 




can be determined by using the following relationship: 
 
Where NA is the Avogadro constant, d is the concentration of the 
compound in solution, h is the Planck constant, and ν is the frequency of the 
incident laser beam. 
Density functional theory calculations were employed with Gaussian 09 
package, utilizing the UB3LYP/6-31G**level of theory for all molecules in 
the gas phase.
33 









 were synthesized according to the literature 
procedure. 
Synthesis of compound 6-5: Compound 6-3 (800 mg, 2.12 mmol) was 
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dissolved in 20 ml of anhydrous THF, the solution was then cooled to -78゜C 
with acetone/dry ice bath. n-BuLi solution (2.5 M, 2.54 mL, 6.35 mmol) was 
added dropwise under -78゜C. The reaction mixture was allowed to stir in -78
゜C for 2 hour, then a THF solution (10 mL) of 4-tert-butyl-benzaldehyde 
(1.02 g, 6.35 mmol) was added dropwise. The reaction mixture was slowly 
warmed to room temperature, and stirred for an additional 12 hours at room 
temperature. Subsequently, the reaction was quenched by water, extracted by 
ethyl acetate and dried over Na2SO4. The organic solvent was then removed 
and the residue was dried under vacuum and then re-dissolved in the mixed 
solvents of anhydrous THF (20 ml) and DMF (5 ml). To the resulting solution 
was added NaH (256 mg, 6.4 mmol, 60% in mineral oil) at 0 °C. After stirring 
for 30 min, CH3I (1.80 g, 12.7 mmol) was added at 0 °C under Argon. The 
reaction mixture was stirred at room temperature for 12 h under Argon. 
Subsequently, the reaction mixture was carefully quenched with H2O (10 mL), 
then extracted with EtOAc (2 × 30 mL). The organic layer was washed with 
brine, dried over Na2SO4, and concentrated in vacuo. The residue was purified 
by column chromatography (n-hexane/EtOAc) to afford one pure isomer of 
6-5 (243 mg, 20%) as a white solid. 
1
H NMR (300 MHz, CDCl3 ) δ = 7.63 (s, 
2H), 7.25 – 7.10 (m, 8H), 5.91 (s, 2H), 5.67 (s, 2H), 4.04 – 3.84 (m, 8H), 3.29 
(s, 6H), 1.21 (s, 18H) ppm. 
13
C NMR (75 MHz, CDCl3) δ = 150.13, 139.27, 
138.19, 136.13, 127.05, 125.61, 125.10, 101.47, 80.47, 65.01, 64.91, 57.10, 
34.38, 31.26, 29.63 ppm. HR-MS (EI): m/z = 574.3288 [M]
+
, calcd. for 
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C36H46O6: m/z = 574.3294.  
Synthesis of compound 6-6:  A magnetically stirred solution of 6-5 (200 mg, 
0.348 mmol) in a water/acetone mixture (2.5:5 mL) was treated with a little 
amount of p-toluenesulfonic acid in one portion at room temperature. The 
resulting suspension was heated at reflux for 3 h before being extracted with 
diethyl ether (3×15 mL). The combined organic fractions were washed with 
brine, dried over MgSO4, filtered and concentrated under reduced pressure to 
afford a crude solid. Subjection of this material to flash chromatography 
(Hexane / EtOAc 17:3) and concentration of the appropriate fractions afforded 
the corresponding di-aldehyde structure 6-6 as a white solid (161 mg, 95%).
1
H 
NMR (300 MHz, CDCl3) δ = 10.37 (s, 2H), 8.19 (s, 2H), 7.35 (dd, J =19.9 Hz, 
8.2 Hz, 8H), 6.14 (s, 2H), 3.43 (d, J = 4.8 Hz, 6H), 1.33 (s, 18H) ppm.
 13
C 
NMR (75 MHz, CDCl3) δ = 192.82, 151.64, 144.28, 137.87, 137.13, 132.31, 
127.77, 126.18, 81.32, 57.90, 35.20, 31.96 ppm. HR-MS (EI): m/z = 486.2773 
[M]
+
, calcd. for C32H38O4: m/z = 486.2770. 
Synthesis of compound 6-13: Compound 6-10 (800 mg, 2.12 mmol) was 
dissolved in 20 ml of anhydrous THF, the solution was then cooled to -78゜C 
with acetone/dry ice bath. n-BuLi solution (2.5 M, 2.54 mL, 6.35 mmol) was 
added dropwise under -78゜C. The reaction mixture was allowed to stir in -78
゜C for 2 hour, then a THF solution (10 mL) of 4-tert-butyl-benzaldehyde 
(1.02 g, 6.35 mmol) was added dropwise. The reaction mixture was slowly 
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warmed to room temperature, and stirred for an additional 12 hours at room 
temperature. Subsequently, the reaction was quenched by water, extracted by 
ethyl acetate and dried over Na2SO4. The organic solvent was then removed 
and the residue was dried under vacuum and then re-dissolved in the mixed 
solvents of anhydrous THF (20 ml) and DMF (5 ml). To the resulting solution 
was added NaH (256 mg, 6.4 mmol, 60% in mineral oil) at 0 °C. After stirring 
for 30 min, CH3I (1.80 g, 12.7 mmol) was added at 0 °C under Argon. The 
reaction mixture was stirred at room temperature for 12 h under Argon. 
Subsequently, the reaction mixture was carefully quenched with H2O (10 mL), 
then extracted with EtOAc (2 × 30 mL). The organic layer was washed with 
brine, dried over Na2SO4, and concentrated in vacuo. The residue was then 
directly used for the next step without further purification.  
A magnetically stirred solution of the previously resulting residue (200 
mg, 0.348 mmol) in a water/acetone mixture (2.5:5 mL) was treated with a 
little amount of p-toluenesulfonic acid in one portion at room temperature. The 
resulting suspension was heated at reflux for 3 h before being extracted with 
diethyl ether (3×15 mL). The combined organic fractions were washed with 
brine, dried over MgSO4, filtered and concentrated under reduced pressure to 
afford a crude solid. Subjection of this material to flash chromatography 
(Hexane / EtOAc 17:3) and concentration of the appropriate fractions afforded 
the corresponding di-aldehyde structure 6-13 as a white solid (185 mg, 18% 
overall yield in three steps). 
1
H NMR (300 MHz, CDCl3) δ = 10.19 (s, 2H), 
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8.21 (ss, 2H), 7.25 (d,  J = 8.5 Hz, 8H), 6.12 (s, 2H), 3.35 (s, 6H), 1.23 (s, 
20H) ppm.
 13
C NMR (75 MHz, CDCl3) δ = 191.13, 150.91, 149.37, 137.14, 
136.63, 132.57, 127.32, 127.13, 125.43, 80.97, 57.13, 34.45, 31.20 ppm. 
HR-MS (EI): m/z = 486.2777 [M]
+
, calcd. for C32H38O4: m/z = 486.2770. 
General Procedure for Synthesis of BODIPY structures: To a solution of 
corresponding di-aldehyde compounds (6-6 or 6-13) (150 mg, 0.309 mmol) 
and 2-ethylpyrrole (147 mg, 1.54 mmol) in degassed anhydrous DCM (50 mL) 
was added four drops of TFA. The reaction mixture was stirred at room 
temperature for four hours under nitrogen atmosphere. Then DDQ (141 mg, 
0.79 mmol) was added, and the solution was stirred at room temperature for 
another 2 h under nitrogen atmosphere and then quenched by addition of a 
saturated NaHCO3 solution. The organic layer was washed with saturated 
brine and dried over anhydrous Na2SO4. The solvent was removed under 
vacuum to afford the crude product of the phenyl-methane bridged structures 
6-7 or 6-14 as brown solids, which was then re-dissolved in anhydrous DCM, 
followed by addition of Et3N (1 mL, excess) at 0゜C. The resulting solution 
was stirred at this temperature for 15 min, until BF3·OEt2 (1 mL, excess) was 
added dropwise, the amount should be strictly controlled for that 
Friedel-Crafts alkylation may take place if too much BF3·OEt2 was added to 
the system. After 2 h, the reaction was quenched by adding a saturated 
NaHCO3 solution, extracted by DCM, and the organic layer was collected and 
washed by brine and dried over anhydrous MgSO4. The solvent was removed 
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under reduced pressure, and the residue was purified by column 
chromatography (silica gel, DCM: hexane = 1:6) to give the desired 
di-BODIPY structures 6-8 and 6-15.  
Compound 6-8: 57 mg, yield 20%.
 1
H NMR (300 MHz, CDCl3) δ = 7.66 (s, 
2H), 7.09 (d, J = 8.3 Hz, 4H), 6.84 (d, J = 8.3 Hz, 4H), 6.77 (d, J = 4.1 Hz, 
2H), 6.40 (d, J = 4.2 Hz, 2H), 5.99 (d, J = 4.2 Hz, 2H), 5.79 (d, J = 4.2 Hz, 
2H), 5.25 (s, 2H), 3.21 – 2.99 (m, 14H), 1.36 (dt, J= 7.6 Hz, 12H), 1.20 (s, 
18H). 
13
C NMR (126 MHz, CDCl3) δ = 164.09, 163.75, 150.33, 140.13, 
139.99, 137.26, 135.11, 133.90, 133.09, 129.88, 129.45, 127.75, 126.92, 
125.08, 117.32, 117.29, 81.20, 56.76, 34.39, 31.23, 22.16, 22.07. HR-MS 
(APCI): m/z = 923.5250 [M+H]
+ 
, calcd. for C56H65B2F4N4O2: m/z = 923.5242. 
Compound 6-15: 72 mg, yield 25%. 
1
H NMR (300 MHz, CDCl3) δ = 8.24 (s, 
1H), 7.16 (d, J = 8.4 Hz, 4H), 7.08 (s, 1H), 6.98 (d, J = 8.3 Hz, 4H), 6.65 (d, J 
= 4.1 Hz, 2H), 6.35 (d, J = 4.2 Hz, 2H), 5.95 (d, J = 4.3 Hz, 2H), 5.81 (d, J = 
4.3 Hz, 2H), 5.30 (s, 2H), 3.21 (s, 6H), 3.05 (m, 8H), 1.41 – 1.28 (m, 12H), 
1.25 (s, 18H) ppm. 
13
C NMR (126 MHz, CDCl3) δ = 164.50, 163.47, 150.43, 
142.64, 139.37, 137.21, 135.07, 133.96, 131.25, 130.60, 130.02, 128.74, 
127.26, 125.09, 123.79, 117.49, 117.23, 81.80, 56.90, 34.44, 31.30, 22.09, 
12.73 ppm. HR-MS (APCI): m/z = 923.5239 [M+H]
+ 
, calcd. for 
C56H65B2F4N4O2: m/z = 923.5242. 
General procedure to synthesize the fully conjugated-BODIPY derivatives 
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6-1 and 6-2: To a stirred solution of 6-8 or 6-15 (120 mg, 0.130 mmol) in 
anhydrous DCM (10 ml), 0.5 ml of BF3·OEt2 was added dropwise under argon 
atmosphere. The mixture was stirred for 20 minutes and then quenched by 
saturated NaHCO3 solution (3x20 mL). After extraction by DCM, the organic 
layer was collected, washed by brine and dried over Na2SO4 and the solvent 
was removed under reduced pressure. The residue (compound 6-9 or 6-16) 
was dried under vacuum and then re-dissolved in 20 mL dry DCM under 
argon atmosphere, followed by adding DDQ (9 mg, 0.04 mmol dissolved in 10 
mL dry toluene) dropwise. Upon addition of DDQ solution, the color of the 
reaction mixture changed slowly from yellow-orange to dark green, and the 
reaction was monitored by TLC until completion. After evaporation of the 
solvent, the residue was purified by column chromatography (silica gel, 
hexane/chloroform (3/1, v/v)) to give compound 6-1 or 6-2.  
Compound 6-1: 31 mg, 28%. 
1
H NMR (300 MHz, CDCl3 ) δ = 8.80 (s, 2H), 
7.71 (d, J = 8.1 Hz, 4H), 7.52 (d, J = 8.2 Hz, 4H), 6.84 (d, J = 3.1 Hz, 2H), 
6.29 (d, J = 6.7 Hz, 4H), 3.09 (dd, J= 7.8 Hz, 8H), 1.36 (d, J = 7.6 Hz, 12H), 
1.30 (s, 18H) ppm. Due to strong aggregation of compound 6-1, the carbon 
NMR spectrum cannot be obtained even after scan for 24 hours. HR-MS 
(APCI): m/z = 857.4553 [M+H]
+ 
, calcd. for C54H55B2F4N4: m/z = 857.4560. 
Compound 6-2: 50 mg, 45%. 
1
H NMR (300 MHz, CDCl3) δ = 8.65 (s, 1H), 
8.49 (s, 1H), 7.38 (dd, J = 7.8 Hz, 8H), 6.95 (s, 2H), 6.57 (d, J = 3.4 Hz, 2H), 
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6.15 (s, 2H), 3.12 (m, 4H), 2.96 (m, 4H), 1.37 – 1.24 (m, 30H) ppm. 13C NMR 
(126 MHz, CDCl3) δ = 157.98, 157.94, 156.38, 152.19, 149.68, 145.95, 
140.85, 139.64, 132.92, 131.93, 131.47, 129.64, 126.56, 125.30, 124.52, 
124.15, 122.54, 117.20, 107.72, 33.90, 30.31, 28.68, 21.14, 20.38, 11.97, 
11.40 ppm. HR-MS (APCI): m/z = 857.4596 [M+H]
+ 
, calcd. for 















1. HR-Mass (APCI) spectra of 6-8 (a), 6-15 (b), 6-1 (c), 6-2 (d). 
(i) HR-Mass (APCI) spectra of 6-8. 
 




(k) HR-Mass (APCI) spectra of 6-1. 
 





2. 1H-NMR and 13C-NMR spectra of compounds 6-8, 6-15, 6-1, 6-2:  
1
H NMR (300 MHz, CDCl3) spectrum of compound 6-8: 
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H NMR (300 MHz, CDCl3) spectrum of compound 6-15: 
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H NMR (300 MHz, CDCl3) spectrum of compound 6-1: 
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